US20060200089A1 - Positive flow valve - Google Patents

Positive flow valve Download PDF

Info

Publication number
US20060200089A1
US20060200089A1 US11/417,773 US41777306A US2006200089A1 US 20060200089 A1 US20060200089 A1 US 20060200089A1 US 41777306 A US41777306 A US 41777306A US 2006200089 A1 US2006200089 A1 US 2006200089A1
Authority
US
United States
Prior art keywords
seal
housing
valve
fluid
medical implement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/417,773
Inventor
George Lopez
Thomas Fangrow
David Arnold
Bruce Hubrecht
Alison Brummett
Thomas Gustus
Dennis Bui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25079940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20060200089(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to US11/417,773 priority Critical patent/US20060200089A1/en
Publication of US20060200089A1 publication Critical patent/US20060200089A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/26Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/04Access sites having pierceable self-sealing members
    • A61M39/045Access sites having pierceable self-sealing members pre-slit to be pierced by blunt instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M2039/0036Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use characterised by a septum having particular features, e.g. having venting channels or being made from antimicrobial or self-lubricating elastomer
    • A61M2039/0072Means for increasing tightness of the septum, e.g. compression rings, special materials, special constructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/26Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • A61M2039/263Valves closing automatically on disconnecting the line and opening on reconnection thereof where the fluid space within the valve is decreasing upon disconnection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/26Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • A61M2039/266Valves closing automatically on disconnecting the line and opening on reconnection thereof where the valve comprises venting channels, e.g. to insure better connection, to help decreasing the fluid space upon disconnection, or to help the fluid space to remain the same during disconnection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/26Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • A61M2039/267Valves closing automatically on disconnecting the line and opening on reconnection thereof having a sealing sleeve around a tubular or solid stem portion of the connector

Definitions

  • This invention relates generally to a medical valve, and in particular to a positive flow valve which, when connected between a medical implement and a catheter to facilitate fluid flow therethrough, induces a positive flow of fluid through a tip of the catheter from the valve upon disconnection of the medical implement, thereby eliminating the problem of blood-clogging or clotting in the catheter.
  • Fluid connectors and valves typically employ needles or luers to pierce a septum or seal covering sterile tubing or to pierce a septum or seal of a medicament container of fluid. Fluid then passes from the container or fluid-filled tubing into a syringe or second set of tubing. Since the ready passage of fluids through the connectors and valves is often critical to patient survival, it is imperative that the connectors and valves function reliably and repeatedly. Connectors and valves that malfunction during use may be life-threatening.
  • a suction force is generated by the withdrawal of the medical implement which draws blood from the patient into the catheter.
  • This blood clot and clog the catheter near its tip rendering it inoperable, and may even result in a clot of blood in the patient, which may prove fatal.
  • Attempts to avoid backflash by coating the inner surface of the catheter near its tip in order to prevent blood from sticking to the interior surfaces of the catheter and clogging it have not been successful.
  • FIG. 1 shows an example of a catheter 50 having a small portion near the tip 52 that is inserted into the patient, and a valve 54 connected between one end of the catheter and a medical implement 56 .
  • FIGS. 2 a and 2 b One way to induce a positive flow in the catheter is illustrated in FIGS. 2 a and 2 b .
  • the proximal end of a valve 180 is enclosed with a stylet or displacer 182 upon withdrawal of the medical implement (not shown).
  • An elongated portion 184 of the stylet 182 takes up at least a portion of the fluid space, thereby reducing the volume of the fluid space, and may eliminate the dead space therein.
  • the elongated portion 184 must be sufficiently long to displace more fluid than that volume of fluid which may be drawn from the catheter towards the valve by the withdrawal of the implement, and hence may be difficult to construct for proper performance.
  • valve 180 has many significant drawbacks, among them the fact that it does not have a seal with a swabbable surface that can be swabbed after each use for sterility.
  • a positive flow valve which is advantageously utilized between a catheter and another medical implement, and with which the flow of a fluid between the implement and catheter (and a patient within which the catheter is employed).
  • the valve of this invention has several features, no single one of which is solely responsible for its desirable attributes.
  • the positive flow valve of the present invention has the attributes of safety, positive flow for eliminating dead space, reliable and repeatable performance, simplicity of manufacture and use, a seal for use in establishing fluid flow which need not be pierced with a sharp spike or cannula, suitability of high pressure applications, and employment of a valve that is swabbable after use to provide sterility and has a fluid-tight seal at high pressure.
  • the present invention is a swabbable, needle-less, positive flow valve that has a fluid space which automatically expands upon insertion of a medical implement and contracts upon withdrawal of the medical implement.
  • the valve When the valve is connected to a catheter, it induces a positive flow from the valve to the catheter tip upon disconnection of the medical implement to avoid the potential problems of blood-clogging.
  • the valve After use, the valve is swabbed in the conventional manner with a suitable substance to maintain sterility.
  • the design of the valve avoids accidental needle or spike sticks.
  • the valve is particularly suited for applications with a catheter where it is desirable to avoid backflash, but may be used for other applications as well.
  • the valve includes a housing having a first end adapted for receiving one end of medical implement, and having a second end in communication with a catheter.
  • the valve includes means for establishing a fluid flow path through the housing and between the medical implement and the catheter, and which is also useful in occluding the flow path through the housing and thereby preventing fluid flow between the medical implement and catheter.
  • this means comprises a seal movably positioned within the housing.
  • the seal has a passage therethrough which defines, in at least one area, a fluid containment area.
  • the seal has a first end adapted for engagement by the medical implement. In a first position, the passage through the seal is closed at its first end, and in a second position, when the medical implement is utilized to press the seal distally within the housing of the valve, the passage through the valve is opened.
  • the fluid containment area therein increases in total volume, thereby retaining a fluid volume therein.
  • the seal returns to its position wherein the passage is closed at the proximal end thereof, and the volume of the fluid containment area is reduced. This reduction in fluid containment volume results in a volume of fluid being forced towards the catheter (i.e. a positive flow is established).
  • FIG. 1 is a schematic cross-sectional view of a valve forming a fluid connection between a syringe and a catheter.
  • FIGS. 2 a and 2 b illustrate a prior art valve which includes a stylet having an elongated portion after use to induce a positive flow.
  • FIG. 3 is a schematic cross-sectional view of a roller-clamp valve which may be manually activated to induce a positive flow through a catheter tip from the valve.
  • FIG. 4 is a longitudinal cross-sectional view of the first embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 5 is a longitudinal cross-sectional view similar to FIG. 4 showing the valve during compression of the seal.
  • FIG. 6 is a longitudinal cross-sectional view of the second embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 7 is a longitudinal cross-sectional view similar to FIG. 6 showing the valve during compression of the seal.
  • FIG. 8 is a longitudinal cross-sectional view of the third embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 9 is a longitudinal cross-sectional view similar to FIG. 8 showing the valve during compression of the seal.
  • FIG. 10 is a longitudinal cross-sectional view of the fourth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 11 is a longitudinal cross-sectional view similar to FIG. 10 showing the valve during compression of the seal.
  • FIG. 12 is a longitudinal cross-sectional view of the fifth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 13 is a longitudinal cross-sectional view similar to FIG. 12 showing the valve during compression of the seal.
  • FIG. 14 is a longitudinal cross-sectional view of the sixth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 15 is a longitudinal cross-sectional view similar to FIG. 14 showing the valve during compression of the seal.
  • FIG. 16 is a longitudinal cross-sectional view of the seventh embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 17 is a longitudinal cross-sectional view similar to FIG. 16 showing the valve during compression of the seal.
  • FIG. 18 is a longitudinal cross-sectional view of the eighth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 19 is a longitudinal cross-sectional view similar to FIG. 18 showing the valve during compression of the seal.
  • FIG. 20 is a longitudinal cross-sectional view of the ninth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 21 is a longitudinal cross-sectional view similar to FIG. 20 showing the valve during compression of the seal.
  • FIG. 22 is a longitudinal cross-sectional view of the tenth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 23 is a longitudinal cross-sectional view similar to FIG. 22 showing the valve during compression of the seal.
  • FIG. 24 is a longitudinal cross-sectional view of the eleventh embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 25 is a longitudinal cross-sectional view similar to FIG. 24 showing the valve during compression of the seal.
  • FIG. 26 is a longitudinal cross-sectional view of the twelfth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 27 is a longitudinal cross-sectional view similar to FIG. 26 showing the valve during compression of the seal.
  • FIG. 28 is a longitudinal cross-sectional view of the thirteenth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 29 is a longitudinal cross-sectional view similar to FIG. 28 showing the valve during compression of the seal.
  • FIG. 30 is a longitudinal cross-sectional view of the fourteenth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 31 is a longitudinal cross-sectional view similar to FIG. 30 showing the valve during compression of the seal.
  • FIG. 32 is a longitudinal cross-sectional view of an alternative seal with a side wall formed with circular tires.
  • a roller clamp may be used to induce a positive flow in a medical valve.
  • the use of a roller clamp in a medical valve 190 to create a positive flow upon disconnection of a medical implement (not shown) is illustrated in FIG. 3 .
  • the roller-clamp valve 190 is activated manually by sliding an external switch 192 to push a roller 194 against tubing 196 which connects a medical implement 198 and a catheter (not shown) to cause a positive pressure therein, thereby creating a positive flow through the catheter tip (not shown).
  • the flow through the tubing 196 can be opened by sliding the switch 192 in the reverse direction.
  • This valve 190 has the same disadvantage of requiring an additional step of operation as does the valve with a stylet illustrated in FIGS. 2 a and 2 b , and also does not include a seal having a swabbable surface. Furthermore, the size of the roller 194 must be sufficiently large to induce a displacement of fluid within the tube which is greater than the amount of fluid which may be drawn by the vacuum force (so as to generate a positive flow), which may require a bulky valve that is hard to operate.
  • FIGS. 4 and 5 illustrate a first embodiment of a valve 210 in accordance with the present invention.
  • this valve 210 includes a valve body or housing 212 , a support member 214 , a seal 216 defining an inner cavity 218 , a pair of clam shells 220 a and 220 b , and a spring 222 . These components are assembled, as depicted in FIG. 4 , without the need for a spike element.
  • the inner cavity 218 forms an expandable fluid space inside the valve 210 .
  • the clam shells 220 a / 220 b are constructed to cause the volume of the fluid space to expand or increase upon insertion of a medical implement and to contract or decrease upon withdrawal of the medical implement.
  • the body or housing 212 has an upper conduit 226 near a proximal end 228 , desirably with a circular opening 230 that is adapted to receive the medical implement.
  • a side wall portion 232 is preferably tapered to cooperate with the clam shells 220 a / 220 b .
  • the body 212 has an upper ledge 234 formed between the proximal end 228 and the side wall portion 232 .
  • proximal is used to denote the end of the valve 210 and other components at or near the body opening 230
  • distal is used to denote the opposite end of the valve.
  • the upper conduit 226 is adapted to receive the tip or nose 236 of an ANSI standard syringe 238 , as shown in phantom in FIG. 5 . It is, however, contemplated that the outer diameter of the upper conduit 226 can be of any size to accommodate the attachment of other connector devices thereto.
  • the proximal end of the upper conduit 226 can be equipped with a locking mechanism to facilitate locking of the valve 210 to a variety of connector devices.
  • the threaded portion of the housing 212 are preferably provided such that the housing 212 can be locked into any compatible Luer-Lock device known to those with skill in the art.
  • the housing 212 of the first embodiment according to this invention includes conventional Luer-Lock threads 240 on the outer diameter of the upper conduit 226 .
  • the support member 214 has at its distal end the inner conduit 242 which may be connected to a terminal end of a catheter (not shown).
  • the support member 214 serves as a support and attachment device for the seal 216 by holding the seal 216 in place inside the internal cavity 244 of the housing 212 .
  • the inner conduit 242 and inner cavity 218 of the seal 216 present a continuous passageway for fluid during use.
  • the seal 216 is prepared from a resilient material that is flexible, inert, and impermeable to fluid, such as silicon.
  • the seal 216 has a seal cap 248 with a generally flat top surface 250 , a shoulder 252 , a side wall 254 , and a base 256 .
  • the side wall 254 advantageously is comprised of wall portions 258 which deform in an accordion-like fashion and assist in the reformation of the seal 216 to close the housing opening 230 upon withdrawal of the syringe 238 .
  • the wall portions 258 expand outwardly in the radial direction.
  • the interior of the seal 216 is hollow to provide the inner cavity 218 , as best seen in FIG. 4 .
  • the shoulder 252 engages the upper ledge 234 provided in the upper conduit 226 of the housing 212 such that the upper ledge 234 confines the movement of the shoulder 252 toward the opening 230 to prevent the seal 216 from being blown through the opening 230 under high pressure in the inner cavity 218 of the seal 216 .
  • the seal cap 248 reseals the valve 210 at the opening 230 , with the top surface 250 of the seal 216 approximately flush with or slightly above or below the opening 230 upon removal of the medical implement 238 .
  • the seal cap 248 substantially fills the opening 230 in the top of the upper conduit 226 .
  • the top surface 250 of the seal cap 248 is essentially flush with the opening 230 , so that the seal cap 248 can be swabbed with alcohol or other disinfectant without leakage of the disinfectant into the valve 210 . Therefore, it is preferable that the top surface 250 be exposed so that it may be swabbed with a disinfectant.
  • the seal cap 248 has a unique shape and includes a precut slit 259 , also having a unique shape.
  • the seal cap 248 desirably has an oval or elliptical shape with a major axis having a length larger than the inner diameter of the circular opening 230 such that the oval seal cap 248 substantially fills the opening 230 in the top of the upper conduit 226 in the decompressed state.
  • the precut slit 259 in the seal cap 248 is squeezed shut by the circular opening 230 in the decompressed state, as seen in FIG. 4 .
  • the precut slit 259 In its resting state, the precut slit 259 is open. During compression of the seal 216 by insertion of a medical implement such as the syringe 238 , as illustrated in FIG. 5 , the precut slit 259 returns to its resting state and opens, as the seal cap 248 is allowed to stretch in the portion of the upper conduit 226 which has a larger inner diameter. Fluid is thus allowed to pass through the slit 259 .
  • the terms “compressed state” and “decompressed state” are used conveniently to refer to compression and decompression of the seal 216 by insertion and withdrawal of the medical implement 238 along the longitudinal axis of the seal 216 . The terms do not relate to the radial compression of the seal cap 248 by the opening 230 of the housing 212 .
  • the seal 216 of FIG. 4 advantageously includes the enlarged, internal, pressure responsive member 260 which is integral with the seal cap 248 .
  • the pressure responsive member 260 enables the valve 210 to maintain a fluid-tight seal even at very high pressures sometimes experienced in medical applications, particularly when the valve 210 is connected to a patient's artery.
  • the clam shells 220 a / 220 b are desirably identical pieces disposed opposite one another symmetrically inside the valve body 212 . They are preferably made of a firm material such as a hard plastic.
  • the external surface 264 a / 264 b of each clam shell 220 a / 220 b is tapered to cooperate with the tapered side wall portion 232 of the housing 212 , and is configured to slide along the side wall portion 232 during compression and decompression.
  • the internal surfaces 266 a / 266 b of the clam shells 220 a / 220 b cooperate with one another to squeeze a portion of the seal side wall 254 , preferably adjacent the shoulder 252 , to form a constricted portion 267 of the seal 216 .
  • the proximal ends 268 a / 268 b of the clam shells 220 a / 220 b engage the shoulder 252 of the seal 216 to facilitate movement of the clam shells 220 a / 220 b with the compression of the seal 216 .
  • the internal surfaces 266 a / 266 b preferably are shaped to cause the constricted portion 267 to be substantially circular.
  • each internal surface 266 a / 266 b has a semi-circular, longitudinal groove that squeezes the seal 216 .
  • the spring 222 is disposed between the distal ends of the clam shells 220 a / 220 b and the base 256 of the seal 216 , but desirably a hard retaining disk 270 is provided adjacent the base 256 of the seal 216 to provide better support for the spring 222 and the seal 216 .
  • the spring 222 may be relaxed or be in slight compression to exert a force on the seal 216 through the clam shells 220 a / 220 b to keep the seal 216 closed.
  • the spring 222 is compressed and stores potential energy from the compression, as illustrated in FIG. 5 .
  • the spring 222 Upon withdrawal of the syringe 238 , the spring 222 releases the potential energy and pushes the clam shells 220 a / 220 b proximally to close the seal 216 , as shown in FIG. 4 .
  • the spring 222 is preferably not attached or bonded to either the clam shells 220 a / 220 b or the retaining disk 270 for ease of assembly.
  • FIGS. 4-5 show a helical spring 222 , any suitable spring known to those of skill in the art may be used.
  • the seal 216 is desirably relaxed longitudinally in the decompressed state ( FIG. 4 ), and compressed longitudinally in the compressed state ( FIG. 5 ).
  • the seal 216 may be stretched longitudinally in tension by the spring 222 in the decompressed state and be relaxed or slightly compressed longitudinal in the compressed state.
  • the base 256 of the seal 216 advantageously fits snugly and securely into a annular groove 274 provided in the retaining disk 270 and an annular groove 276 provided in the support member 214 .
  • the annular grooves 274 , 276 form a locking mechanism to support and secure the seal 216 within the cavity 244 of the housing 212 .
  • FIG. 5 shows the compressed state of the valve 210 upon insertion of the syringe 238 .
  • a medical implement other than a syringe as known to those of skill in the art may be used.
  • the nose 236 of the syringe 238 is placed on the seal cap 248 inside the opening 230 of the housing 212 .
  • the application of pressure on the syringe 238 creates pressure on the seal cap 248 , and the resulting downward pressure compresses the seal 216 . This pushes the seal cap 248 away from the circular opening 230 and toward the lower portion of the housing cavity 244 which has a larger inner diameter, thereby allowing the precut slit 259 to open.
  • FIG. 5 shows the valve 210 opened by insertion of the nose 236 of the syringe 238 into the opening 230 .
  • the valve 210 can be oriented in the position diagramed in FIGS. 4 and 5 , or it can be rotated 180 ′ such that fluid flows in the opposite direction.
  • the inner cavity 218 of the seal 216 In the compressed state shown in FIG. 5 , the inner cavity 218 of the seal 216 generally contracts (becomes shorter) as compared to the decompressed state shown in FIG. 4 .
  • the constricted portion 267 of the inner cavity 218 defined by the clam shells 220 a / 220 b , however, expands (becomes larger) in volume when the seal 216 is in the compressed state. This results from a movement of the clam shells 220 a / 220 b apart from one another as they slide along the tapered side wall 232 of the housing 212 .
  • the amount of general contraction of the seal 216 in relation to the amount of expansion of the constricted portion 267 during compression determine whether the valve 210 generates a positive, negative, or zero flow upon decompression, as discussed below.
  • the seal 216 Upon removal of the syringe 238 from the upper conduit 226 , as shown in FIG. 4 , the seal 216 is free to move toward its decompressed state, and the clam shells 220 a / 220 b are pushed proximally toward the opening 230 .
  • the movement causes a general expansion of the inner cavity 218 (i.e., the cavity increases in length), but causes a contraction (i.e., reduction in size) of the volume of the constricted portion 267 of the seal 216 . If the volume change associated with the contraction of the constricted portion 267 equals the volume change associated with the expansion of the inner cavity 218 , the fluid space or inner cavity will have zero flow.
  • valve 210 to be a positive-flow valve requires that the clam shells be configured to allow greater expansion of the constricted portion 267 (i.e., an increase in fluid volume in that area of the seal 216 ) than the general contraction volume change associated with the expansion of the inner cavity 218 of the seal 216 upon compression and, hence, greater contraction (i.e., decrease in fluid volume within that area of the seal) of the constricted portion 267 than the general expansion (i.e., increase in fluid volume in that area of the seal) of the seal 216 upon decompression.
  • the valve 210 to induce positive flow upon disconnection of the medical implement 238 therefrom, the total fluid volume within the valve 210 must decrease.
  • this decrease in fluid volume is effectuated by causing the fluid volume within the seal to decrease as between its compressed (when syringe attached) and uncompressed (when syringe detached) states.
  • This reduction or decrease in available fluid volume within the valve 210 causes fluid to flow towards the catheter/patient, preventing blood from being drawn into the catheter.
  • valve 210 is advantageously configured to be a positive-flow valve 210 eliminates any dead space during decompression of the seal 210 as the syringe 238 is withdrawn, as illustrated in FIG. 4 . Furthermore, as the syringe 238 is withdrawn, the slit 259 remains open until the very end, i.e., until the seal cap 248 is squeezed by the circular opening 230 at the top of the upper conduit 226 . This further assists in eliminating dead space and avoiding backflash. This feature is particularly advantageous in the case where the valve 210 is connected through a catheter to a patient, because it prevents blood from being drawn into the catheter and clogging it. This invention therefore eliminates a significant risk by solving the problem of backflash.
  • the seal 216 As the seal 216 is free to move to its decompressed state, it essentially fills the opening 230 .
  • the ability of the seal 216 to return to its original shape and be deformed in its decompressed state is determined by the resiliency of the material used to prepare the seal 216 .
  • the ability of the seal 216 to return to its decompressed state is facilitated by the spring 222 and the gaps between the wall portions 258 of the seal 216 .
  • the ability of the seal 216 to deform reversibly and return to its decompressed state is particularly useful because (1) it immediately stops fluid flow through the valve 210 , and (2) it maintains sterility of the valve.
  • the ability of the seal 216 to return reversibly to its decompressed state permits reuse of the valve 210 .
  • the surface 250 of the seal cap 248 is essentially flush with the opening 230 of the housing 212 .
  • this flush surface 250 can advantageously be sterilized with alcohol or other surface-decontaminating substances.
  • the support member 214 and body 212 advantageously shield both connections from the surrounding environment to protect the sterility of the connection.
  • a cover cap (not shown) can be supplied to fit over the upper conduit 226 as further protection for the surface 250 of the seal cap 248 when not in use. Such a cover cap, however, is not needed to maintain sterility since the seal 216 may be swabbed with a disinfectant before and/or after each use. Reversibility of the seal 216 makes the valve 210 particularly attractive as a connector valve to provide fluid communication between two fluid lines. Therefore, the present invention provides for placing a first fluid line in communication with a second fluid line using the valve 210 disclosed herein. The reversibility of the valve 210 permits multiple fluid lines to be successively added, for example, to a fluid line in direct communication with a patient's vein. Since the valve 210 is easily sterilized and sealable, fluid lines can be added and removed without disconnecting venous contact of the catheter.
  • valve body 212 and support member 214 are preferably prepared from a hard plastic, but it is additionally contemplated that the valve 210 could be prepared from other medically inert materials known to those skilled in the art.
  • Another feature of this invention is that it relies neither on a needle nor on a spike in order to establish fluid flow through the valve. This completely eliminates the risk of skin puncture or fear of puncture during use and manufacture. It also eliminates coring of the seal 216 by a spike element and all the risks associated therewith. Further, the fluid flow rate is not limited by the size of a through passage in a needle or spike, as is the case in some prior art valves.
  • the upper ledge 234 confines the movement of the shoulder 252 toward the opening 250 to prevent the seal 216 from being blown through the opening 230 under high pressure in the cavity 218 . This makes the valve 210 particularly suited for high pressure applications.
  • the valve 310 includes a valve body or housing 312 , a support member 314 , a skirt 316 , a seal 318 , a resilient member 320 , and a pair of clam shells 322 a / 322 b .
  • the housing 312 is desirably similar to the housing 212 of FIG. 4 and has a tapered side wall 324 .
  • the second embodiment of the valve 310 has a bell-shaped skirt 316 .
  • the skirt 316 has an annular ring 328 which is disposed toward an inner conduit 330 of the support member 314 .
  • the skirt 316 creates a shield for the inner conduit 330 .
  • This inner conduit 330 is preferably cylindrical in shape and slightly tapered.
  • the inner conduit may be connected to a terminal end of a catheter (not shown), which has an opposite, open end that is generally inserted into a patient.
  • the support member 314 serves as a support and attachment device for the seal 318 by holding the seal 318 in place inside the housing 312 .
  • the support member 314 also serves as a support and attachment device for the skirt 316 .
  • the support member 314 has an edge portion 332 which engages a ledge 334 of the skirt 316 in assembly. This attachment secures the skirt 316 in place.
  • the skirt 316 desirably includes a Luer-Lock portion 336 that enables the valve 310 to be removably attached to, for example, a fluid line or catheter connected to a patient.
  • the valve 310 in this embodiment includes a skirt 316 separate from the housing 312 for ease of assembly.
  • a different embodiment can provide a unitary member which replaces the housing 312 and skirt 316 . It is therefore contemplated that such an embodiment would fall within the scope of this invention.
  • the seal 318 is similar to the seal 210 of FIG. 4 .
  • the seal 318 is also preferably silicon and has a similar seal cap 340 with a precut slit 342 , shoulder 344 , and pressure responsive member 348 . These components serve the same function as those of the seal 210 .
  • the seal 318 has a side wall 350 that is generally circular cylindrical and has a distal portion 352 that is sized to be slip-fitted with the proximal end 354 of the inner conduit 330 of the support member 314 . During compression of the seal 318 , the side wall 350 simply slides over the proximal end 354 of the inner conduit 330 , forming a fluid-tight seal therewith.
  • the seal 318 defines an inner cavity 358 above the proximal end 354 of the inner conduit 330 .
  • the inner cavity 358 forms an expandable fluid space inside the valve 310 .
  • the inner conduit 330 and inner cavity 358 comprise aligned hollow tubes in fluid communication with each other when the precut slit 342 of the seal 318 opens during compression of the seal 310 .
  • the clam shells 322 a / 322 b are constructed to cause an increase in fluid space upon insertion of a medical implement into the valve 310 and a decrease in fluid space upon withdrawal of the medical implement such as a syringe 362 partially shown in phantom in FIG. 7 .
  • the internal surfaces 364 a / 364 b of the clam shells desirably have longitudinal grooves that cooperate with one another to squeeze a portion of the seal side wall 350 to form a constricted portion 366 thereof.
  • the second embodiment employs the resilient member 320 disposed between the clam shells 322 a / 322 b and the support member 314 .
  • the resilient member 320 advantageously is inert and impermeable to fluid such as silicon, and includes wall portions 368 which deform in an accordion-like fashion and assist in the reformation of the seal 318 to close the housing opening 370 upon withdrawal of the syringe 362 .
  • the resilient member 320 thus is similar in construction with and serves the same function as the spring 222 of the seal 210 of FIGS. 4 and 5 . It is contemplated that a spring (not shown) similar to the spring 222 of FIG. 4 may be used in place of the resilient member 320 , as may other suitable structures known to those of skill in the art.
  • the resilient member 320 has a base 346 .
  • the base 346 fits snugly and securely within an annular groove 374 provided in the housing 312 and an annular groove 377 provided in the support member 314 , as shown in FIG. 6 .
  • the annular grooves 376 , 377 hence form a locking mechanism to support and secure the resilient member 320 within the housing 312 .
  • the shoulder 344 engages an upper ledge 382 provided in an upper conduit 384 of the housing 312 such that the upper ledge 382 confines the movement of the shoulder 344 toward the opening 370 to prevent the seal 318 from being blown through the opening 370 under high pressure in the inner cavity 358 of the seal 318 .
  • the resilient member 320 is desirably relaxed or slightly compressed longitudinally in the decompressed state ( FIG. 6 ), and compressed longitudinally in the compressed state ( FIG. 7 ).
  • the resilient member 320 is desirably not attached or bonded to either of the clam shells 322 a / 322 b or the housing 312 .
  • FIG. 7 illustrates compression and FIG. 6 illustrates decompression during valve activation.
  • the syringe 362 is placed on the seal cap 340 inside the opening 370 of the housing 312 , and the application of pressure on the syringe 362 creates pressure on the seal cap 340 .
  • the downward pressure pushes the seal cap 340 away from the circular opening 370 and toward the distal lower portion of the housing 312 which has a larger inner diameter, thereby allowing the precut slit 342 to open.
  • the side wall 350 slides over the proximal end 354 of the inner conduit 330 , and the resilient member 320 deforms in an accordion-like manner, storing potential energy of the compression. Fluid is able to flow into the syringe 362 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 318 shown in FIG. 7 generally causes a contraction or reduction in the volume of the inner cavity 358 of the seal 318 .
  • the valve 310 has a net gain in volume of the inner cavity 318 , however, because the general reduction in volume within the inner cavity 358 is less than an increase in volume within the constricted portion 366 of the inner cavity 358 defined by the clam shells 322 a / 322 b .
  • the expansion results from the movement of the clam shells 322 a / 322 b apart from one another during compression, facilitated by the tapered side wall 324 of the housing 312 .
  • FIG. 6 illustrates the valve after withdrawal of the syringe 362 .
  • the seal 318 returns to its decompressed state and essentially fills the opening 370 , and the clam shells 322 a / 322 b are pushed proximally toward the opening 370 by the resilient member 320 . Because of the contraction of the inner cavity 358 at the constricted portion 366 by the clam shells 322 a / 322 b , there is a net loss or reduction in fluid space, resulting in a positive flow from the valve 310 through, e.g., a catheter tip (not shown).
  • the positive-flow valve 310 advantageously eliminates any dead space during decompression of the seal 318 . This is further assisted by the seal 318 with the slit 342 remaining open until the very end, i.e., until the seal cap 340 is squeezed by the upper conduit 384 .
  • valve 310 can be reused because the seal 318 can return reversibly in the decompressed state.
  • the seal surface 340 is also swabbable for sterility. Other features of the valve 310 are discussed previously in connection with the first embodiment of this invention and will not be repeated.
  • a third embodiment of the valve 410 of the present invention comprises a valve body or housing 412 , a support member 414 , a flexible tubing 416 , a seal 418 , a ring member 420 , a pair of clam shells 422 a / 422 b , and a spring 424 .
  • the flexible tubing 416 may be connected to a catheter (not shown) and, together with the seal 418 , defines an inner cavity 426 .
  • the inner cavity 426 forms an expandable fluid space of the valve 410 .
  • the clam shells 422 a / 422 b desirably are substantially the same as the clam shells 220 a / 220 b of FIG.
  • the housing 412 is desirably similar to the housing 212 of FIG. 4 .
  • the support member 414 has a hollow center 430 which supports the flexible tubing, and a proximal end 432 which encloses a distal end 434 of the housing 412 .
  • the support member 414 desirably locks onto the housing 412 via any method known to those of skill in the art.
  • the proximal end 432 of the support member 414 supports the spring 424 , which in turn supports the clam shells 422 a / 422 b and seal 418 .
  • the seal 418 is prepared from a resilient material that is flexible, inert, and impermeable to fluid, such as silicon. Referring to FIG. 8 , the seal 418 is substantially similar to the seal 210 of FIG. 4 , with a portion of the side wall 438 cut off near the shoulder 440 region. As a result, the side wall 438 of the seal 418 is substantially shorter than the side wall 254 of the seal 210 in FIG. 4 . A distal end 442 of the side wall 254 is attached, preferably by adhesive, to a proximal end 444 of the flexible tubing 416 .
  • the distal end 442 abuts the ring member 420 which is disposed between the seal 418 and the clam shells 422 a / 422 b and attached at its inner surface 446 to a portion of the tubing 416 , desirably also by adhesive. Other suitable means of attachment may be used.
  • the ring member 420 is desirably made of polycarbon.
  • the clam shells 422 a / 422 b desirably form a sliding contact at their proximal ends with the ring member 420 for ease of assembly, but may alternatively be affixed to the ring member 420 by adhesive or similar means.
  • the clam shells 422 a / 422 b are desirably the same as the clam shells 220 a / 220 b of FIG. 4 , having tapered external surfaces 450 a / 450 b to cooperate with the tapered side wall portion 452 of the housing 412 for sliding and grooved internal surfaces 454 a / 454 b that cooperate with one another to squeeze a portion of the tubing 416 to form a constricted portion 456 .
  • the spring 424 is substantially the same as the spring 222 of FIG. 4 and serves the same function, being disposed between the distal ends of the clam shells 422 a / 422 b and the proximal end 432 of the support member 414 .
  • the spring 424 may be relaxed or in slight compression to exert a force on the seal 418 through the clam shells 422 a / 422 b to keep the slit 466 in the seal cap 460 closed.
  • the spring 424 is compressed and stores potential energy from the compression, as illustrated in FIG. 9 .
  • the spring 424 Upon withdrawal of the syringe 428 , the spring 424 releases the potential energy and pushes the clam shells 422 a / 422 b proximally to close the seal 418 , as shown in FIG. 8 .
  • the spring 424 is preferably not attached or bonded to either the clam shells 422 a / 422 b or the support member 414 for ease of assembly.
  • the spring 424 can be a helical spring or any other suitable spring known to those with skill in the art.
  • FIG. 9 shows the compressed state of the valve 410 upon insertion of the syringe 428 .
  • the syringe 428 is placed on the seal cap 460 inside the opening 464 of the housing 412 and the application of pressure on the syringe 428 creates pressure on the seal cap 460 .
  • the downward pressure pushes the seal cap 460 away from the circular opening 464 and toward the distal end of the housing 412 , which has a larger inner diameter, thereby allowing the precut slit 466 of the seal cap 460 to open.
  • the resilient tubing 416 and the clam shells 422 a / 422 b also move distally as the spring 424 deforms in compression, storing potential energy. Fluid is able to flow into the syringe 428 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 418 shown in FIG. 9 generally causes a reduction in the volume of the inner cavity 426 formed by the seal 418 and tubing 416 .
  • the valve 410 has a net gain in fluid volume.
  • the increase in fluid volume results from the movement of the clam shells 422 a / 422 b apart from one another during seal compression, facilitated by the tapered side wall 452 of the housing 412 and resiliency of the tubing 416 .
  • FIG. 8 illustrates the valve 410 after withdrawal of the syringe 428 .
  • the seal 418 returns to its decompressed state and essentially fills the opening 464 , and the clam shells 422 a / 422 b are pushed proximally toward the opening 464 by the spring 424 .
  • the positive-flow valve 410 advantageously eliminates any dead space during decompression of the seal 418 . This is further assisted by the seal 418 , with the slit 466 remaining open until the very end, i.e., until the seal cap 460 is squeezed by upper conduit 470 .
  • valve 410 can be reused because the seal 418 can return reversibly to the decompressed state.
  • the seal surface 472 is also swabbable for sterility. Other features of the valve 410 are discussed previously in connection with the earlier embodiments of this invention and will not be repeated.
  • a valve 510 comprises a valve body or housing 512 , a support member 514 , a skirt 516 , a retaining member 518 , a seal 520 , a pair of clam shells 522 a / 522 b , and a resilient member 524 .
  • the valve 510 has several features that are the same or similar to those of the valve 310 of FIGS. 8 and 9 , having a similar resilient member 524 and clam shells 522 a / 522 b .
  • the clam shells 522 a / 522 b have internal surfaces 526 a / 526 b that cooperate with one another to squeeze a portion of the seal side wall 528 to form a constricted portion 530 thereof.
  • the seal 510 is preferably made of silicon and has a seal cap 532 with a precut slit 534 , shoulder 536 , lower lip 538 , and pressure responsive member 540 that are similar to the seal 210 of FIG. 4 . These components serve the same function as those of the seal 210 .
  • the side wall 528 may be formed with ringed wall portions 258 , as in the seal 210 , but FIG. 4 shows the side wall 528 that is generally circular cylindrical.
  • the seal 520 defines an inner cavity 542 which forms an expandable fluid space inside the valve 510 .
  • the side wall 528 deforms outwardly into a circumferential cusp or bulge 544 in the unconstricted region between the clam shells 522 a / 522 b and the support member 514 .
  • the side wall 528 returns to its decompressed shape upon decompression of the seal 520 .
  • the seal 520 is desirably relaxed longitudinally in the decompressed state ( FIG. 10 ), and compressed longitudinally in the compressed state ( FIG. 11 ).
  • the seal 520 may be stretched longitudinally in tension by the resilient member 524 in the decompressed state and be relaxed or slightly compressed longitudinal in the compressed state.
  • the skirt 516 is a bell-shaped skirt that is similar to the skirt 316 of FIG. 8 .
  • the skirt 516 creates a shield for an inner conduit 548 of the support member 514 .
  • the inner conduit 548 may be connected to a terminal end of a catheter (not shown) which has an open end that is generally inserted into a patient.
  • the support member 514 serves as a support and attachment device for the seal 520 by holding the seal 520 in place inside the housing 512 .
  • the support member 514 also serves as a support and attachment device for the skirt 516 . Similar to the valve 310 of FIG. 8 , the support member 514 shown in FIG. 10 has an edge portion 550 which engages a ledge 552 of the skirt 516 in assembly. This attachment secures the skirt 516 in place.
  • the skirt 516 desirably includes a Luer-Lock portion 554 that enables the valve 510 to be removably attached to, for example, a fluid line or catheter connected to a patient.
  • the retaining member 518 is desirably provided to secure the lower lip 538 of the seal 520 and support the resilient member 524 .
  • the retaining member 518 is held inside the housing 512 by the support member 514 , and is provided for ease of assembling the valve 510 .
  • the retaining member 518 has an annular groove 556
  • the support member 514 has an annular groove 558 .
  • the annular grooves 556 , 558 form a locking mechanism to support and secure the seal 520 within the housing 512 by engaging the lower lip 538 snugly with the grooves 556 , 558 .
  • a different embodiment may provide a unitary member which replaces the support member 514 and the retaining member 518 . It is therefore contemplated that such an embodiment would fall within the scope of this invention.
  • FIG. 11 illustrates compression
  • FIG. 10 illustrates decompression during valve activation.
  • a medical implement such as the syringe 562 partially shown in phantom is placed on the seal cap 532 inside the opening 564 of the housing 512 , and the application of pressure on the syringe 562 creates pressure on the seal cap 532 .
  • the downward pressure pushes the seal cap 532 away from the circular opening 564 and toward the lower portion of the housing 512 , which has a larger inner diameter, thereby allowing the precut slit 534 to open.
  • the side wall 528 deforms outwardly at the unconstricted region into a circumferential cusp 544 , and the resilient member 524 deforms in an accordion-like manner, storing potential energy of the compression. Fluid is able to flow into the syringe 562 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 520 shown in FIG. 11 generally causes a reduction in the fluid volume of the inner cavity 542 of the seal 520 .
  • the valve 510 has a net gain in volume of the inner cavity 542 , however, because the general reduction in volume within the inner cavity 542 is less than the increase in volume within the constricted portion 530 as defined by the clam shells 522 a / 522 b and of the cusp 544 at the unconstricted region of the seal 520 .
  • FIG. 10 illustrates the valve 510 after withdrawal of the syringe 562 .
  • the seal 520 returns to its decompressed state and essentially fills the opening 564 , and the clam shells 522 a / 522 b are pushed back up toward the opening 564 by the resilient member 524 .
  • the positive-flow valve 510 advantageously eliminates any dead space during decompression of the seal 520 . This is further assisted by the seal 520 , with the slit 534 remaining open until the very end, i.e., until the seal cap 532 is squeezed by the circular opening 564 at the top of the upper conduit 570 .
  • valve 510 can be reused because the seal 520 can return reversibly in the decompressed state.
  • the seal surface 572 is also swabbable for sterility. Other features of the valve 510 are discussed previously in connection with the earlier embodiments of this invention.
  • FIGS. 12 and 13 show a fifth embodiment valve 610 in accordance with the present invention, the valve 610 comprising a valve body or housing 612 , a seal 614 , a ring member 616 , and a spring 618 .
  • the housing 612 is similar to the housing 212 of FIG. 4 , with a circular opening 620 , and a tapered side wall 622 , but may have a straight side wall instead.
  • the seal 614 is similar to the seal 318 of FIG. 8 , having a substantially cylindrical side wall 624 and defining an inner cavity 626 which forms an expandable fluid space inside the valve 610 .
  • the side wall 624 may have different and variable thickness (not shown).
  • the components are dimensioned and configured to cause the fluid space to expand upon insertion of a medical implement and to contract upon withdrawal of the medical implement such as a syringe 630 partially shown in phantom in FIG. 13 .
  • the distal portion of the seal 614 is connected to a fluid line such as a catheter (not shown), and may be secured to the housing by means known to those with skill in the art, such as by the use of a support member (not shown) similar to the support member 214 shown in FIG. 15 .
  • the ring member 616 is desirably an annular disk 616 made of a hard plastic and disposed between a shoulder 634 of the seal 614 and a proximal end 636 of the spring 618 .
  • the ring member 616 serves as a constraint for the seal 614 during compression and efficiently transfers the compressive force to the spring 618 , assisting in the deformation of the seal 614 .
  • the ring member 616 efficiently transfers the spring force to the seal cap 638 of the seal 614 to close the opening 620 .
  • the ring member 616 facilitates the deformation and reformation of the seal 614 , it is not necessary for the seal 614 to work. In that case, the spring 618 will contact the seal cap 638 directly.
  • the spring 618 is substantially the same as the spring 222 of FIG. 4 and serves the same function, being disposed between the ring member 616 and a distal end 642 of the housing 612 .
  • the distal end 642 may be a separate component from the housing 612 for ease of assembly.
  • the spring 618 In the decompressed state shown in FIG. 12 , the spring 618 may be relaxed or be in slight compression to exert a force on the seal 614 through the ring member 616 to keep the seal 614 closed.
  • the spring 618 is compressed and stores potential energy from the compression, as illustrated in FIG. 13 .
  • the spring 618 Upon withdrawal of the syringe 630 , the spring 618 releases the potential energy and pushes the ring member 616 to close the seal 616 as shown in FIG. 12 .
  • the spring 618 is preferably not fixed with either the ring member 616 or the distal end 642 of the housing 612 for ease of assembly.
  • the spring 618 can be a helical spring or any other suitable spring known to those with skill in the art.
  • the side wall 624 of the seal 614 is constrained by the ring member 616 and housing 612 , and is substantially relaxed in the decompressed state.
  • the side wall 624 bulges in the unconstrained region between the ring member 616 and the distal end 642 of the housing 612 , causing an increase in the fluid space within the valve 610 .
  • the side wall 624 returns to its decompressed shape upon decompression of the seal 614 .
  • the side wall 624 may be stretched in tension by the spring 618 in the decompressed state and goes through a relaxed position before deforming under compression to its bulged condition.
  • FIG. 13 illustrates compression and FIG. 12 illustrates decompression during valve activation.
  • the syringe 630 is placed on the seal cap 638 inside the opening 620 of the housing and the application of pressure on the syringe 630 creates pressure on the seal cap 638 .
  • the downward pressure pushes the seal cap 638 and the ring member 616 away from the circular opening 620 and toward the lower portion of the housing 612 which has a larger inner diameter, thereby allowing the precut slit 646 of the seal cap 638 to open.
  • the side wall 624 deforms outwardly and bulges at the unconstricted region, as the spring 618 is compressed, storing potential energy of the compression.
  • Fluid is able to flow into the syringe 630 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 614 shown in FIG. 13 results in a net gain in volume of the inner cavity.
  • FIG. 12 illustrates the valve 610 after withdrawal of the syringe 630 .
  • the seal 614 returns to its decompressed state and essentially fills the opening 620 , and the ring member 616 is pushed back up toward the opening 620 as the spring 618 releases its potential energy. Because of the contraction of the inner cavity 626 of the seal 614 , there is a net loss in fluid space, resulting in a positive flow from the valve 610 through, e.g., a catheter tip (not shown).
  • the positive-flow valve 610 advantageously eliminates any dead space during decompression of the seal 614 . This is further assisted by the seal 614 with the slit 646 remaining open until the very end, i.e., until the seal cap 638 is squeezed by the circular opening 620 at the top of the upper conduit 650 of the housing 612 .
  • valve 610 can be reused because the seal 614 can return reversibly in the decompressed state.
  • the seal surface 652 is also swabbable for sterility. Other features of the valve 610 are discussed previously in connection with the earlier embodiments of this invention.
  • FIGS. 14 and 15 A sixth embodiment of a valve 710 is illustrated in FIGS. 14 and 15 .
  • the valve 710 comprises a valve body or housing 712 and a seal 714 .
  • the housing 712 has an upper conduit 716 near a proximal end with a circular opening 718 that is preferably adapted to receive a medical implement.
  • a side wall portion 720 is protruded to facilitate deformation of the seal 714 .
  • a distal end 724 of the housing 712 forms a lower passage 726 (partially shown) which supports and constrains a distal portion 728 of the seal 714 , and is connected, for example, to a fluid line such as a catheter (not shown).
  • a support member may be used to detachably lock onto the housing 712 and support the seal 714 , such as those shown in FIG. 4 ( 214 ) or FIG. 12 ( 514 ).
  • the seal 714 is generally similar to the seal 614 of FIGS. 12 and 13 , and has a substantially cylindrical side wall 721 , although the side wall 732 may have a slight bulge 733 as shown in FIG. 14 . It defines an inner cavity 734 which forms an expandable fluid space inside the valve 710 .
  • the seal 714 In the decompressed state, the seal 714 is constrained by the upper conduit 716 and lower passage 726 of the housing 712 , and is substantially relaxed in the decompressed state.
  • the components are dimensioned and configured to cause the fluid space to expand or increase upon insertion of the medical implement and to contract or decrease upon withdrawal of the medical implement such as the syringe 730 partially shown in phantom in FIG. 15 .
  • the side wall 732 bulge in the unconstrained region between the upper conduit 716 and lower passage 726 and the bulge 738 is substantially round.
  • the side wall 732 return to its decompressed shape upon decompression of the seal 714 .
  • FIG. 15 illustrates compression and FIG. 14 illustrates decompression during valve activation.
  • the syringe 730 is placed on the seal cap 742 of the seal 714 inside the opening 718 of the housing 712 and the application of pressure on the syringe 730 creates pressure on the seal cap 742 .
  • the downward pressure pushes the seal cap 742 away from the circular opening 718 and toward the protruded portion 720 of the housing 712 which has a larger inner diameter, thereby allowing the precut slit 746 of the seal cap 742 to open.
  • the side wall 732 deforms outwardly and bulges at the unconstricted region 738 , storing potential energy of the compression.
  • Fluid is able to flow into the syringe 730 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 714 shown in FIG. 15 generates a net gain in volume of the inner cavity.
  • FIG. 14 illustrates the valve 710 after withdrawal of the syringe 730 .
  • the seal 714 returns to its decompressed state and essentially fills the opening 718 . Because of the contraction of the inner cavity 734 of the seal, there is a net loss in fluid space, resulting in a positive flow from the valve 710 through, e.g., a catheter tip (not shown).
  • the positive-flow valve 710 advantageously eliminates any dead space during decompression of the seal 714 . This is further assisted by the seal 714 with the slit 746 remaining open until the very end, i.e., until the seal cap 742 is squeezed by the circular opening 718 at the top of the upper conduit 716 .
  • valve 710 can be reused because the seal 710 can return reversibly in the decompressed state.
  • the seal surface 748 is also swabbable for sterility. Other features of the valve 710 are discussed previously in connection with the earlier embodiments of this invention.
  • FIGS. 16 and 17 illustrate a valve 710 in accordance with a seventh embodiment of the present invention, the valve 756 comprising a valve body or housing 758 and a seal 760 that are substantially the same as the housing 712 and seal 714 of FIGS. 14 and 15 , with a distal portion 762 of the seal 760 connected to a fluid line such as a catheter (not shown).
  • the seal 760 is configured to deform upon compression into a diamond-shaped cusp 764 instead of a round bulge 738 as illustrated in FIGS. 14 and 15 .
  • This type of construction may facilitate deformation and reformation of the seal 760 , and may be more easily formed.
  • the valve activation of this embodiment is virtually identical to that in FIGS.
  • seal side wall 770 except for the deformed shape of the seal side wall 770 . It is contemplated, therefore, that a seal that may deform into a variety of shapes other than round and diamond shapes to achieve positive flow may be employed, as long as the it is dimensioned and configured to cause the fluid space of the valve to expand upon insertion of a medical implement and to contract upon withdrawal of the medical implement such as the syringe 774 partially shown in phantom in FIG. 28 .
  • an eighth embodiment valve 810 of the present invention is similar to the embodiments shown in FIGS. 14-17 .
  • the valve 810 also includes a housing 812 having an internal cavity 814 with an upper conduit 816 , and a seal 818 disposed inside the internal cavity 814 and having an inner cavity 820 that defines a fluid space.
  • the housing 812 has a distal end 824 which supports a side wall 826 of the seal 818 .
  • a distal portion 828 of the seal 818 is connected to a fluid line such as a catheter (not shown).
  • the pressure at the inner cavity 820 of the seal 818 is P 1 .
  • Between the housing 812 and the seal 818 is an enclosed pressure chamber 832 at pressure P 2 .
  • the valve activation utilizes the pressure difference between P 2 in the pressure chamber 832 and P 1 in the inner cavity 820 of the seal 818 .
  • the side wall 826 of the seal 818 may deform without substantial resistance or resiliency such as a membrane, or the seal is not constrained longitudinal by the distal portion 824 of the housing 812 and may slide in and out of the internal cavity 814 of the housing 812 through the distal end 824 .
  • FIG. 19 illustrates compression and FIG. 18 illustrates decompression during valve activation.
  • the syringe 836 is placed on the seal cap 838 of the seal 818 inside the opening 840 of the housing 812 and the application of pressure on the syringe creates pressure on the seal cap 838 .
  • the downward pressure pushes the seal cap 838 away from the circular opening 840 and toward the lower portion of the housing 812 which has a larger inner diameter, thereby allowing the precut slit 844 of the seal cap 838 to open.
  • the entry of the fluid causes the pressure at the inner cavity 814 of the seal 812 to increase to P 3 .
  • the side wall 826 deforms outwardly and bulges at the unconstricted region 848 .
  • Potential energy is stored in the change in pressure differential between the inner cavity 820 and the pressure chamber 832 .
  • the side wall 826 of the seal 818 need not deform and store energy, but may do so. Fluid is able to flow into the syringe 836 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 818 shown in FIG. 19 causes a net gain or increase in fluid volume within the inner cavity.
  • FIG. 18 illustrates the valve 810 after withdrawal of the syringe 836 .
  • the seal 818 returns to its decompressed state and essentially fills the opening 840 , and the pressure in the inner cavity 820 returns to P 1 and releases the potential energy. Because of the contraction of the inner cavity 820 of the seal 818 , there is a net loss in fluid space, resulting in a positive flow from the valve 810 through, e.g., a catheter tip (not shown).
  • the positive-flow valve 810 advantageously eliminates any dead space during decompression of the seal 818 . This is further assisted by the seal 818 with the slit 844 remaining open until the very end, i.e., until the seal cap 838 is squeezed by the circular opening 840 at the top of the upper conduit 816 .
  • valve 810 can be reused because the seal 818 can return reversibly in the decompressed state.
  • the seal surface 854 is also swabbable for sterility. Other features of the valve 810 are discussed previously in connection with the earlier embodiments of this invention.
  • FIGS. 20 and 21 A ninth embodiment of a valve 910 comprising a housing 912 , a support member 914 , a skirt 916 , a seal 918 , and a scissor-like cross member 920 , is depicted in FIGS. 20 and 21 .
  • the housing 912 has an upper conduit 924 with a circular opening 926 .
  • the support member 914 has an inner conduit 928 which is connected to a fluid line such as a catheter (not shown).
  • the seal 918 has a side wall 930 desirably formed of alternating wall portions 932 and defines an inner cavity 934 which forms an expandable fluid space inside the valve 910 .
  • the cross member 920 is dimensioned and configured to assist in causing the fluid space to expand upon insertion of a medical implement and to contract upon withdrawal of the medical implement such as the syringe 936 partially shown in phantom in FIG. 21 .
  • the cross member 920 has two longitudinal member 940 attached together which rotates with respect to one another, and is desirably made of a hard material such as a hard plastic.
  • the cross member 920 is disposed at a constricted portion 942 of the seal 918 within the inner cavity 934 with the longitudinal members 940 preferably substantially disposed vertically.
  • the ends 944 of the longitudinal members 940 are desirably attached to the side wall 930 as shown in FIG. 20 .
  • the longitudinal members 940 rotate to a substantially horizontal orientation upon compression by the insertion of the syringe 936 as shown in FIG. 21 . This rotation is referred to as the deformation of the cross member 920 .
  • the longitudinal members 940 may be attached to rotate freely with respect to one another.
  • the longitudinal members 940 may be spring-loaded or attached such that they rotate under a rotational force but reform to their relaxed position upon release of the force. Upon withdrawal of the syringe 936 as shown in FIG. 20 , the longitudinal members 940 return to the substantially vertical positions, referred to as the reformation of the cross member 920 .
  • the longitudinal members 940 are desirably longitudinal plates 940 with sufficient width to expand the constricted portion 942 of the seal 918 in the substantially horizontal position but not so wide that they impedes flow therethrough. Alternatively, they may contain holes (not shown) through which fluid can pass.
  • FIG. 21 illustrates compression and FIG. 20 illustrates decompression during valve activation.
  • the syringe 926 is placed on the seal cap 950 of the seal 918 inside the opening 926 of the housing 912 and the application of pressure on the syringe 936 creates pressure on the seal cap 950 .
  • the downward pressure pushes the seal cap 950 away from the circular opening 926 and toward the lower portion of the housing 912 which has a larger inner diameter, thereby allowing the precut slit 952 of seal cap 950 to open.
  • the side wall 930 of the seal 918 deforms in an accordion-like manner, and the cross member 920 deforms and opens up the constricted portion 922 of the seal 918 , storing potential energy of the compression. Fluid is able to flow into the syringe 936 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 918 and deformation of the cross 920 shown in FIG. 21 generally causes a contraction of the volume of the inner cavity 934 of the seal 918 .
  • the valve 910 has a net gain in volume of the inner cavity 934 , however, because the general contraction of the inner cavity 934 is less than by the expansion of the constricted portion 942 pushed apart by the cross member 920 .
  • the expansion results from the movement of the longitudinal members 940 of the cross member 920 during compression.
  • FIG. 20 illustrates the valve 910 after withdrawal of the syringe 936 .
  • the seal 918 returns to its decompressed state and essentially fills the opening 926 , and the cross member 920 reforms to allow the constricted region 942 of the seal 918 to narrow. Because of the contraction of the inner cavity 934 at the constricted portion 942 , there is a net loss in fluid space, resulting in a positive flow from the valve 910 through, e.g., a catheter tip (not shown).
  • the positive-flow valve 910 advantageously eliminates any dead space during decompression of the seal 918 . This is further assisted by the seal 918 with the slit 952 remaining open until the very end, i.e., until the seal cap 950 is squeezed by the circular opening 926 at the top of the upper conduit 924 .
  • valve 910 can be reused because the seal 918 can return reversibly in the decompressed state.
  • the seal surface 960 is also swabbable for sterility. Other features of the valve 910 are discussed previously in connection with the earlier embodiments of this invention.
  • FIGS. 22 and 23 illustrate a valve 1010 in accordance with a tenth embodiment of the present invention, the valve 1010 comprising a valve body or housing 1012 , a support member 1014 (partially shown), a seal 1016 , a ring member 1018 , a resilient reel 1020 , and a scissor-like cross member 1022 .
  • the support member 1014 has an inner conduit (not shown) which is connected to a fluid line such as a catheter (not shown).
  • the seal 1016 has a seal cap 1028 with slit 1030 , shoulder 1032 , and pressure responsive member 1034 .
  • the ring member 1018 forms a sliding contact with a distal end 1036 of the seal 1016 and is preferably made from a hard plastic.
  • the ring member 1018 desirably has a shoulder 1038 which is constrained by a ledge 1040 of the housing 1012 in the upward direction.
  • the distal end of the ring member 1018 contacts an upper flange 1044 of the resilient reel 1020 and facilitates transfer of the compressive force due to insertion of a medical implement to cause deformation of the reel 1020 .
  • the reel 1020 is made from a material that is flexible, inert, and impermeable to fluid, such as silicon. It has a lower flange 1046 that is supported and secured by the support member 1014 and a central body portion 1048 that is substantially cylindrical.
  • the seal 1016 , ring member 1018 , and resilient reel 1020 define an inner cavity 1050 which forms an expandable fluid space inside the valve 1010 .
  • the cross member 1022 is substantially the same of the cross member 920 of FIGS. 20 and 21 and is dimensioned and configured to assist in causing the fluid space to increase upon insertion of a medical implement and to decrease upon withdrawal of the medical implement such as the syringe 1054 partially shown in phantom in FIG. 23 .
  • the cross member 1022 has two longitudinal members 1056 rotatably attached together.
  • the cross member 1022 is disposed adjacent the central body portion 1048 of the reel 1020 within the inner cavity 1050 with the longitudinal members 1056 preferably pointed toward the vertical direction and desirably attached to the central body portion 1048 at its four ends 1058 as shown in FIG. 22 .
  • the longitudinal members 1056 rotate to a substantially horizontal orientation upon compression by the insertion of the syringe 1054 as shown in FIG. 23 . This rotation is referred to as the deformation of the cross member 1022 .
  • the longitudinal members 1050 may be attached to rotate freely with respect to one another. Alternatively, the longitudinal members 1056 may be spring-loaded or attached such that they rotate under a rotational force but reform to their relaxed position upon release of the force. Upon withdrawal of the syringe 1056 as shown in FIG. 22 , the longitudinal members 1056 return to the substantially vertical positions, referred to as the reformation of the cross member 1022 .
  • the longitudinal members 1026 are desirably longitudinal plates 1056 with sufficient width to open up the central body portion 1048 of the reel 1020 in the substantially horizontal position but not so wide that they impedes flow therethrough. Alternatively, they may contain holes (not shown) through which fluid can pass.
  • FIG. 23 illustrates compression and FIG. 22 illustrates decompression during valve activation.
  • the syringe 1054 is placed on the seal cap 1028 inside the opening 1062 of the housing 1012 and the application of pressure on the syringe 1054 creates pressure on the seal cap 1028 .
  • the downward pressure pushes the seal cap 1028 away from the circular opening 1062 and toward the lower portion of the housing 1012 which has a larger inner diameter, thereby allowing the precut slit 1030 to open.
  • the ring member 1018 moves toward the support member 1014 and compresses the resilient reel 1020 .
  • the upper flange 1044 of the resilient reel 1020 is pushed by the ring member 1018 toward the lower flange 1046 .
  • the central body portion 1048 bulges outwardly as the cross member 1022 deforms, storing potential energy of the compression. Fluid is able to flow into the syringe 1054 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 1016 and deformation of the cross 1022 shown in FIG. 23 generally causes a reduction in the volume of the inner cavity of the seal 1016 .
  • the valve 1010 has a net gain in volume of the inner cavity 1050 , however, because the expansion of the central body portion 1048 of the flexible reel 120 causes an increase in fluid volume which reduction resulting in is greater than the general contraction of the inner cavity 1050 .
  • the expansion results from the movement of the longitudinal members 1056 of the cross member 1022 to open up the central body portion 1048 of the resilient reel 1020 during compression.
  • FIG. 22 illustrates the valve 1010 after withdrawal of the syringe 1054 .
  • the seal 1016 returns to its decompressed state and essentially fills the opening 1062 , and the cross member 1022 reforms to allow the central body region 1048 of the resilient reel 1022 to narrow. Because of the contraction of the inner cavity 1050 at the central body portion 1048 , there is a net loss in fluid space, resulting in a positive flow from the valve 1010 through, e.g., a catheter tip (not shown).
  • the positive-flow valve 1010 advantageously eliminates any dead space during decompression of the seal 1016 . This is further assisted by the seal 1016 with the slit 1030 remaining open until the very end, i.e., until the seal cap 1028 is squeezed by the circular opening 1062 at the top of the upper conduit 1066 of the housing.
  • valve 1010 can be reused because the seal 1016 can return reversibly in the decompressed state.
  • the seal surface 1068 is also swabbable for sterility. Other features of the valve 1010 are discussed previously in connection with the earlier embodiments of this invention.
  • FIGS. 24 and 25 An eleventh embodiment of a valve 1110 in accordance with the present invention is illustrated in FIGS. 24 and 25 , and comprises a valve body or housing 1112 and a seal 1114 .
  • the housing 1112 has an upper conduit 1116 near a proximal end with a circular opening 1118 that is preferably adapted to receive a medical implement such as a syringe 1120 partially shown in phantom in FIG. 25 .
  • the housing 1112 has a lower conduit 1124 (partially shown) near a distal end which is connected to a fluid line such as a catheter (not shown).
  • the rest of the housing 1112 is desirably made of a firm material such as a hard plastic.
  • the seal 1114 is generally similar to the seal 318 of FIG. 6 with a similar shoulder 1132 , seal cap 1134 , and pressure responsive element 1136 .
  • the cylindrical side wall 350 of FIG. 6 is replaced with a spreader 1140 , which includes two legs 1142 a , 1142 b that extend from the shoulder 1132 outwardly at distal ends 1144 a , 1144 b that bear against the protruded right and left side walls 1126 a , 1126 b , as best seen in FIG. 24 .
  • the distal end 1144 a may be attached to the protruded side wall 1126 a
  • the distal end 1144 b may be attached to the protruded side wall 1126 b , by adhesives or other available means.
  • An inner cavity 1150 is formed by the seal 1114 and a distal portion 1152 of the housing 1112 , and defines a fluid space of the valve 1110 .
  • the spreader 1140 extends further outwardly and pushes the protruded side walls 1126 a , 1126 b outwardly.
  • the seal 1114 and housing 1112 are configured and dimensioned to assist in causing the fluid space to expand upon insertion of the medical implement 1120 and to contract upon withdrawal of the medical implement 1120 .
  • FIG. 25 illustrates compression and FIG. 24 illustrates decompression during valve activation.
  • the syringe 1120 is placed on the seal cap 1134 inside the opening 1118 of the housing 1112 and the application of pressure on the syringe 1120 creates pressure on the seal cap 1134 .
  • the downward pressure pushes the seal cap 1134 away from the circular opening 1118 and toward the lower portion of the housing 1112 which has a larger inner diameter, thereby allowing the precut slit 1156 oft he seal cap 1134 to open.
  • the spreader 1140 extends outwardly, stretching the resilient ribbed portions 1128 a , 1128 b and pushing the protruded right and left side walls 1126 a , 1126 b of the housing 1112 outwardly, storing potential energy of the compression. Fluid is able to flow into the syringe 1120 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 1114 and deformation of the spreader 1140 shown in FIG. 36 results in a net gain in volume of the inner cavity 1150 .
  • FIG. 24 illustrates the valve 1110 after withdrawal of the syringe 1120 .
  • the seal 1114 returns to its decompressed state and essentially fills the opening 1118 , and the spreader 1140 and resilient ribbed portions 1128 a , 1128 b reform to allow the protruded right and left side walls 1126 a , 1126 b to move inwardly.
  • the positive-flow valve 1110 advantageously eliminates any dead space during decompression of the seal 1114 . This is further assisted by the seal 14 with the slit 1156 remaining open until the very end, i.e., until the seal cap 1134 is squeezed by the circular opening 1156 at the top of the upper conduit 1116 .
  • valve 1110 can be reused because the seal 1114 can return reversibly in the decompressed state.
  • the seal surface 1160 is also swabbable for sterility. Other features of the valve 1110 are discussed previously in connection with the earlier embodiments of this invention.
  • a twelfth embodiment valve 1210 is illustrated in FIGS. 26 and 27 , and comprises a valve body or housing 1212 , a support member 1214 (partially shown), a seal 1216 , a ring member 1218 , and a resilient reel 1226 .
  • the housing 1212 , support member 1214 , and ring member 1218 are substantially the same as those shown in FIGS. 22 and 23 .
  • the housing 1212 has an upper conduit 1224 with a circular opening 1226 .
  • the support member 1214 has an inner conduit (not shown) which is connected to a fluid line such as a catheter (not shown).
  • the distal end 1228 of the ring member 1218 contacts an upper flange 1232 of the resilient reel 1220 and facilitates transfer of the compressive force due to insertion of a medical implement such as a syringe to cause deformation of the reel 1220 .
  • the reel 1220 further includes a central body portion 1234 and a lower flange 1236 that is desirably supported and secured by the support member 1214 .
  • the seal 1216 is similar to the seal 1114 of FIGS. 24 and 25 , and has a similar seal cap 1240 with slit 1242 , shoulder 1244 , and pressure responsive member 1246 .
  • the seal 1246 has a spreader 1250 that extends from the shoulder 1244 outwardly and forms a circular distal ring 1252 that bears against the central body portion 1234 of the resilient reel 1220 , as best seen in FIG. 26 .
  • the distal ring 1252 may be attached to the central body portion 1234 by adhesives or other available means.
  • An inner cavity 1254 is formed by the seal 1216 and a distal portion 1256 of the resilient reel, and defines a fluid space of the valve 1210 .
  • the spreader 1250 extends further outwardly and pushes the central body portion 1234 of the resilient reel 1220 outwardly.
  • the seal 1216 and resilient reel 1220 are configured and dimensioned to assist in causing the fluid space to increase upon insertion of a medical implement and to decrease upon withdrawal of the medical implement such as the syringe 1260 partially shown in phantom in FIG. 27 .
  • FIG. 27 illustrates compression and FIG. 26 illustrates decompression during valve activation.
  • the syringe 1260 is placed on the seal cap 1240 inside the opening 1226 of the housing 1212 and the application of pressure on the syringe 1260 creates pressure on the seal cap 1240 .
  • the downward pressure pushes the seal cap 1240 away from the circular opening 1226 and toward the lower portion of the housing 1212 which has a larger inner diameter, thereby allowing the precut slit 1242 to open.
  • the ring member 1218 moves toward the support member 1214 and compresses the resilient reel 1220 .
  • the upper flange 1232 of the resilient reel 1220 is pushed by the ring member 1214 toward the lower flange 1236 .
  • the central body portion 1234 bulges outwardly as the spreader 1250 deforms and pushes the central body portion 1234 outwardly, storing potential energy of the compression. Fluid is able to flow into the syringe 1260 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 1216 and deformation of the spreader 1250 and reel 1220 shown in FIG. 27 causes an increase in volume of the inner cavity 1254 because of the expansion of the central body portion 1234 of the flexible reel 1220 .
  • the expansion results from the movement of the spreaders 1250 to open up the central body portion 1234 of the resilient reel 1220 during compression.
  • FIG. 26 illustrates the valve 1210 after withdrawal of the syringe 1260 .
  • the seal 1216 returns to its decompressed state and essentially fills the opening 1226 , and the spreader 1250 reforms to allow the central body region 1234 of the resilient reel 1220 to narrow. Because of the contraction of the inner cavity 1254 at the central body portion 1234 , there is a net loss in fluid space, resulting in a positive flow from the valve 1210 through, e.g., a catheter tip (not shown).
  • the positive-flow valve 1210 advantageously eliminates any dead space during decompression of the seal 1216 . This is further assisted by the seal 1216 with the slit 1242 remaining open until the very end, i.e., until the seal cap 1240 is squeezed by the circular opening 1226 at the top of the upper conduit 1224 .
  • valve 1210 can be reused because the seal 1216 can return reversibly in the decompressed state.
  • the seal surface 1266 is also swabbable for sterility. Other features of the valve 1210 are discussed previously in connection with the earlier embodiments of this invention.
  • FIGS. 28 and 29 A thirteenth embodiment valve 1310 in accordance with the present invention is illustrated in FIGS. 28 and 29 .
  • the valve 1310 comprises a body or housing 1312 , a support member 1314 (partially shown), an upper seal 1316 , and a lower seal 1318 .
  • the housing 1312 has an upper conduit 1322 near a proximal end with a circular opening 1324 that is preferably adapted to receive a medical implement such as a syringe 1326 partially shown in phantom in FIG. 40 .
  • the body 1312 has an upper side wall 1330 distal to the upper conduit 1322 that is desirably circular in cross section with a diameter larger than the diameter of the circular opening 1324 .
  • the body 1312 has a lower side wall 1332 distal to the upper side wall 1330 with a diameter larger than the diameter of the upper side wall 1330 .
  • a middle conduit 1338 is advantageously formed between the upper side wall 1330 and lower side wall 1332 .
  • the upper side wall 1330 is advantageously tapered from the upper conduit 1322 to the middle conduit 1338 and the lower side wall 1332 is advantageously tapered from the middle conduit 1338 to a distal end 1340 of the housing 1312 .
  • the middle conduit 1338 has a diameter larger than the diameter of the upper conduit 1322 and smaller than the diameter of the distal end 1340 of the housing 1312 .
  • the support member 1314 has at its distal end an inner conduit (not shown) which may be connected to a terminal of a catheter (not shown).
  • the support member 1314 serves as a support and attachment device for the upper and lower seals 1316 , 1318 by holding the seals 1316 , 1318 in place inside the internal cavity 1346 of the housing 1312 .
  • the upper and lower seals 1316 , 1318 are prepared from a resilient material that is flexible, inert, and impermeable to fluid, such as silicon.
  • the upper seal 1316 has a seal cap 1350 with a generally flat top surface 1352 , a shoulder 1354 , a side wall 1356 , and a base 1358 .
  • the side wall 1356 advantageously is comprised of ringed wall portions 1360 which deform in an accordion-like fashion and assist in the reformation of the seal 1316 to enclose the housing opening 1324 upon withdrawal of the syringe 1326 .
  • the diameter of the ringed wall portions 1360 expand outwardly in the radial direction.
  • the interior of the upper seal 1316 is hollow to provide an upper inner cavity 1362 , as best seen in FIG. 28 .
  • the shoulder 1354 engages an upper ledge 1366 provided in the upper conduit 1322 of the housing 1312 such that the upper ledge 1366 confines the movement of the shoulder 1354 toward the opening 1324 to prevent the upper seal 1316 from being blown through the opening 1324 under high pressure in the upper inner cavity 1362 of the seal 1316 ,
  • the seal cap 1350 of the upper seal 1316 reseals in the valve 1310 at the opening 1324 with the top surface 1352 of the seal 1316 flush with or above the opening 1324 upon removal of the medical implement 1326 .
  • the seal cap 1350 substantially fills the opening 1324 in the top of the upper conduit 1322 . It is preferred the top surface 1352 be exposed after assembly so that it may be swabbed with alcohol or other disinfectant.
  • the seal cap 1350 of the upper seal 1316 desirably has a unique shape with a precut slit 1370 such that the seal cap 1350 is squeezed shut by the opening 1324 when assembled and the slit 1370 opens automatically during compression.
  • the seal 1316 desirably also includes a pressure responsive member 1372 to further assist in creating a fluid-tight seal in the decompressed state.
  • the lower seal 1318 desirably is generally similar to the upper seal 1316 .
  • the lower seal has a similar seal cap 1380 with a generally flat top surface 1382 , a shoulder 1384 , and a side wall 1386 .
  • the side wall 1386 defines a lower inner cavity 1390 and may include similar ringed wall portions (not shown).
  • the seal cap 1380 is disposed at the middle conduit 1338 at the decompressed state and reseals the lower inner cavity 1390 at the middle conduit 1338 upon removal of the medical implement 1326 .
  • the lower inner cavity 1390 forms a fluid space of the valve 1310 , being in fluid communication through the lower conduit (not shown) to, e.g., a catheter (not shown).
  • the valve components are configured and dimensioned to assist in causing the fluid space to increase upon insertion of the medical implement 1326 and to decrease upon withdrawal of the medical implement 1326 .
  • the seal cap 1380 advantageously provides a fluid tight seal, having a shape and a precut slit 1394 similar to those of the upper seal 1316 .
  • the lower seal 1318 also includes desirably a pressure responsive member 1396 similar to the pressure responsive member 1372 of the upper seal 1316 .
  • the components of the lower seal 1318 are generally larger than those of the upper seal 1316 because of the geometry of the valve housing 1312 .
  • FIG. 29 shows the compressed state of the valve 1310 upon insertion of the syringe 1326 .
  • the syringe 1326 is placed on the upper seal cap 1350 inside the opening 1324 of the housing 1212 .
  • the application of pressure on the syringe 1326 creates pressure on the seal cap 1330 , and the resulting downward pressure compresses the upper seal 1316 .
  • the downward movement is facilitated by the compression of the ringed wall portions 1360 of the side wall 1356 of the upper seal 1316 .
  • FIG. 29 shows the valve 1310 opened by insertion of the syringe 1326 into the opening 1324 .
  • the fluid space In the compressed state shown in FIG. 29 , the fluid space generally contract under pressure from the decompressed state shown in FIG. 28 .
  • the upper and lower seals 1316 , 1318 are free to move toward their decompressed states. The movement normally would cause a general expansion of the fluid space.
  • a decrease in volume results in the lower inner cavity 1390 of the valve 1310 .
  • the decrease in the fluid space advantageously generates a positive flow from the valve 1310 through, e.g., a catheter tip (not shown) to eliminate dead space.
  • any dead space within the upper inner cavity 1362 is also minimized since, as the syringe 1326 is withdrawn, the slit 1370 remains open until the very end, i.e., until the seal cap 1350 is squeezed by the circular opening 1324 at the top of the upper conduit 1322 .
  • the elimination of backflash is particularly advantageous in the case where the valve 1310 is connected through a catheter to a patient, because it prevents the introduction of blood into the catheter.
  • the upper seals 1316 As the upper seals 1316 is free to move to its decompressed state, it essentially fills the circular opening 1324 .
  • the surface 1352 of the seal cap 1316 is essentially flush with the opening 1324 of the housing 1312 .
  • this flush surface 1352 can advantageously be sterilized with alcohol or other surface decontaminating substances.
  • a cover cap (not shown) can further be used to fit over the upper conduit to protect the surface 1352 of the seal cap 1350 .
  • FIGS. 30 and 32 A fourteenth embodiment of a valve 1410 of the present invention is illustrated in FIGS. 30 and 32 , and comprises a valve body or housing 1412 , a seal 1414 , a piston 1416 , and a spring 1418 .
  • the housing 1412 has an upper conduit 1420 near a proximal end with a circular opening 1422 that is preferably adapted to receive a medical implement such as a syringe 1423 partially shown in phantom in FIG. 30 .
  • the housing 1412 has a side conduit 1424 which is connected to a fluid line such as a catheter (not shown).
  • a lower chamber 1426 of the housing 1412 Disposed in a lower chamber 1426 of the housing 1412 is the spring 1418 supporting the piston 1416 which bears against a distal end 1430 of the seal 1414 disposed in an upper chamber 1432 of the housing 1412 .
  • the lower chamber 1426 of the housing 1412 advantageously includes an orifice 1434 for venting the air therein to facilitate movement of the spring 1418 .
  • the upper chamber 1432 and lower chamber 1426 expand and contract according to the movement of the piston 1416 under pressure from the seal 1414 and the spring 1418 .
  • the housing 1412 advantageously includes a side aperture 1438 additional fluid to be transferred to the patient through the upper chamber 1432 and side conduit 1424 when necessary.
  • the seal 1414 has seal cap 1442 with precut slit 1444 , a shoulder 1446 , and a pressure responsive member 1448 .
  • the seal has a side wall 1450 which defines an inner cavity 1452 and has the distal end 1430 that cooperates with the piston 1416 for efficient transfer of pressure between them.
  • Near the distal end 1430 of the seal 1414 is desirably a transverse fluid passage 1456 for fluid communication between the seal 1414 and the upper chamber 1432 .
  • FIGS. 30 and 32 illustrate that the transverse fluid passage 1456 also facilitates fluid flow between the side aperture 1438 and the side conduit 1424 , it need not do so if fluid can flow around the seal 1414 in the upper chamber 1432 .
  • the upper chamber 1432 and the inner cavity 1450 of the seal 1414 forms the fluid space of the valve 1410 .
  • FIG. 31 illustrates compression and FIG. 30 illustrated decompression during valve activation.
  • the syringe 1423 is placed on the seal cap 1442 inside the opening 1422 of the housing 1412 and the application of pressure on the syringe 1423 creates pressure on the seal cap 1442 .
  • the downward pressure pushes the seal cap 1442 away from the circular opening 1422 and toward the lower portion of the housing 1412 which has a larger inner diameter, thereby allowing the precut slit 1444 to open.
  • the side wall 1450 moves further into the upper chamber 1432 and pushes the piston 1476 downward against the spring 1418 , which is compressed, storing potential energy of the compression.
  • Fluid is able to flow into the syringe 1423 , or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • the compression of the seal 1414 shown in FIG. 42 generates a net gain or increase in volume of the fluid space of the valve 1410 .
  • FIG. 30 illustrates the valve 1410 after withdrawal of the syringe 1423 .
  • the seal 1414 returns to its decompressed state and essentially fills the opening 1422 , and the piston 1416 moves back to its decompressed position as the spring 1418 releases its potential energy.
  • the positive-flow valve 1410 advantageously eliminates any dead space during decompression of the seal 1414 . This is further assisted by the seal 141 with the slit 1444 remaining open until the very end, i.e., until the seal cap 1442 is squeezed by the circular opening 1422 at the top of the upper conduit 1420 .
  • valve 1410 can be reused because the seal 1414 can return reversibly in the decompressed state.
  • the seal surface 1460 is also swabbable for sterility. Other features of the valve 1410 are discussed previously in connection with the earlier embodiments of this invention.
  • valve embodiment valve may have a fluid space inside a straight tubing which bends upon insertion of a medical implement and reforms upon withdrawal of the medical implement, thereby effecting positive flow.
  • many of the ringed side wall of the seals can be replaced by circular tires 1580 stacked in series one on top of an adjacent larger-diameter lower tire, as illustrated in FIG. 32 .
  • the circular tires 1580 are preferably solid throughout the diameter of the cross-section thereof. Like the ringed side wall portions 1360 , these circular tires 1580 will deform and reform upon, respectively, compression and decompression of the seal.
  • the fluid space inside the valve increases upon insertion of a medical implement in the compressed state and decreases upon withdrawal of the medical implement in the decompressed state.
  • the structure defining the fluid space is substantially relaxed and does not store substantial amount of potential energy. Insertion of the medical implement causes a change in the structure that allows it to store potential energy. The potential energy is released upon withdrawal of the medical implement and the structure returns to a substantially relaxed condition.
  • at least some components of the structure defining the fluid space stores potential energy under strain or deformation. Upon insertion of a medical implement in the compressed state, the potential energy in those components is released and is stored in other components of the structure or in another form. The stored potential energy in the compressed state is released when the medical implement is removed, and the original potential energy is restored in the structure.

Abstract

A closed system, spikeless, positive-flow valve device includes a body defining an internal cavity. At the proximal end of the body is an opening which is preferably sufficiently large to receive an ANSI standard tip of a medical implement. The valve includes a plastic, resilient silicon seal which fills the upper cavity and opening with an oval seal cap having a slit. The opening presses the oval seal cap to keep the slit closed in the decompressed state. The slit opens as the nose of the medical implement compresses the seal into the cavity and the seal cap is free from the opening. The housing also includes a fluid space which facilitates fluid flow between the medical implement and a catheter tip. The fluid space within the valve automatically and reversibly increases upon insertion of the medical implement into the cavity and decreases upon withdrawal of the medical implement, such that a positive flow from the valve toward the catheter tip is effected upon withdrawal of the medical implement, thereby preventing a flow of blood from a patient into the catheter when the medical implement is removed from the valve.

Description

    BACKGROUND OF THE INVENTION
  • This application is a continuation of pending U.S. application Ser. No. 11/085,808, filed Mar. 21, 2005, which in a continuation of pending U.S. application Ser. No. 10/163,719, filed Jun. 5, 2002, which is a continuation of U.S. application Ser. No. 09/411,988, filed Oct. 4, 1999, now U.S. Pat. No. 6,428,52, which is a continuation of U.S. application Ser. No. 08/767,587, filed Dec. 16, 1996, now abandoned, all of which are incorporated by reference in their entirety.
  • FIELD OF THE INVENTION
  • This invention relates generally to a medical valve, and in particular to a positive flow valve which, when connected between a medical implement and a catheter to facilitate fluid flow therethrough, induces a positive flow of fluid through a tip of the catheter from the valve upon disconnection of the medical implement, thereby eliminating the problem of blood-clogging or clotting in the catheter.
  • DESCRIPTION OF THE RELATED ART
  • The manipulation of fluids for parenteral administration in hospitals and medical settings routinely involves the use of connectors and valves for facilitating the movement of fluids between two points. Fluid connectors and valves typically employ needles or luers to pierce a septum or seal covering sterile tubing or to pierce a septum or seal of a medicament container of fluid. Fluid then passes from the container or fluid-filled tubing into a syringe or second set of tubing. Since the ready passage of fluids through the connectors and valves is often critical to patient survival, it is imperative that the connectors and valves function reliably and repeatedly. Connectors and valves that malfunction during use may be life-threatening.
  • Many connectors or valves, especially those employing several mechanical components, have a relatively high volume of fluid space within them. There is potential for the creation of a “dead space” (i.e. an increase in the fluid containment area which will cause fluid within the patient to be drawn therein) in the fluid space during removal or disconnection of the tubing or other medical implements such as conduits, syringes, IV sets (both peripheral and central lines), piggyback lines, and similar components which can be used in connection with a medical valve. Withdrawal of the medical implement creates a suction force which draws fluid back toward the valve in a phenomenon known as “backflash.” This is particularly troublesome in the case where the valve is connected through a catheter to a patient. A suction force is generated by the withdrawal of the medical implement which draws blood from the patient into the catheter. This blood clot and clog the catheter near its tip, rendering it inoperable, and may even result in a clot of blood in the patient, which may prove fatal. Attempts to avoid backflash by coating the inner surface of the catheter near its tip in order to prevent blood from sticking to the interior surfaces of the catheter and clogging it have not been successful.
  • The risk of blood clogging of the catheter is significantly heightened where the inner diameter of the catheter is small (e.g., 27 gauge). These small catheters have the advantage, however, that they reduce the trauma and discomfort caused by insertion into a patient. Because these catheters have a very small passage therethrough, even a small suction force may draw sufficient amount of fluid back through a catheter toward the valve to introduce blood into the catheter tip, which blood may clog the catheter's passage. This back flow is hereinafter referred to as a negative flow. FIG. 1 shows an example of a catheter 50 having a small portion near the tip 52 that is inserted into the patient, and a valve 54 connected between one end of the catheter and a medical implement 56. The problem associated with the creation of “dead space” or a drawing of fluid from the catheter towards the valve is illustrated by this Figure. As illustrated therein, when the tip or nose of the medical implement 56 is withdrawn from the valve 54, the space previously occupied by the implement 56 becomes “dead space.” This newly created space has a lower pressure than the fluid within the valve, catheter and patient, such that fluid is drawn into that space, and thus travels from the patient in the direction of the dead space. To avoid blood from being drawn into the catheter, a zero flow or a positive flow, defined as flow or fluid displacement directed from the valve through the catheter tip to the patient, must be effected at the time the medical implement is withdrawn. For a sufficient margin of safety, a positive flow toward the patient is desirable.
  • To avoid negative flow or backflash, healthcare workers presently practice the method of disconnecting the valve and simultaneously transferring fluid through the catheter by manipulating the medical implement to induce positive flow. This method is clumsy and difficult, and may result in an inaccurate transfer of medicament.
  • One way to induce a positive flow in the catheter is illustrated in FIGS. 2 a and 2 b. Here, the proximal end of a valve 180 is enclosed with a stylet or displacer 182 upon withdrawal of the medical implement (not shown). An elongated portion 184 of the stylet 182 takes up at least a portion of the fluid space, thereby reducing the volume of the fluid space, and may eliminate the dead space therein. The elongated portion 184, however, must be sufficiently long to displace more fluid than that volume of fluid which may be drawn from the catheter towards the valve by the withdrawal of the implement, and hence may be difficult to construct for proper performance. The use of the stylet 182 further requires an additional step that may be overlooked by the nurse and the stylet 182 may be misplaced or lost. In addition, this specific type of valve 180 has many significant drawbacks, among them the fact that it does not have a seal with a swabbable surface that can be swabbed after each use for sterility.
  • SUMMARY OF THE INVENTION
  • In accordance with the present invention there is provided a positive flow valve which is advantageously utilized between a catheter and another medical implement, and with which the flow of a fluid between the implement and catheter (and a patient within which the catheter is employed). The valve of this invention has several features, no single one of which is solely responsible for its desirable attributes.
  • In general, the positive flow valve of the present invention has the attributes of safety, positive flow for eliminating dead space, reliable and repeatable performance, simplicity of manufacture and use, a seal for use in establishing fluid flow which need not be pierced with a sharp spike or cannula, suitability of high pressure applications, and employment of a valve that is swabbable after use to provide sterility and has a fluid-tight seal at high pressure.
  • The present invention is a swabbable, needle-less, positive flow valve that has a fluid space which automatically expands upon insertion of a medical implement and contracts upon withdrawal of the medical implement. When the valve is connected to a catheter, it induces a positive flow from the valve to the catheter tip upon disconnection of the medical implement to avoid the potential problems of blood-clogging. After use, the valve is swabbed in the conventional manner with a suitable substance to maintain sterility. The design of the valve avoids accidental needle or spike sticks. The valve is particularly suited for applications with a catheter where it is desirable to avoid backflash, but may be used for other applications as well.
  • Preferably, the valve includes a housing having a first end adapted for receiving one end of medical implement, and having a second end in communication with a catheter. The valve includes means for establishing a fluid flow path through the housing and between the medical implement and the catheter, and which is also useful in occluding the flow path through the housing and thereby preventing fluid flow between the medical implement and catheter.
  • Preferably, this means comprises a seal movably positioned within the housing. The seal has a passage therethrough which defines, in at least one area, a fluid containment area. The seal has a first end adapted for engagement by the medical implement. In a first position, the passage through the seal is closed at its first end, and in a second position, when the medical implement is utilized to press the seal distally within the housing of the valve, the passage through the valve is opened.
  • Most importantly, when the medical implement is utilized to press the seal distally and establish fluid flow therethrough, the fluid containment area therein increases in total volume, thereby retaining a fluid volume therein. When the medical implement is retracted from the valve, the seal returns to its position wherein the passage is closed at the proximal end thereof, and the volume of the fluid containment area is reduced. This reduction in fluid containment volume results in a volume of fluid being forced towards the catheter (i.e. a positive flow is established).
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The preferred embodiments of this invention, illustrating all its features, will now be discussed in detail. These embodiments depict the novel and nonobvious method and valve of this invention shown in the accompanying drawings, which are for illustrative purposes only. The drawings include the following Figures, with like numerals indicating like parts:
  • FIG. 1 is a schematic cross-sectional view of a valve forming a fluid connection between a syringe and a catheter.
  • FIGS. 2 a and 2 b illustrate a prior art valve which includes a stylet having an elongated portion after use to induce a positive flow.
  • FIG. 3 is a schematic cross-sectional view of a roller-clamp valve which may be manually activated to induce a positive flow through a catheter tip from the valve.
  • FIG. 4 is a longitudinal cross-sectional view of the first embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 5 is a longitudinal cross-sectional view similar to FIG. 4 showing the valve during compression of the seal.
  • FIG. 6 is a longitudinal cross-sectional view of the second embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 7 is a longitudinal cross-sectional view similar to FIG. 6 showing the valve during compression of the seal.
  • FIG. 8 is a longitudinal cross-sectional view of the third embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 9 is a longitudinal cross-sectional view similar to FIG. 8 showing the valve during compression of the seal.
  • FIG. 10 is a longitudinal cross-sectional view of the fourth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 11 is a longitudinal cross-sectional view similar to FIG. 10 showing the valve during compression of the seal.
  • FIG. 12 is a longitudinal cross-sectional view of the fifth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 13 is a longitudinal cross-sectional view similar to FIG. 12 showing the valve during compression of the seal.
  • FIG. 14 is a longitudinal cross-sectional view of the sixth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 15 is a longitudinal cross-sectional view similar to FIG. 14 showing the valve during compression of the seal.
  • FIG. 16 is a longitudinal cross-sectional view of the seventh embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 17 is a longitudinal cross-sectional view similar to FIG. 16 showing the valve during compression of the seal.
  • FIG. 18 is a longitudinal cross-sectional view of the eighth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 19 is a longitudinal cross-sectional view similar to FIG. 18 showing the valve during compression of the seal.
  • FIG. 20 is a longitudinal cross-sectional view of the ninth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 21 is a longitudinal cross-sectional view similar to FIG. 20 showing the valve during compression of the seal.
  • FIG. 22 is a longitudinal cross-sectional view of the tenth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 23 is a longitudinal cross-sectional view similar to FIG. 22 showing the valve during compression of the seal.
  • FIG. 24 is a longitudinal cross-sectional view of the eleventh embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 25 is a longitudinal cross-sectional view similar to FIG. 24 showing the valve during compression of the seal.
  • FIG. 26 is a longitudinal cross-sectional view of the twelfth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 27 is a longitudinal cross-sectional view similar to FIG. 26 showing the valve during compression of the seal.
  • FIG. 28 is a longitudinal cross-sectional view of the thirteenth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 29 is a longitudinal cross-sectional view similar to FIG. 28 showing the valve during compression of the seal.
  • FIG. 30 is a longitudinal cross-sectional view of the fourteenth embodiment of the positive-flow valve of this invention before compressing the seal.
  • FIG. 31 is a longitudinal cross-sectional view similar to FIG. 30 showing the valve during compression of the seal.
  • FIG. 32 is a longitudinal cross-sectional view of an alternative seal with a side wall formed with circular tires.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • The Applicant has recognized that a roller clamp may be used to induce a positive flow in a medical valve. The use of a roller clamp in a medical valve 190 to create a positive flow upon disconnection of a medical implement (not shown) is illustrated in FIG. 3. The roller-clamp valve 190 is activated manually by sliding an external switch 192 to push a roller 194 against tubing 196 which connects a medical implement 198 and a catheter (not shown) to cause a positive pressure therein, thereby creating a positive flow through the catheter tip (not shown). The flow through the tubing 196 can be opened by sliding the switch 192 in the reverse direction.
  • This valve 190, however, has the same disadvantage of requiring an additional step of operation as does the valve with a stylet illustrated in FIGS. 2 a and 2 b, and also does not include a seal having a swabbable surface. Furthermore, the size of the roller 194 must be sufficiently large to induce a displacement of fluid within the tube which is greater than the amount of fluid which may be drawn by the vacuum force (so as to generate a positive flow), which may require a bulky valve that is hard to operate.
  • First Embodiment
  • FIGS. 4 and 5 illustrate a first embodiment of a valve 210 in accordance with the present invention. In general, this valve 210 includes a valve body or housing 212, a support member 214, a seal 216 defining an inner cavity 218, a pair of clam shells 220 a and 220 b, and a spring 222. These components are assembled, as depicted in FIG. 4, without the need for a spike element. The inner cavity 218 forms an expandable fluid space inside the valve 210. As discussed below, the clam shells 220 a/220 b are constructed to cause the volume of the fluid space to expand or increase upon insertion of a medical implement and to contract or decrease upon withdrawal of the medical implement.
  • The body or housing 212 has an upper conduit 226 near a proximal end 228, desirably with a circular opening 230 that is adapted to receive the medical implement. A side wall portion 232 is preferably tapered to cooperate with the clam shells 220 a/220 b. The body 212 has an upper ledge 234 formed between the proximal end 228 and the side wall portion 232. There is desirably a threaded portion on the housing 212 adjacent the circular opening 230 in the top of the upper conduit 226, as best seen in FIG. 4. Note that “proximal” is used to denote the end of the valve 210 and other components at or near the body opening 230, while “distal” is used to denote the opposite end of the valve.
  • In the first embodiment, the upper conduit 226 is adapted to receive the tip or nose 236 of an ANSI standard syringe 238, as shown in phantom in FIG. 5. It is, however, contemplated that the outer diameter of the upper conduit 226 can be of any size to accommodate the attachment of other connector devices thereto. Advantageously, the proximal end of the upper conduit 226 can be equipped with a locking mechanism to facilitate locking of the valve 210 to a variety of connector devices. For example, referring to FIG. 4, the threaded portion of the housing 212 are preferably provided such that the housing 212 can be locked into any compatible Luer-Lock device known to those with skill in the art. The housing 212 of the first embodiment according to this invention includes conventional Luer-Lock threads 240 on the outer diameter of the upper conduit 226.
  • The support member 214 has at its distal end the inner conduit 242 which may be connected to a terminal end of a catheter (not shown). The support member 214 serves as a support and attachment device for the seal 216 by holding the seal 216 in place inside the internal cavity 244 of the housing 212. The inner conduit 242 and inner cavity 218 of the seal 216 present a continuous passageway for fluid during use.
  • The seal 216 is prepared from a resilient material that is flexible, inert, and impermeable to fluid, such as silicon. The seal 216 has a seal cap 248 with a generally flat top surface 250, a shoulder 252, a side wall 254, and a base 256. The side wall 254 advantageously is comprised of wall portions 258 which deform in an accordion-like fashion and assist in the reformation of the seal 216 to close the housing opening 230 upon withdrawal of the syringe 238. During compression of the seal 216, the wall portions 258 expand outwardly in the radial direction. The interior of the seal 216 is hollow to provide the inner cavity 218, as best seen in FIG. 4. There are preferably gaps between the wall portions 258 which facilitate deformation and reformation of the seal 216. The shoulder 252 engages the upper ledge 234 provided in the upper conduit 226 of the housing 212 such that the upper ledge 234 confines the movement of the shoulder 252 toward the opening 230 to prevent the seal 216 from being blown through the opening 230 under high pressure in the inner cavity 218 of the seal 216.
  • The seal cap 248 reseals the valve 210 at the opening 230, with the top surface 250 of the seal 216 approximately flush with or slightly above or below the opening 230 upon removal of the medical implement 238. Preferably, the seal cap 248 substantially fills the opening 230 in the top of the upper conduit 226. After assembly, the top surface 250 of the seal cap 248 is essentially flush with the opening 230, so that the seal cap 248 can be swabbed with alcohol or other disinfectant without leakage of the disinfectant into the valve 210. Therefore, it is preferable that the top surface 250 be exposed so that it may be swabbed with a disinfectant.
  • To provide a fluid-tight seal at the opening 230 and to eliminate the need for a spike element to induce fluid flow upon insertion of a medical implement, the seal cap 248 has a unique shape and includes a precut slit 259, also having a unique shape. The seal cap 248 desirably has an oval or elliptical shape with a major axis having a length larger than the inner diameter of the circular opening 230 such that the oval seal cap 248 substantially fills the opening 230 in the top of the upper conduit 226 in the decompressed state. The precut slit 259 in the seal cap 248 is squeezed shut by the circular opening 230 in the decompressed state, as seen in FIG. 4. In its resting state, the precut slit 259 is open. During compression of the seal 216 by insertion of a medical implement such as the syringe 238, as illustrated in FIG. 5, the precut slit 259 returns to its resting state and opens, as the seal cap 248 is allowed to stretch in the portion of the upper conduit 226 which has a larger inner diameter. Fluid is thus allowed to pass through the slit 259. Note that the terms “compressed state” and “decompressed state” are used conveniently to refer to compression and decompression of the seal 216 by insertion and withdrawal of the medical implement 238 along the longitudinal axis of the seal 216. The terms do not relate to the radial compression of the seal cap 248 by the opening 230 of the housing 212.
  • To further assist in creating a fluid-tight seal in the decompressed state, the seal 216 of FIG. 4 advantageously includes the enlarged, internal, pressure responsive member 260 which is integral with the seal cap 248. The pressure responsive member 260 enables the valve 210 to maintain a fluid-tight seal even at very high pressures sometimes experienced in medical applications, particularly when the valve 210 is connected to a patient's artery.
  • As shown in FIGS. 4 and 5, the clam shells 220 a/220 b are desirably identical pieces disposed opposite one another symmetrically inside the valve body 212. They are preferably made of a firm material such as a hard plastic. The external surface 264 a/264 b of each clam shell 220 a/220 b is tapered to cooperate with the tapered side wall portion 232 of the housing 212, and is configured to slide along the side wall portion 232 during compression and decompression. The internal surfaces 266 a/266 b of the clam shells 220 a/220 b cooperate with one another to squeeze a portion of the seal side wall 254, preferably adjacent the shoulder 252, to form a constricted portion 267 of the seal 216. The proximal ends 268 a/268 b of the clam shells 220 a/220 b engage the shoulder 252 of the seal 216 to facilitate movement of the clam shells 220 a/220 b with the compression of the seal 216. The internal surfaces 266 a/266 b preferably are shaped to cause the constricted portion 267 to be substantially circular. In this embodiment, each internal surface 266 a/266 b has a semi-circular, longitudinal groove that squeezes the seal 216.
  • The spring 222 is disposed between the distal ends of the clam shells 220 a/220 b and the base 256 of the seal 216, but desirably a hard retaining disk 270 is provided adjacent the base 256 of the seal 216 to provide better support for the spring 222 and the seal 216. In the decompressed state shown in FIG. 4, the spring 222 may be relaxed or be in slight compression to exert a force on the seal 216 through the clam shells 220 a/220 b to keep the seal 216 closed. During insertion of the syringe 238, the spring 222 is compressed and stores potential energy from the compression, as illustrated in FIG. 5. Upon withdrawal of the syringe 238, the spring 222 releases the potential energy and pushes the clam shells 220 a/220 b proximally to close the seal 216, as shown in FIG. 4. The spring 222 is preferably not attached or bonded to either the clam shells 220 a/220 b or the retaining disk 270 for ease of assembly. Although FIGS. 4-5 show a helical spring 222, any suitable spring known to those of skill in the art may be used.
  • The seal 216 is desirably relaxed longitudinally in the decompressed state (FIG. 4), and compressed longitudinally in the compressed state (FIG. 5). Alternatively, the seal 216 may be stretched longitudinally in tension by the spring 222 in the decompressed state and be relaxed or slightly compressed longitudinal in the compressed state. The base 256 of the seal 216 advantageously fits snugly and securely into a annular groove 274 provided in the retaining disk 270 and an annular groove 276 provided in the support member 214. The annular grooves 274,276 form a locking mechanism to support and secure the seal 216 within the cavity 244 of the housing 212.
  • To illustrate valve activation, FIG. 5 shows the compressed state of the valve 210 upon insertion of the syringe 238. A medical implement other than a syringe as known to those of skill in the art may be used. The nose 236 of the syringe 238 is placed on the seal cap 248 inside the opening 230 of the housing 212. The application of pressure on the syringe 238 creates pressure on the seal cap 248, and the resulting downward pressure compresses the seal 216. This pushes the seal cap 248 away from the circular opening 230 and toward the lower portion of the housing cavity 244 which has a larger inner diameter, thereby allowing the precut slit 259 to open. The downward movement is facilitated by the compression of the spring 222 which stores the potential energy of compression and by the gaps between the wall portions 258 of the side wall 254 of the seal 216. Fluid is now able to flow into the syringe 238, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient. FIG. 5 shows the valve 210 opened by insertion of the nose 236 of the syringe 238 into the opening 230. For intravenous applications, the valve 210 can be oriented in the position diagramed in FIGS. 4 and 5, or it can be rotated 180′ such that fluid flows in the opposite direction.
  • In the compressed state shown in FIG. 5, the inner cavity 218 of the seal 216 generally contracts (becomes shorter) as compared to the decompressed state shown in FIG. 4. The constricted portion 267 of the inner cavity 218, defined by the clam shells 220 a/220 b, however, expands (becomes larger) in volume when the seal 216 is in the compressed state. This results from a movement of the clam shells 220 a/220 b apart from one another as they slide along the tapered side wall 232 of the housing 212. The amount of general contraction of the seal 216 in relation to the amount of expansion of the constricted portion 267 during compression determine whether the valve 210 generates a positive, negative, or zero flow upon decompression, as discussed below.
  • Upon removal of the syringe 238 from the upper conduit 226, as shown in FIG. 4, the seal 216 is free to move toward its decompressed state, and the clam shells 220 a/220 b are pushed proximally toward the opening 230. The movement causes a general expansion of the inner cavity 218 (i.e., the cavity increases in length), but causes a contraction (i.e., reduction in size) of the volume of the constricted portion 267 of the seal 216. If the volume change associated with the contraction of the constricted portion 267 equals the volume change associated with the expansion of the inner cavity 218, the fluid space or inner cavity will have zero flow. If the increase in volume associated with the expansion of the inner cavity 218 is greater than the reduction in volume associated with the contraction of the constricted portion 267, there will be a net gain in fluid space, resulting in an undesirable negative flow toward the valve 210 through, e.g., a catheter tip (not shown). If the reduction in volume associated with the contraction of the constricted portion 267 is greater than the increase in volume associated with the expansion of the inner cavity 218, there will be a desirable positive flow from the valve 210 through the catheter tip (not shown). Thus, for the valve 210 to be a positive-flow valve requires that the clam shells be configured to allow greater expansion of the constricted portion 267 (i.e., an increase in fluid volume in that area of the seal 216) than the general contraction volume change associated with the expansion of the inner cavity 218 of the seal 216 upon compression and, hence, greater contraction (i.e., decrease in fluid volume within that area of the seal) of the constricted portion 267 than the general expansion (i.e., increase in fluid volume in that area of the seal) of the seal 216 upon decompression. In other words, for the valve 210 to induce positive flow upon disconnection of the medical implement 238 therefrom, the total fluid volume within the valve 210 must decrease. In the instant case, this decrease in fluid volume is effectuated by causing the fluid volume within the seal to decrease as between its compressed (when syringe attached) and uncompressed (when syringe detached) states. This reduction or decrease in available fluid volume within the valve 210 causes fluid to flow towards the catheter/patient, preventing blood from being drawn into the catheter.
  • That the valve 210 is advantageously configured to be a positive-flow valve 210 eliminates any dead space during decompression of the seal 210 as the syringe 238 is withdrawn, as illustrated in FIG. 4. Furthermore, as the syringe 238 is withdrawn, the slit 259 remains open until the very end, i.e., until the seal cap 248 is squeezed by the circular opening 230 at the top of the upper conduit 226. This further assists in eliminating dead space and avoiding backflash. This feature is particularly advantageous in the case where the valve 210 is connected through a catheter to a patient, because it prevents blood from being drawn into the catheter and clogging it. This invention therefore eliminates a significant risk by solving the problem of backflash.
  • As the seal 216 is free to move to its decompressed state, it essentially fills the opening 230. The ability of the seal 216 to return to its original shape and be deformed in its decompressed state is determined by the resiliency of the material used to prepare the seal 216. Advantageously, the ability of the seal 216 to return to its decompressed state is facilitated by the spring 222 and the gaps between the wall portions 258 of the seal 216. The ability of the seal 216 to deform reversibly and return to its decompressed state is particularly useful because (1) it immediately stops fluid flow through the valve 210, and (2) it maintains sterility of the valve.
  • The ability of the seal 216 to return reversibly to its decompressed state permits reuse of the valve 210. Following disconnection, and before reuse, the surface 250 of the seal cap 248 is essentially flush with the opening 230 of the housing 212. Thus, this flush surface 250 can advantageously be sterilized with alcohol or other surface-decontaminating substances. The support member 214 and body 212 advantageously shield both connections from the surrounding environment to protect the sterility of the connection.
  • A cover cap (not shown) can be supplied to fit over the upper conduit 226 as further protection for the surface 250 of the seal cap 248 when not in use. Such a cover cap, however, is not needed to maintain sterility since the seal 216 may be swabbed with a disinfectant before and/or after each use. Reversibility of the seal 216 makes the valve 210 particularly attractive as a connector valve to provide fluid communication between two fluid lines. Therefore, the present invention provides for placing a first fluid line in communication with a second fluid line using the valve 210 disclosed herein. The reversibility of the valve 210 permits multiple fluid lines to be successively added, for example, to a fluid line in direct communication with a patient's vein. Since the valve 210 is easily sterilized and sealable, fluid lines can be added and removed without disconnecting venous contact of the catheter.
  • The valve body 212 and support member 214 are preferably prepared from a hard plastic, but it is additionally contemplated that the valve 210 could be prepared from other medically inert materials known to those skilled in the art. Another feature of this invention is that it relies neither on a needle nor on a spike in order to establish fluid flow through the valve. This completely eliminates the risk of skin puncture or fear of puncture during use and manufacture. It also eliminates coring of the seal 216 by a spike element and all the risks associated therewith. Further, the fluid flow rate is not limited by the size of a through passage in a needle or spike, as is the case in some prior art valves.
  • As shown in FIG. 4, another feature of the invention is that the upper ledge 234 confines the movement of the shoulder 252 toward the opening 250 to prevent the seal 216 from being blown through the opening 230 under high pressure in the cavity 218. This makes the valve 210 particularly suited for high pressure applications.
  • Second Embodiment
  • In a second embodiment of the present invention illustrated in FIGS. 6 and 7, the valve 310 includes a valve body or housing 312, a support member 314, a skirt 316, a seal 318, a resilient member 320, and a pair of clam shells 322 a/322 b. The housing 312 is desirably similar to the housing 212 of FIG. 4 and has a tapered side wall 324.
  • Referring to FIGS. 6 and 7, the second embodiment of the valve 310 has a bell-shaped skirt 316. The skirt 316 has an annular ring 328 which is disposed toward an inner conduit 330 of the support member 314. The skirt 316 creates a shield for the inner conduit 330. This inner conduit 330 is preferably cylindrical in shape and slightly tapered. The inner conduit may be connected to a terminal end of a catheter (not shown), which has an opposite, open end that is generally inserted into a patient. The support member 314 serves as a support and attachment device for the seal 318 by holding the seal 318 in place inside the housing 312.
  • The support member 314 also serves as a support and attachment device for the skirt 316. As best seen in FIG. 6, the support member 314 has an edge portion 332 which engages a ledge 334 of the skirt 316 in assembly. This attachment secures the skirt 316 in place. The skirt 316 desirably includes a Luer-Lock portion 336 that enables the valve 310 to be removably attached to, for example, a fluid line or catheter connected to a patient. It is noted that the valve 310 in this embodiment includes a skirt 316 separate from the housing 312 for ease of assembly. A different embodiment can provide a unitary member which replaces the housing 312 and skirt 316. It is therefore contemplated that such an embodiment would fall within the scope of this invention.
  • The seal 318 is similar to the seal 210 of FIG. 4. The seal 318 is also preferably silicon and has a similar seal cap 340 with a precut slit 342, shoulder 344, and pressure responsive member 348. These components serve the same function as those of the seal 210. Instead of a side wall formed with wall portions 258, the seal 318 has a side wall 350 that is generally circular cylindrical and has a distal portion 352 that is sized to be slip-fitted with the proximal end 354 of the inner conduit 330 of the support member 314. During compression of the seal 318, the side wall 350 simply slides over the proximal end 354 of the inner conduit 330, forming a fluid-tight seal therewith. The seal 318 defines an inner cavity 358 above the proximal end 354 of the inner conduit 330. The inner cavity 358 forms an expandable fluid space inside the valve 310. The inner conduit 330 and inner cavity 358 comprise aligned hollow tubes in fluid communication with each other when the precut slit 342 of the seal 318 opens during compression of the seal 310.
  • Similar in form and function to the clam shells 220 a/220 b of FIGS. 4 and 5, the clam shells 322 a/322 b are constructed to cause an increase in fluid space upon insertion of a medical implement into the valve 310 and a decrease in fluid space upon withdrawal of the medical implement such as a syringe 362 partially shown in phantom in FIG. 7. The internal surfaces 364 a/364 b of the clam shells desirably have longitudinal grooves that cooperate with one another to squeeze a portion of the seal side wall 350 to form a constricted portion 366 thereof.
  • Instead of the spring 222 in FIG. 4, the second embodiment employs the resilient member 320 disposed between the clam shells 322 a/322 b and the support member 314. The resilient member 320 advantageously is inert and impermeable to fluid such as silicon, and includes wall portions 368 which deform in an accordion-like fashion and assist in the reformation of the seal 318 to close the housing opening 370 upon withdrawal of the syringe 362. The resilient member 320 thus is similar in construction with and serves the same function as the spring 222 of the seal 210 of FIGS. 4 and 5. It is contemplated that a spring (not shown) similar to the spring 222 of FIG. 4 may be used in place of the resilient member 320, as may other suitable structures known to those of skill in the art.
  • As shown in FIGS. 6 and 7, the resilient member 320 has a base 346. The base 346 fits snugly and securely within an annular groove 374 provided in the housing 312 and an annular groove 377 provided in the support member 314, as shown in FIG. 6. The annular grooves 376,377 hence form a locking mechanism to support and secure the resilient member 320 within the housing 312. The shoulder 344 engages an upper ledge 382 provided in an upper conduit 384 of the housing 312 such that the upper ledge 382 confines the movement of the shoulder 344 toward the opening 370 to prevent the seal 318 from being blown through the opening 370 under high pressure in the inner cavity 358 of the seal 318.
  • The resilient member 320 is desirably relaxed or slightly compressed longitudinally in the decompressed state (FIG. 6), and compressed longitudinally in the compressed state (FIG. 7). The resilient member 320 is desirably not attached or bonded to either of the clam shells 322 a/322 b or the housing 312.
  • FIG. 7 illustrates compression and FIG. 6 illustrates decompression during valve activation. In the compressed state, the syringe 362 is placed on the seal cap 340 inside the opening 370 of the housing 312, and the application of pressure on the syringe 362 creates pressure on the seal cap 340. The downward pressure pushes the seal cap 340 away from the circular opening 370 and toward the distal lower portion of the housing 312 which has a larger inner diameter, thereby allowing the precut slit 342 to open. The side wall 350 slides over the proximal end 354 of the inner conduit 330, and the resilient member 320 deforms in an accordion-like manner, storing potential energy of the compression. Fluid is able to flow into the syringe 362, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • The compression of the seal 318 shown in FIG. 7 generally causes a contraction or reduction in the volume of the inner cavity 358 of the seal 318. The valve 310 has a net gain in volume of the inner cavity 318, however, because the general reduction in volume within the inner cavity 358 is less than an increase in volume within the constricted portion 366 of the inner cavity 358 defined by the clam shells 322 a/322 b. The expansion results from the movement of the clam shells 322 a/322 b apart from one another during compression, facilitated by the tapered side wall 324 of the housing 312.
  • FIG. 6 illustrates the valve after withdrawal of the syringe 362. The seal 318 returns to its decompressed state and essentially fills the opening 370, and the clam shells 322 a/322 b are pushed proximally toward the opening 370 by the resilient member 320. Because of the contraction of the inner cavity 358 at the constricted portion 366 by the clam shells 322 a/322 b, there is a net loss or reduction in fluid space, resulting in a positive flow from the valve 310 through, e.g., a catheter tip (not shown). The positive-flow valve 310 advantageously eliminates any dead space during decompression of the seal 318. This is further assisted by the seal 318 with the slit 342 remaining open until the very end, i.e., until the seal cap 340 is squeezed by the upper conduit 384.
  • In addition, the valve 310 can be reused because the seal 318 can return reversibly in the decompressed state. The seal surface 340 is also swabbable for sterility. Other features of the valve 310 are discussed previously in connection with the first embodiment of this invention and will not be repeated.
  • Third Embodiment
  • As shown in FIGS. 8 and 9, a third embodiment of the valve 410 of the present invention comprises a valve body or housing 412, a support member 414, a flexible tubing 416, a seal 418, a ring member 420, a pair of clam shells 422 a/422 b, and a spring 424. The flexible tubing 416 may be connected to a catheter (not shown) and, together with the seal 418, defines an inner cavity 426. The inner cavity 426 forms an expandable fluid space of the valve 410. The clam shells 422 a/422 b desirably are substantially the same as the clam shells 220 a/220 b of FIG. 4 and are constructed to cause the fluid space within the valve 410 to increase upon insertion of a medical implement and to decrease upon withdrawal of the medical implement such as a syringe 428 partially shown in phantom in FIG. 9. The housing 412 is desirably similar to the housing 212 of FIG. 4.
  • The support member 414 has a hollow center 430 which supports the flexible tubing, and a proximal end 432 which encloses a distal end 434 of the housing 412. The support member 414 desirably locks onto the housing 412 via any method known to those of skill in the art. The proximal end 432 of the support member 414 supports the spring 424, which in turn supports the clam shells 422 a/422 b and seal 418.
  • The seal 418 is prepared from a resilient material that is flexible, inert, and impermeable to fluid, such as silicon. Referring to FIG. 8, the seal 418 is substantially similar to the seal 210 of FIG. 4, with a portion of the side wall 438 cut off near the shoulder 440 region. As a result, the side wall 438 of the seal 418 is substantially shorter than the side wall 254 of the seal 210 in FIG. 4. A distal end 442 of the side wall 254 is attached, preferably by adhesive, to a proximal end 444 of the flexible tubing 416. The distal end 442 abuts the ring member 420 which is disposed between the seal 418 and the clam shells 422 a/422 b and attached at its inner surface 446 to a portion of the tubing 416, desirably also by adhesive. Other suitable means of attachment may be used. The ring member 420 is desirably made of polycarbon.
  • The clam shells 422 a/422 b desirably form a sliding contact at their proximal ends with the ring member 420 for ease of assembly, but may alternatively be affixed to the ring member 420 by adhesive or similar means. The clam shells 422 a/422 b are desirably the same as the clam shells 220 a/220 b of FIG. 4, having tapered external surfaces 450 a/450 b to cooperate with the tapered side wall portion 452 of the housing 412 for sliding and grooved internal surfaces 454 a/454 b that cooperate with one another to squeeze a portion of the tubing 416 to form a constricted portion 456.
  • The spring 424 is substantially the same as the spring 222 of FIG. 4 and serves the same function, being disposed between the distal ends of the clam shells 422 a/422 b and the proximal end 432 of the support member 414. In the decompressed state shown in FIG. 8, the spring 424 may be relaxed or in slight compression to exert a force on the seal 418 through the clam shells 422 a/422 b to keep the slit 466 in the seal cap 460 closed. During insertion of the syringe 428, the spring 424 is compressed and stores potential energy from the compression, as illustrated in FIG. 9. Upon withdrawal of the syringe 428, the spring 424 releases the potential energy and pushes the clam shells 422 a/422 b proximally to close the seal 418, as shown in FIG. 8. The spring 424 is preferably not attached or bonded to either the clam shells 422 a/422 b or the support member 414 for ease of assembly. The spring 424 can be a helical spring or any other suitable spring known to those with skill in the art.
  • FIG. 9 shows the compressed state of the valve 410 upon insertion of the syringe 428. In the compressed state, the syringe 428 is placed on the seal cap 460 inside the opening 464 of the housing 412 and the application of pressure on the syringe 428 creates pressure on the seal cap 460. The downward pressure pushes the seal cap 460 away from the circular opening 464 and toward the distal end of the housing 412, which has a larger inner diameter, thereby allowing the precut slit 466 of the seal cap 460 to open. The resilient tubing 416 and the clam shells 422 a/422 b also move distally as the spring 424 deforms in compression, storing potential energy. Fluid is able to flow into the syringe 428, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • The compression of the seal 418 shown in FIG. 9 generally causes a reduction in the volume of the inner cavity 426 formed by the seal 418 and tubing 416. However, because of an expansion of the constricted portion 456 defined by the clam shells 422 a/422 b an increase in fluid volume is created which is greater than the general reduction in fluid volume within the inner cavity 426, the valve 410 has a net gain in fluid volume. The increase in fluid volume results from the movement of the clam shells 422 a/422 b apart from one another during seal compression, facilitated by the tapered side wall 452 of the housing 412 and resiliency of the tubing 416.
  • FIG. 8 illustrates the valve 410 after withdrawal of the syringe 428. The seal 418 returns to its decompressed state and essentially fills the opening 464, and the clam shells 422 a/422 b are pushed proximally toward the opening 464 by the spring 424. Because of the contraction of the inner cavity 426 at the constricted portion 456 by the clam shells 422 a/422 b, there is a net loss in fluid space, resulting in a positive flow from the valve 410 through, e.g., a catheter tip (not shown). The positive-flow valve 410 advantageously eliminates any dead space during decompression of the seal 418. This is further assisted by the seal 418, with the slit 466 remaining open until the very end, i.e., until the seal cap 460 is squeezed by upper conduit 470.
  • In addition, the valve 410 can be reused because the seal 418 can return reversibly to the decompressed state. The seal surface 472 is also swabbable for sterility. Other features of the valve 410 are discussed previously in connection with the earlier embodiments of this invention and will not be repeated.
  • Fourth Embodiment
  • A fourth embodiment of the present invention is illustrated in FIGS. 10 and 11. As illustrated therein, a valve 510, comprises a valve body or housing 512, a support member 514, a skirt 516, a retaining member 518, a seal 520, a pair of clam shells 522 a/522 b, and a resilient member 524. The valve 510 has several features that are the same or similar to those of the valve 310 of FIGS. 8 and 9, having a similar resilient member 524 and clam shells 522 a/522 b. The clam shells 522 a/522 b have internal surfaces 526 a/526 b that cooperate with one another to squeeze a portion of the seal side wall 528 to form a constricted portion 530 thereof.
  • The seal 510 is preferably made of silicon and has a seal cap 532 with a precut slit 534, shoulder 536, lower lip 538, and pressure responsive member 540 that are similar to the seal 210 of FIG. 4. These components serve the same function as those of the seal 210. The side wall 528 may be formed with ringed wall portions 258, as in the seal 210, but FIG. 4 shows the side wall 528 that is generally circular cylindrical. The seal 520 defines an inner cavity 542 which forms an expandable fluid space inside the valve 510. During compression of the seal 520, the side wall 528 deforms outwardly into a circumferential cusp or bulge 544 in the unconstricted region between the clam shells 522 a/522 b and the support member 514. The side wall 528 returns to its decompressed shape upon decompression of the seal 520. The seal 520 is desirably relaxed longitudinally in the decompressed state (FIG. 10), and compressed longitudinally in the compressed state (FIG. 11). Alternatively, the seal 520 may be stretched longitudinally in tension by the resilient member 524 in the decompressed state and be relaxed or slightly compressed longitudinal in the compressed state.
  • Referring to FIG. 10, the skirt 516 is a bell-shaped skirt that is similar to the skirt 316 of FIG. 8. The skirt 516 creates a shield for an inner conduit 548 of the support member 514. The inner conduit 548 may be connected to a terminal end of a catheter (not shown) which has an open end that is generally inserted into a patient. The support member 514 serves as a support and attachment device for the seal 520 by holding the seal 520 in place inside the housing 512.
  • The support member 514 also serves as a support and attachment device for the skirt 516. Similar to the valve 310 of FIG. 8, the support member 514 shown in FIG. 10 has an edge portion 550 which engages a ledge 552 of the skirt 516 in assembly. This attachment secures the skirt 516 in place. The skirt 516 desirably includes a Luer-Lock portion 554 that enables the valve 510 to be removably attached to, for example, a fluid line or catheter connected to a patient.
  • The retaining member 518 is desirably provided to secure the lower lip 538 of the seal 520 and support the resilient member 524. The retaining member 518 is held inside the housing 512 by the support member 514, and is provided for ease of assembling the valve 510. The retaining member 518 has an annular groove 556, and the support member 514 has an annular groove 558. The annular grooves 556,558 form a locking mechanism to support and secure the seal 520 within the housing 512 by engaging the lower lip 538 snugly with the grooves 556,558. It is noted that a different embodiment may provide a unitary member which replaces the support member 514 and the retaining member 518. It is therefore contemplated that such an embodiment would fall within the scope of this invention.
  • FIG. 11 illustrates compression and FIG. 10 illustrates decompression during valve activation. In the compressed state, a medical implement such as the syringe 562 partially shown in phantom is placed on the seal cap 532 inside the opening 564 of the housing 512, and the application of pressure on the syringe 562 creates pressure on the seal cap 532. The downward pressure pushes the seal cap 532 away from the circular opening 564 and toward the lower portion of the housing 512, which has a larger inner diameter, thereby allowing the precut slit 534 to open. The side wall 528 deforms outwardly at the unconstricted region into a circumferential cusp 544, and the resilient member 524 deforms in an accordion-like manner, storing potential energy of the compression. Fluid is able to flow into the syringe 562, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • The compression of the seal 520 shown in FIG. 11 generally causes a reduction in the fluid volume of the inner cavity 542 of the seal 520. The valve 510 has a net gain in volume of the inner cavity 542, however, because the general reduction in volume within the inner cavity 542 is less than the increase in volume within the constricted portion 530 as defined by the clam shells 522 a/522 b and of the cusp 544 at the unconstricted region of the seal 520.
  • FIG. 10 illustrates the valve 510 after withdrawal of the syringe 562. The seal 520 returns to its decompressed state and essentially fills the opening 564, and the clam shells 522 a/522 b are pushed back up toward the opening 564 by the resilient member 524. Because of the contraction of the inner cavity 542 of the seal 520, there is a net loss in fluid space, resulting in a positive flow from the valve 510 through, e.g., a catheter tip (not shown). The positive-flow valve 510 advantageously eliminates any dead space during decompression of the seal 520. This is further assisted by the seal 520, with the slit 534 remaining open until the very end, i.e., until the seal cap 532 is squeezed by the circular opening 564 at the top of the upper conduit 570.
  • In addition, the valve 510 can be reused because the seal 520 can return reversibly in the decompressed state. The seal surface 572 is also swabbable for sterility. Other features of the valve 510 are discussed previously in connection with the earlier embodiments of this invention.
  • Fifth Embodiment
  • FIGS. 12 and 13 show a fifth embodiment valve 610 in accordance with the present invention, the valve 610 comprising a valve body or housing 612, a seal 614, a ring member 616, and a spring 618. The housing 612 is similar to the housing 212 of FIG. 4, with a circular opening 620, and a tapered side wall 622, but may have a straight side wall instead. The seal 614 is similar to the seal 318 of FIG. 8, having a substantially cylindrical side wall 624 and defining an inner cavity 626 which forms an expandable fluid space inside the valve 610. The side wall 624 may have different and variable thickness (not shown). The components are dimensioned and configured to cause the fluid space to expand upon insertion of a medical implement and to contract upon withdrawal of the medical implement such as a syringe 630 partially shown in phantom in FIG. 13. The distal portion of the seal 614 is connected to a fluid line such as a catheter (not shown), and may be secured to the housing by means known to those with skill in the art, such as by the use of a support member (not shown) similar to the support member 214 shown in FIG. 15.
  • The ring member 616 is desirably an annular disk 616 made of a hard plastic and disposed between a shoulder 634 of the seal 614 and a proximal end 636 of the spring 618. The ring member 616 serves as a constraint for the seal 614 during compression and efficiently transfers the compressive force to the spring 618, assisting in the deformation of the seal 614. During decompression, the ring member 616 efficiently transfers the spring force to the seal cap 638 of the seal 614 to close the opening 620. Although the ring member 616 facilitates the deformation and reformation of the seal 614, it is not necessary for the seal 614 to work. In that case, the spring 618 will contact the seal cap 638 directly.
  • The spring 618 is substantially the same as the spring 222 of FIG. 4 and serves the same function, being disposed between the ring member 616 and a distal end 642 of the housing 612. In an alternative embodiment, the distal end 642 may be a separate component from the housing 612 for ease of assembly. In the decompressed state shown in FIG. 12, the spring 618 may be relaxed or be in slight compression to exert a force on the seal 614 through the ring member 616 to keep the seal 614 closed. During insertion of the syringe 630, the spring 618 is compressed and stores potential energy from the compression, as illustrated in FIG. 13. Upon withdrawal of the syringe 630, the spring 618 releases the potential energy and pushes the ring member 616 to close the seal 616 as shown in FIG. 12. The spring 618 is preferably not fixed with either the ring member 616 or the distal end 642 of the housing 612 for ease of assembly. The spring 618 can be a helical spring or any other suitable spring known to those with skill in the art.
  • The side wall 624 of the seal 614 is constrained by the ring member 616 and housing 612, and is substantially relaxed in the decompressed state. During compression of the seal 614, the side wall 624 bulges in the unconstrained region between the ring member 616 and the distal end 642 of the housing 612, causing an increase in the fluid space within the valve 610. The side wall 624 returns to its decompressed shape upon decompression of the seal 614. Alternatively, the side wall 624 may be stretched in tension by the spring 618 in the decompressed state and goes through a relaxed position before deforming under compression to its bulged condition.
  • FIG. 13 illustrates compression and FIG. 12 illustrates decompression during valve activation. In the compressed state, the syringe 630 is placed on the seal cap 638 inside the opening 620 of the housing and the application of pressure on the syringe 630 creates pressure on the seal cap 638. The downward pressure pushes the seal cap 638 and the ring member 616 away from the circular opening 620 and toward the lower portion of the housing 612 which has a larger inner diameter, thereby allowing the precut slit 646 of the seal cap 638 to open. The side wall 624 deforms outwardly and bulges at the unconstricted region, as the spring 618 is compressed, storing potential energy of the compression. Fluid is able to flow into the syringe 630, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient. The compression of the seal 614 shown in FIG. 13 results in a net gain in volume of the inner cavity.
  • FIG. 12 illustrates the valve 610 after withdrawal of the syringe 630. The seal 614 returns to its decompressed state and essentially fills the opening 620, and the ring member 616 is pushed back up toward the opening 620 as the spring 618 releases its potential energy. Because of the contraction of the inner cavity 626 of the seal 614, there is a net loss in fluid space, resulting in a positive flow from the valve 610 through, e.g., a catheter tip (not shown). The positive-flow valve 610 advantageously eliminates any dead space during decompression of the seal 614. This is further assisted by the seal 614 with the slit 646 remaining open until the very end, i.e., until the seal cap 638 is squeezed by the circular opening 620 at the top of the upper conduit 650 of the housing 612.
  • In addition, the valve 610 can be reused because the seal 614 can return reversibly in the decompressed state. The seal surface 652 is also swabbable for sterility. Other features of the valve 610 are discussed previously in connection with the earlier embodiments of this invention.
  • Sixth Embodiment
  • A sixth embodiment of a valve 710 is illustrated in FIGS. 14 and 15. The valve 710 comprises a valve body or housing 712 and a seal 714. The housing 712 has an upper conduit 716 near a proximal end with a circular opening 718 that is preferably adapted to receive a medical implement. A side wall portion 720 is protruded to facilitate deformation of the seal 714. A distal end 724 of the housing 712 forms a lower passage 726 (partially shown) which supports and constrains a distal portion 728 of the seal 714, and is connected, for example, to a fluid line such as a catheter (not shown). Alternatively, a support member (not shown) may be used to detachably lock onto the housing 712 and support the seal 714, such as those shown in FIG. 4 (214) or FIG. 12 (514).
  • The seal 714 is generally similar to the seal 614 of FIGS. 12 and 13, and has a substantially cylindrical side wall 721, although the side wall 732 may have a slight bulge 733 as shown in FIG. 14. It defines an inner cavity 734 which forms an expandable fluid space inside the valve 710. In the decompressed state, the seal 714 is constrained by the upper conduit 716 and lower passage 726 of the housing 712, and is substantially relaxed in the decompressed state. The components are dimensioned and configured to cause the fluid space to expand or increase upon insertion of the medical implement and to contract or decrease upon withdrawal of the medical implement such as the syringe 730 partially shown in phantom in FIG. 15. During compression of the seal 714, the side wall 732 bulge in the unconstrained region between the upper conduit 716 and lower passage 726 and the bulge 738 is substantially round. The side wall 732 return to its decompressed shape upon decompression of the seal 714.
  • FIG. 15 illustrates compression and FIG. 14 illustrates decompression during valve activation. In the compressed state, the syringe 730 is placed on the seal cap 742 of the seal 714 inside the opening 718 of the housing 712 and the application of pressure on the syringe 730 creates pressure on the seal cap 742. The downward pressure pushes the seal cap 742 away from the circular opening 718 and toward the protruded portion 720 of the housing 712 which has a larger inner diameter, thereby allowing the precut slit 746 of the seal cap 742 to open. The side wall 732 deforms outwardly and bulges at the unconstricted region 738, storing potential energy of the compression. Fluid is able to flow into the syringe 730, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient. The compression of the seal 714 shown in FIG. 15 generates a net gain in volume of the inner cavity.
  • FIG. 14 illustrates the valve 710 after withdrawal of the syringe 730. The seal 714 returns to its decompressed state and essentially fills the opening 718. Because of the contraction of the inner cavity 734 of the seal, there is a net loss in fluid space, resulting in a positive flow from the valve 710 through, e.g., a catheter tip (not shown). The positive-flow valve 710 advantageously eliminates any dead space during decompression of the seal 714. This is further assisted by the seal 714 with the slit 746 remaining open until the very end, i.e., until the seal cap 742 is squeezed by the circular opening 718 at the top of the upper conduit 716.
  • In addition, the valve 710 can be reused because the seal 710 can return reversibly in the decompressed state. The seal surface 748 is also swabbable for sterility. Other features of the valve 710 are discussed previously in connection with the earlier embodiments of this invention.
  • Seventh Embodiment
  • FIGS. 16 and 17 illustrate a valve 710 in accordance with a seventh embodiment of the present invention, the valve 756 comprising a valve body or housing 758 and a seal 760 that are substantially the same as the housing 712 and seal 714 of FIGS. 14 and 15, with a distal portion 762 of the seal 760 connected to a fluid line such as a catheter (not shown). The seal 760, however, is configured to deform upon compression into a diamond-shaped cusp 764 instead of a round bulge 738 as illustrated in FIGS. 14 and 15. This type of construction may facilitate deformation and reformation of the seal 760, and may be more easily formed. The valve activation of this embodiment is virtually identical to that in FIGS. 14 and 15, except for the deformed shape of the seal side wall 770. It is contemplated, therefore, that a seal that may deform into a variety of shapes other than round and diamond shapes to achieve positive flow may be employed, as long as the it is dimensioned and configured to cause the fluid space of the valve to expand upon insertion of a medical implement and to contract upon withdrawal of the medical implement such as the syringe 774 partially shown in phantom in FIG. 28.
  • Eighth Embodiment
  • As illustrated in FIGS. 18 and 19, an eighth embodiment valve 810 of the present invention is similar to the embodiments shown in FIGS. 14-17. The valve 810 also includes a housing 812 having an internal cavity 814 with an upper conduit 816, and a seal 818 disposed inside the internal cavity 814 and having an inner cavity 820 that defines a fluid space. The housing 812 has a distal end 824 which supports a side wall 826 of the seal 818. A distal portion 828 of the seal 818 is connected to a fluid line such as a catheter (not shown). The pressure at the inner cavity 820 of the seal 818 is P1. Between the housing 812 and the seal 818 is an enclosed pressure chamber 832 at pressure P2. The valve activation utilizes the pressure difference between P2 in the pressure chamber 832 and P1 in the inner cavity 820 of the seal 818.
  • Upon insertion of a medical implement such as a syringe 836 shown in phantom in FIG. 19, the pressure at the inner cavity 820 of the seal 818 increases from P1 to P3 and the fluid space inside the seal 818 expands from the decompressed state of FIG. 18. The expansion of the fluid space results primarily from a difference in pressure between P3 and P2. This valve 810 is particularly advantageous in the case where the side wall 826 of the seal 818 deforms without storing substantial potential energy. For instance, the side wall 826 of the seal 818 may deform without substantial resistance or resiliency such as a membrane, or the seal is not constrained longitudinal by the distal portion 824 of the housing 812 and may slide in and out of the internal cavity 814 of the housing 812 through the distal end 824.
  • FIG. 19 illustrates compression and FIG. 18 illustrates decompression during valve activation. In the compressed state, the syringe 836 is placed on the seal cap 838 of the seal 818 inside the opening 840 of the housing 812 and the application of pressure on the syringe creates pressure on the seal cap 838. The downward pressure pushes the seal cap 838 away from the circular opening 840 and toward the lower portion of the housing 812 which has a larger inner diameter, thereby allowing the precut slit 844 of the seal cap 838 to open. The entry of the fluid causes the pressure at the inner cavity 814 of the seal 812 to increase to P3. As a result, the side wall 826 deforms outwardly and bulges at the unconstricted region 848. Potential energy is stored in the change in pressure differential between the inner cavity 820 and the pressure chamber 832. The side wall 826 of the seal 818 need not deform and store energy, but may do so. Fluid is able to flow into the syringe 836, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient. The compression of the seal 818 shown in FIG. 19 causes a net gain or increase in fluid volume within the inner cavity.
  • FIG. 18 illustrates the valve 810 after withdrawal of the syringe 836. The seal 818 returns to its decompressed state and essentially fills the opening 840, and the pressure in the inner cavity 820 returns to P1 and releases the potential energy. Because of the contraction of the inner cavity 820 of the seal 818, there is a net loss in fluid space, resulting in a positive flow from the valve 810 through, e.g., a catheter tip (not shown). The positive-flow valve 810 advantageously eliminates any dead space during decompression of the seal 818. This is further assisted by the seal 818 with the slit 844 remaining open until the very end, i.e., until the seal cap 838 is squeezed by the circular opening 840 at the top of the upper conduit 816.
  • In addition, the valve 810 can be reused because the seal 818 can return reversibly in the decompressed state. The seal surface 854 is also swabbable for sterility. Other features of the valve 810 are discussed previously in connection with the earlier embodiments of this invention.
  • Ninth Embodiment
  • A ninth embodiment of a valve 910 comprising a housing 912, a support member 914, a skirt 916, a seal 918, and a scissor-like cross member 920, is depicted in FIGS. 20 and 21. The housing 912 has an upper conduit 924 with a circular opening 926. The support member 914 has an inner conduit 928 which is connected to a fluid line such as a catheter (not shown). The seal 918 has a side wall 930 desirably formed of alternating wall portions 932 and defines an inner cavity 934 which forms an expandable fluid space inside the valve 910. The cross member 920 is dimensioned and configured to assist in causing the fluid space to expand upon insertion of a medical implement and to contract upon withdrawal of the medical implement such as the syringe 936 partially shown in phantom in FIG. 21.
  • The cross member 920 has two longitudinal member 940 attached together which rotates with respect to one another, and is desirably made of a hard material such as a hard plastic. The cross member 920 is disposed at a constricted portion 942 of the seal 918 within the inner cavity 934 with the longitudinal members 940 preferably substantially disposed vertically. The ends 944 of the longitudinal members 940 are desirably attached to the side wall 930 as shown in FIG. 20. The longitudinal members 940 rotate to a substantially horizontal orientation upon compression by the insertion of the syringe 936 as shown in FIG. 21. This rotation is referred to as the deformation of the cross member 920. The longitudinal members 940 may be attached to rotate freely with respect to one another. Alternatively, the longitudinal members 940 may be spring-loaded or attached such that they rotate under a rotational force but reform to their relaxed position upon release of the force. Upon withdrawal of the syringe 936 as shown in FIG. 20, the longitudinal members 940 return to the substantially vertical positions, referred to as the reformation of the cross member 920. The longitudinal members 940 are desirably longitudinal plates 940 with sufficient width to expand the constricted portion 942 of the seal 918 in the substantially horizontal position but not so wide that they impedes flow therethrough. Alternatively, they may contain holes (not shown) through which fluid can pass.
  • FIG. 21 illustrates compression and FIG. 20 illustrates decompression during valve activation. In the compressed state, the syringe 926 is placed on the seal cap 950 of the seal 918 inside the opening 926 of the housing 912 and the application of pressure on the syringe 936 creates pressure on the seal cap 950. The downward pressure pushes the seal cap 950 away from the circular opening 926 and toward the lower portion of the housing 912 which has a larger inner diameter, thereby allowing the precut slit 952 of seal cap 950 to open. The side wall 930 of the seal 918 deforms in an accordion-like manner, and the cross member 920 deforms and opens up the constricted portion 922 of the seal 918, storing potential energy of the compression. Fluid is able to flow into the syringe 936, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient. The compression of the seal 918 and deformation of the cross 920 shown in FIG. 21 generally causes a contraction of the volume of the inner cavity 934 of the seal 918. The valve 910 has a net gain in volume of the inner cavity 934, however, because the general contraction of the inner cavity 934 is less than by the expansion of the constricted portion 942 pushed apart by the cross member 920. The expansion results from the movement of the longitudinal members 940 of the cross member 920 during compression.
  • FIG. 20 illustrates the valve 910 after withdrawal of the syringe 936. The seal 918 returns to its decompressed state and essentially fills the opening 926, and the cross member 920 reforms to allow the constricted region 942 of the seal 918 to narrow. Because of the contraction of the inner cavity 934 at the constricted portion 942, there is a net loss in fluid space, resulting in a positive flow from the valve 910 through, e.g., a catheter tip (not shown). The positive-flow valve 910 advantageously eliminates any dead space during decompression of the seal 918. This is further assisted by the seal 918 with the slit 952 remaining open until the very end, i.e., until the seal cap 950 is squeezed by the circular opening 926 at the top of the upper conduit 924.
  • In addition, the valve 910 can be reused because the seal 918 can return reversibly in the decompressed state. The seal surface 960 is also swabbable for sterility. Other features of the valve 910 are discussed previously in connection with the earlier embodiments of this invention.
  • Tenth Embodiment
  • FIGS. 22 and 23 illustrate a valve 1010 in accordance with a tenth embodiment of the present invention, the valve 1010 comprising a valve body or housing 1012, a support member 1014 (partially shown), a seal 1016, a ring member 1018, a resilient reel 1020, and a scissor-like cross member 1022. The support member 1014 has an inner conduit (not shown) which is connected to a fluid line such as a catheter (not shown). The seal 1016 has a seal cap 1028 with slit 1030, shoulder 1032, and pressure responsive member 1034.
  • The ring member 1018 forms a sliding contact with a distal end 1036 of the seal 1016 and is preferably made from a hard plastic. The ring member 1018 desirably has a shoulder 1038 which is constrained by a ledge 1040 of the housing 1012 in the upward direction. The distal end of the ring member 1018 contacts an upper flange 1044 of the resilient reel 1020 and facilitates transfer of the compressive force due to insertion of a medical implement to cause deformation of the reel 1020. The reel 1020 is made from a material that is flexible, inert, and impermeable to fluid, such as silicon. It has a lower flange 1046 that is supported and secured by the support member 1014 and a central body portion 1048 that is substantially cylindrical. The seal 1016, ring member 1018, and resilient reel 1020 define an inner cavity 1050 which forms an expandable fluid space inside the valve 1010.
  • The cross member 1022 is substantially the same of the cross member 920 of FIGS. 20 and 21 and is dimensioned and configured to assist in causing the fluid space to increase upon insertion of a medical implement and to decrease upon withdrawal of the medical implement such as the syringe 1054 partially shown in phantom in FIG. 23. The cross member 1022 has two longitudinal members 1056 rotatably attached together. The cross member 1022 is disposed adjacent the central body portion 1048 of the reel 1020 within the inner cavity 1050 with the longitudinal members 1056 preferably pointed toward the vertical direction and desirably attached to the central body portion 1048 at its four ends 1058 as shown in FIG. 22. The longitudinal members 1056 rotate to a substantially horizontal orientation upon compression by the insertion of the syringe 1054 as shown in FIG. 23. This rotation is referred to as the deformation of the cross member 1022. The longitudinal members 1050 may be attached to rotate freely with respect to one another. Alternatively, the longitudinal members 1056 may be spring-loaded or attached such that they rotate under a rotational force but reform to their relaxed position upon release of the force. Upon withdrawal of the syringe 1056 as shown in FIG. 22, the longitudinal members 1056 return to the substantially vertical positions, referred to as the reformation of the cross member 1022. The longitudinal members 1026 are desirably longitudinal plates 1056 with sufficient width to open up the central body portion 1048 of the reel 1020 in the substantially horizontal position but not so wide that they impedes flow therethrough. Alternatively, they may contain holes (not shown) through which fluid can pass.
  • FIG. 23 illustrates compression and FIG. 22 illustrates decompression during valve activation. In the compressed state, the syringe 1054 is placed on the seal cap 1028 inside the opening 1062 of the housing 1012 and the application of pressure on the syringe 1054 creates pressure on the seal cap 1028. The downward pressure pushes the seal cap 1028 away from the circular opening 1062 and toward the lower portion of the housing 1012 which has a larger inner diameter, thereby allowing the precut slit 1030 to open. The ring member 1018 moves toward the support member 1014 and compresses the resilient reel 1020. The upper flange 1044 of the resilient reel 1020 is pushed by the ring member 1018 toward the lower flange 1046. The central body portion 1048 bulges outwardly as the cross member 1022 deforms, storing potential energy of the compression. Fluid is able to flow into the syringe 1054, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • The compression of the seal 1016 and deformation of the cross 1022 shown in FIG. 23 generally causes a reduction in the volume of the inner cavity of the seal 1016. The valve 1010 has a net gain in volume of the inner cavity 1050, however, because the expansion of the central body portion 1048 of the flexible reel 120 causes an increase in fluid volume which reduction resulting in is greater than the general contraction of the inner cavity 1050. The expansion results from the movement of the longitudinal members 1056 of the cross member 1022 to open up the central body portion 1048 of the resilient reel 1020 during compression.
  • FIG. 22 illustrates the valve 1010 after withdrawal of the syringe 1054. The seal 1016 returns to its decompressed state and essentially fills the opening 1062, and the cross member 1022 reforms to allow the central body region 1048 of the resilient reel 1022 to narrow. Because of the contraction of the inner cavity 1050 at the central body portion 1048, there is a net loss in fluid space, resulting in a positive flow from the valve 1010 through, e.g., a catheter tip (not shown). The positive-flow valve 1010 advantageously eliminates any dead space during decompression of the seal 1016. This is further assisted by the seal 1016 with the slit 1030 remaining open until the very end, i.e., until the seal cap 1028 is squeezed by the circular opening 1062 at the top of the upper conduit 1066 of the housing.
  • In addition, the valve 1010 can be reused because the seal 1016 can return reversibly in the decompressed state. The seal surface 1068 is also swabbable for sterility. Other features of the valve 1010 are discussed previously in connection with the earlier embodiments of this invention.
  • Eleventh Embodiment
  • An eleventh embodiment of a valve 1110 in accordance with the present invention is illustrated in FIGS. 24 and 25, and comprises a valve body or housing 1112 and a seal 1114. The housing 1112 has an upper conduit 1116 near a proximal end with a circular opening 1118 that is preferably adapted to receive a medical implement such as a syringe 1120 partially shown in phantom in FIG. 25. The housing 1112 has a lower conduit 1124 (partially shown) near a distal end which is connected to a fluid line such as a catheter (not shown). Disposed between the upper conduit 1116 and lower conduit 1124 are protruded right and left side walls 1126 a,1126 b connected to resilient ribbed portions 1128 a,1128 b which allow the side walls 1126 a,1126 b to be stretched outwardly and reform inwardly in a substantially horizontal direction. Aside from the resilient ribbed portions 1128 a, 1128 b, the rest of the housing 1112 is desirably made of a firm material such as a hard plastic.
  • The seal 1114 is generally similar to the seal 318 of FIG. 6 with a similar shoulder 1132, seal cap 1134, and pressure responsive element 1136. The cylindrical side wall 350 of FIG. 6, however, is replaced with a spreader 1140, which includes two legs 1142 a, 1142 b that extend from the shoulder 1132 outwardly at distal ends 1144 a, 1144 b that bear against the protruded right and left side walls 1126 a,1126 b, as best seen in FIG. 24. The distal end 1144 a may be attached to the protruded side wall 1126 a, and the distal end 1144 b may be attached to the protruded side wall 1126 b, by adhesives or other available means. An inner cavity 1150 is formed by the seal 1114 and a distal portion 1152 of the housing 1112, and defines a fluid space of the valve 1110. During compression of the seal 1114, the spreader 1140 extends further outwardly and pushes the protruded side walls 1126 a,1126 b outwardly. The seal 1114 and housing 1112 are configured and dimensioned to assist in causing the fluid space to expand upon insertion of the medical implement 1120 and to contract upon withdrawal of the medical implement 1120.
  • FIG. 25 illustrates compression and FIG. 24 illustrates decompression during valve activation. In the compressed state, the syringe 1120 is placed on the seal cap 1134 inside the opening 1118 of the housing 1112 and the application of pressure on the syringe 1120 creates pressure on the seal cap 1134. The downward pressure pushes the seal cap 1134 away from the circular opening 1118 and toward the lower portion of the housing 1112 which has a larger inner diameter, thereby allowing the precut slit 1156 oft he seal cap 1134 to open. The spreader 1140 extends outwardly, stretching the resilient ribbed portions 1128 a, 1128 b and pushing the protruded right and left side walls 1126 a,1126 b of the housing 1112 outwardly, storing potential energy of the compression. Fluid is able to flow into the syringe 1120, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient. The compression of the seal 1114 and deformation of the spreader 1140 shown in FIG. 36 results in a net gain in volume of the inner cavity 1150.
  • FIG. 24 illustrates the valve 1110 after withdrawal of the syringe 1120. The seal 1114 returns to its decompressed state and essentially fills the opening 1118, and the spreader 1140 and resilient ribbed portions 1128 a,1128 b reform to allow the protruded right and left side walls 1126 a,1126 b to move inwardly. Because of the contraction of the inner cavity 1150, there is a net loss in fluid space, resulting in a positive flow from the valve 1110 through, e.g., a catheter tip (not shown). The positive-flow valve 1110 advantageously eliminates any dead space during decompression of the seal 1114. This is further assisted by the seal 14 with the slit 1156 remaining open until the very end, i.e., until the seal cap 1134 is squeezed by the circular opening 1156 at the top of the upper conduit 1116.
  • In addition, the valve 1110 can be reused because the seal 1114 can return reversibly in the decompressed state. The seal surface 1160 is also swabbable for sterility. Other features of the valve 1110 are discussed previously in connection with the earlier embodiments of this invention.
  • Twelfth Embodiment
  • A twelfth embodiment valve 1210 is illustrated in FIGS. 26 and 27, and comprises a valve body or housing 1212, a support member 1214 (partially shown), a seal 1216, a ring member 1218, and a resilient reel 1226. The housing 1212, support member 1214, and ring member 1218 are substantially the same as those shown in FIGS. 22 and 23. The housing 1212 has an upper conduit 1224 with a circular opening 1226. The support member 1214 has an inner conduit (not shown) which is connected to a fluid line such as a catheter (not shown). The distal end 1228 of the ring member 1218 contacts an upper flange 1232 of the resilient reel 1220 and facilitates transfer of the compressive force due to insertion of a medical implement such as a syringe to cause deformation of the reel 1220. The reel 1220 further includes a central body portion 1234 and a lower flange 1236 that is desirably supported and secured by the support member 1214.
  • The seal 1216 is similar to the seal 1114 of FIGS. 24 and 25, and has a similar seal cap 1240 with slit 1242, shoulder 1244, and pressure responsive member 1246. The seal 1246 has a spreader 1250 that extends from the shoulder 1244 outwardly and forms a circular distal ring 1252 that bears against the central body portion 1234 of the resilient reel 1220, as best seen in FIG. 26. The distal ring 1252 may be attached to the central body portion 1234 by adhesives or other available means. An inner cavity 1254 is formed by the seal 1216 and a distal portion 1256 of the resilient reel, and defines a fluid space of the valve 1210. During compression of the seal 1216, the spreader 1250 extends further outwardly and pushes the central body portion 1234 of the resilient reel 1220 outwardly. The seal 1216 and resilient reel 1220 are configured and dimensioned to assist in causing the fluid space to increase upon insertion of a medical implement and to decrease upon withdrawal of the medical implement such as the syringe 1260 partially shown in phantom in FIG. 27.
  • FIG. 27 illustrates compression and FIG. 26 illustrates decompression during valve activation. In the compressed state, the syringe 1260 is placed on the seal cap 1240 inside the opening 1226 of the housing 1212 and the application of pressure on the syringe 1260 creates pressure on the seal cap 1240. The downward pressure pushes the seal cap 1240 away from the circular opening 1226 and toward the lower portion of the housing 1212 which has a larger inner diameter, thereby allowing the precut slit 1242 to open. The ring member 1218 moves toward the support member 1214 and compresses the resilient reel 1220. The upper flange 1232 of the resilient reel 1220 is pushed by the ring member 1214 toward the lower flange 1236. The central body portion 1234 bulges outwardly as the spreader 1250 deforms and pushes the central body portion 1234 outwardly, storing potential energy of the compression. Fluid is able to flow into the syringe 1260, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient.
  • The compression of the seal 1216 and deformation of the spreader 1250 and reel 1220 shown in FIG. 27 causes an increase in volume of the inner cavity 1254 because of the expansion of the central body portion 1234 of the flexible reel 1220. The expansion results from the movement of the spreaders 1250 to open up the central body portion 1234 of the resilient reel 1220 during compression.
  • FIG. 26 illustrates the valve 1210 after withdrawal of the syringe 1260. The seal 1216 returns to its decompressed state and essentially fills the opening 1226, and the spreader 1250 reforms to allow the central body region 1234 of the resilient reel 1220 to narrow. Because of the contraction of the inner cavity 1254 at the central body portion 1234, there is a net loss in fluid space, resulting in a positive flow from the valve 1210 through, e.g., a catheter tip (not shown). The positive-flow valve 1210 advantageously eliminates any dead space during decompression of the seal 1216. This is further assisted by the seal 1216 with the slit 1242 remaining open until the very end, i.e., until the seal cap 1240 is squeezed by the circular opening 1226 at the top of the upper conduit 1224.
  • In addition, the valve 1210 can be reused because the seal 1216 can return reversibly in the decompressed state. The seal surface 1266 is also swabbable for sterility. Other features of the valve 1210 are discussed previously in connection with the earlier embodiments of this invention.
  • Thirteenth Embodiment
  • A thirteenth embodiment valve 1310 in accordance with the present invention is illustrated in FIGS. 28 and 29. The valve 1310 comprises a body or housing 1312, a support member 1314 (partially shown), an upper seal 1316, and a lower seal 1318. The housing 1312 has an upper conduit 1322 near a proximal end with a circular opening 1324 that is preferably adapted to receive a medical implement such as a syringe 1326 partially shown in phantom in FIG. 40. The body 1312 has an upper side wall 1330 distal to the upper conduit 1322 that is desirably circular in cross section with a diameter larger than the diameter of the circular opening 1324. The body 1312 has a lower side wall 1332 distal to the upper side wall 1330 with a diameter larger than the diameter of the upper side wall 1330. A middle conduit 1338 is advantageously formed between the upper side wall 1330 and lower side wall 1332. The upper side wall 1330 is advantageously tapered from the upper conduit 1322 to the middle conduit 1338 and the lower side wall 1332 is advantageously tapered from the middle conduit 1338 to a distal end 1340 of the housing 1312. The middle conduit 1338 has a diameter larger than the diameter of the upper conduit 1322 and smaller than the diameter of the distal end 1340 of the housing 1312.
  • The support member 1314 has at its distal end an inner conduit (not shown) which may be connected to a terminal of a catheter (not shown). The support member 1314 serves as a support and attachment device for the upper and lower seals 1316, 1318 by holding the seals 1316, 1318 in place inside the internal cavity 1346 of the housing 1312.
  • The upper and lower seals 1316, 1318 are prepared from a resilient material that is flexible, inert, and impermeable to fluid, such as silicon. The upper seal 1316 has a seal cap 1350 with a generally flat top surface 1352, a shoulder 1354, a side wall 1356, and a base 1358. The side wall 1356 advantageously is comprised of ringed wall portions 1360 which deform in an accordion-like fashion and assist in the reformation of the seal 1316 to enclose the housing opening 1324 upon withdrawal of the syringe 1326. During compression of the upper seal 1316, the diameter of the ringed wall portions 1360 expand outwardly in the radial direction. The interior of the upper seal 1316 is hollow to provide an upper inner cavity 1362, as best seen in FIG. 28. The shoulder 1354 engages an upper ledge 1366 provided in the upper conduit 1322 of the housing 1312 such that the upper ledge 1366 confines the movement of the shoulder 1354 toward the opening 1324 to prevent the upper seal 1316 from being blown through the opening 1324 under high pressure in the upper inner cavity 1362 of the seal 1316,
  • The seal cap 1350 of the upper seal 1316 reseals in the valve 1310 at the opening 1324 with the top surface 1352 of the seal 1316 flush with or above the opening 1324 upon removal of the medical implement 1326. The seal cap 1350 substantially fills the opening 1324 in the top of the upper conduit 1322. It is preferred the top surface 1352 be exposed after assembly so that it may be swabbed with alcohol or other disinfectant. The seal cap 1350 of the upper seal 1316 desirably has a unique shape with a precut slit 1370 such that the seal cap 1350 is squeezed shut by the opening 1324 when assembled and the slit 1370 opens automatically during compression. The seal 1316 desirably also includes a pressure responsive member 1372 to further assist in creating a fluid-tight seal in the decompressed state.
  • As shown in FIGS. 28 and 29, the lower seal 1318 desirably is generally similar to the upper seal 1316. The lower seal has a similar seal cap 1380 with a generally flat top surface 1382, a shoulder 1384, and a side wall 1386. The side wall 1386 defines a lower inner cavity 1390 and may include similar ringed wall portions (not shown). The seal cap 1380 is disposed at the middle conduit 1338 at the decompressed state and reseals the lower inner cavity 1390 at the middle conduit 1338 upon removal of the medical implement 1326. The lower inner cavity 1390 forms a fluid space of the valve 1310, being in fluid communication through the lower conduit (not shown) to, e.g., a catheter (not shown). The valve components are configured and dimensioned to assist in causing the fluid space to increase upon insertion of the medical implement 1326 and to decrease upon withdrawal of the medical implement 1326.
  • The seal cap 1380 advantageously provides a fluid tight seal, having a shape and a precut slit 1394 similar to those of the upper seal 1316. The lower seal 1318 also includes desirably a pressure responsive member 1396 similar to the pressure responsive member 1372 of the upper seal 1316. The components of the lower seal 1318 are generally larger than those of the upper seal 1316 because of the geometry of the valve housing 1312.
  • To illustrate valve activation, FIG. 29 shows the compressed state of the valve 1310 upon insertion of the syringe 1326. The syringe 1326 is placed on the upper seal cap 1350 inside the opening 1324 of the housing 1212. The application of pressure on the syringe 1326 creates pressure on the seal cap 1330, and the resulting downward pressure compresses the upper seal 1316. This pushes the seal cap 1350 away from the circular opening 1324 and toward the middle conduit 1338 at a region with a larger inner diameter, thereby allowing the precut slit 1370 to open. The downward movement is facilitated by the compression of the ringed wall portions 1360 of the side wall 1356 of the upper seal 1316. The downward force is transferred to the lower seal 1318 through the base 1358 of the upper seal 1316 which cooperates with the seal cap 1380 of the lower seal 1318. The application of the pressure pushes the lower seal cap 1380 away from the middle conduit 1338 and toward the lower portion of the housing 1312 which has a larger inner diameter, thereby allowing the precut slit 1394 to open. Fluid is now able to flow into the syringe 1326, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient. FIG. 29 shows the valve 1310 opened by insertion of the syringe 1326 into the opening 1324.
  • In the compressed state shown in FIG. 29, the fluid space generally contract under pressure from the decompressed state shown in FIG. 28. Upon removal of the syringe 1326 from the upper conduit 1322, as shown in FIG. 28, the upper and lower seals 1316,1318 are free to move toward their decompressed states. The movement normally would cause a general expansion of the fluid space. However, because of the fluid communication between the upper inner cavity 1362 and lower inner cavity 1390, and the closing of the precut slit 1394 of the lower seal 1318 upon compression, a decrease in volume results in the lower inner cavity 1390 of the valve 1310. The decrease in the fluid space advantageously generates a positive flow from the valve 1310 through, e.g., a catheter tip (not shown) to eliminate dead space. Advantageously, any dead space within the upper inner cavity 1362 is also minimized since, as the syringe 1326 is withdrawn, the slit 1370 remains open until the very end, i.e., until the seal cap 1350 is squeezed by the circular opening 1324 at the top of the upper conduit 1322. The elimination of backflash is particularly advantageous in the case where the valve 1310 is connected through a catheter to a patient, because it prevents the introduction of blood into the catheter.
  • As the upper seals 1316 is free to move to its decompressed state, it essentially fills the circular opening 1324. The ability of the upper seal 1316 to return reversibly to its decompressed state, together with the resiliency of the lower seal 1318, permits the reuse of the valve 1310. Following disconnection, and before reuse, the surface 1352 of the seal cap 1316 is essentially flush with the opening 1324 of the housing 1312. Thus, this flush surface 1352 can advantageously be sterilized with alcohol or other surface decontaminating substances. A cover cap (not shown) can further be used to fit over the upper conduit to protect the surface 1352 of the seal cap 1350.
  • Fourteenth Embodiment
  • A fourteenth embodiment of a valve 1410 of the present invention is illustrated in FIGS. 30 and 32, and comprises a valve body or housing 1412, a seal 1414, a piston 1416, and a spring 1418. The housing 1412 has an upper conduit 1420 near a proximal end with a circular opening 1422 that is preferably adapted to receive a medical implement such as a syringe 1423 partially shown in phantom in FIG. 30. The housing 1412 has a side conduit 1424 which is connected to a fluid line such as a catheter (not shown). Disposed in a lower chamber 1426 of the housing 1412 is the spring 1418 supporting the piston 1416 which bears against a distal end 1430 of the seal 1414 disposed in an upper chamber 1432 of the housing 1412. The lower chamber 1426 of the housing 1412 advantageously includes an orifice 1434 for venting the air therein to facilitate movement of the spring 1418. The upper chamber 1432 and lower chamber 1426 expand and contract according to the movement of the piston 1416 under pressure from the seal 1414 and the spring 1418. The housing 1412 advantageously includes a side aperture 1438 additional fluid to be transferred to the patient through the upper chamber 1432 and side conduit 1424 when necessary.
  • The seal 1414 has seal cap 1442 with precut slit 1444, a shoulder 1446, and a pressure responsive member 1448. The seal has a side wall 1450 which defines an inner cavity 1452 and has the distal end 1430 that cooperates with the piston 1416 for efficient transfer of pressure between them. Near the distal end 1430 of the seal 1414 is desirably a transverse fluid passage 1456 for fluid communication between the seal 1414 and the upper chamber 1432. Although FIGS. 30 and 32 illustrate that the transverse fluid passage 1456 also facilitates fluid flow between the side aperture 1438 and the side conduit 1424, it need not do so if fluid can flow around the seal 1414 in the upper chamber 1432. The upper chamber 1432 and the inner cavity 1450 of the seal 1414 forms the fluid space of the valve 1410.
  • FIG. 31 illustrates compression and FIG. 30 illustrated decompression during valve activation. In the compressed state, the syringe 1423 is placed on the seal cap 1442 inside the opening 1422 of the housing 1412 and the application of pressure on the syringe 1423 creates pressure on the seal cap 1442. The downward pressure pushes the seal cap 1442 away from the circular opening 1422 and toward the lower portion of the housing 1412 which has a larger inner diameter, thereby allowing the precut slit 1444 to open. The side wall 1450 moves further into the upper chamber 1432 and pushes the piston 1476 downward against the spring 1418, which is compressed, storing potential energy of the compression. Fluid is able to flow into the syringe 1423, or vice versa, depending on whether fluid is to be withdrawn from the patient or medication injected into the patient. The compression of the seal 1414 shown in FIG. 42 generates a net gain or increase in volume of the fluid space of the valve 1410.
  • FIG. 30 illustrates the valve 1410 after withdrawal of the syringe 1423. The seal 1414 returns to its decompressed state and essentially fills the opening 1422, and the piston 1416 moves back to its decompressed position as the spring 1418 releases its potential energy. Because of the contraction of the upper chamber 1432 of the housing 1412, there is a net loss in fluid space, resulting in a positive flow from the valve 1410 through, e.g., a catheter tip (not shown). The positive-flow valve 1410 advantageously eliminates any dead space during decompression of the seal 1414. This is further assisted by the seal 141 with the slit 1444 remaining open until the very end, i.e., until the seal cap 1442 is squeezed by the circular opening 1422 at the top of the upper conduit 1420.
  • In addition, the valve 1410 can be reused because the seal 1414 can return reversibly in the decompressed state. The seal surface 1460 is also swabbable for sterility. Other features of the valve 1410 are discussed previously in connection with the earlier embodiments of this invention.
  • Additional Embodiments
  • Additional embodiments of the present invention are contemplated without departing from the spirit and scope of the present invention. For instance, the volume inside a straight tubing contracts when the tube is bent. Thus, one valve embodiment valve may have a fluid space inside a straight tubing which bends upon insertion of a medical implement and reforms upon withdrawal of the medical implement, thereby effecting positive flow.
  • In addition, many of the ringed side wall of the seals (such as the portions 1360 of the seal 1316 of FIG. 28) can be replaced by circular tires 1580 stacked in series one on top of an adjacent larger-diameter lower tire, as illustrated in FIG. 32. The circular tires 1580 are preferably solid throughout the diameter of the cross-section thereof. Like the ringed side wall portions 1360, these circular tires 1580 will deform and reform upon, respectively, compression and decompression of the seal.
  • CONCLUSION
  • In the embodiments described above, the fluid space inside the valve increases upon insertion of a medical implement in the compressed state and decreases upon withdrawal of the medical implement in the decompressed state. In some embodiments, the structure defining the fluid space is substantially relaxed and does not store substantial amount of potential energy. Insertion of the medical implement causes a change in the structure that allows it to store potential energy. The potential energy is released upon withdrawal of the medical implement and the structure returns to a substantially relaxed condition. In other embodiments, at least some components of the structure defining the fluid space stores potential energy under strain or deformation. Upon insertion of a medical implement in the compressed state, the potential energy in those components is released and is stored in other components of the structure or in another form. The stored potential energy in the compressed state is released when the medical implement is removed, and the original potential energy is restored in the structure.
  • The above presents a description of the best mode contemplated of carrying out the present invention, and of the manner and process of using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains to make and use this invention. This invention is, however, susceptible to modifications and alternate constructions from that discussed above which are fully equivalent. In particular, many of the features of the co-pending applications, serial nos. and can be incorporated into the present invention, and these applications are incorporated herein by reference. The embodiments described are meant to be illustrative and not exhaustive. Consequently, it is not the intention to limit this invention to the particular embodiments disclosed. On the contrary, the intention is to cover all modifications and alternate constructions coming within the spirit and scope of the invention as generally expressed by the following claims, which particularly point out and distinctly claim the subject matter of the invention.

Claims (7)

1. A medical connector for controlling a flow of fluid between first and second medical implements, the medical connector comprising:
a housing comprising a first end, a second end, and an interior cavity, the first end including a first opening adapted to snugly receive an ANSI-standard luer of the first medical implement, and the interior cavity comprising a region near the first end with a first cross-sectional area smaller than a second cross-sectional area in a region closer to the second end of the housing than the first cross-sectional area, the second end of the housing including an external conduit with a second opening and a skirt portion with an internal screw thread adapted to be removably connected to the second medical implement, and the exterior surface of the housing having a first portion near the first end defining a first external cross-sectional width and a second portion in the distal direction from the first portion defining a second external cross-sectional width larger than the first external cross-sectional width wherein the second portion is in the proximal direction from the skirt portion of the second end;
a region on the housing near the first end including an exterior surface with a mounting structure adapted to be rotatably attached to a screw thread on an internal surface of the first medical implement, the exterior surface of the housing also including a shoulder portion wider in diameter than the mounting structure, the shoulder portion configured to halt the advancement of the first medical implement along the mounting structure;
a flexible member comprising a first opening in the region of the first end of the housing and a second opening in the region of the second end of the housing, and a fluid passageway within the flexible member; and
an interior conduit having a fluid passageway and positioned within the interior cavity, the conduit in fluid communication with the fluid passageway of the flexible member, and a portion of the flexible member overlapping the interior conduit;
wherein the flexible member is configured to move from a substantially closed position to a substantially open position upon insertion of the luer of the first medical implement into the first opening of the housing, the flexible member overlaps the interior conduit to a greater extent in the substantially open position than in the substantially closed position, and the flexible member is configured to move from the substantially open position to the substantially closed position upon withdrawal of the luer of the first medical implement from the first opening of the housing, the volume of the fluid passageway within the flexible member being larger in the substantially open position than in the substantially closed position so that fluid contained within the flexible member upon the withdrawal of the luer of the first medical implement is forced toward the second end of the housing, the fluid passageway of the flexible member and the interior conduit cooperating to form a substantially non-tortuous fluid passageway through the valve when the flexible member is in the substantially open position.
2. The medical connector of claim 1, wherein an end of the flexible member closest to the first end of the housing is displaced in the direction of the second end of the housing as the flexible member moves from the substantially closed position to the substantially open position.
3. The medical connector of claim 1, wherein the shape of the flexible member urges the fluid passageway more tightly closed near the first end of the housing when the passageway is under fluid pressure.
4. The medical connector of claim 1, wherein an external surface on the flexible member in the substantially closed position contacts an internal surface of the interior cavity of the housing in a region near the first end of the housing.
5. The medical connector of claim 4, wherein a portion of an interior surface of the housing between the first end and the second end is tapered.
6. The medical connector of claim 5, wherein the fluid passageway is wider when the flexible member is in its substantially open position than in its substantially closed position.
7. The medical connector of claim 6, wherein a first external surface of the housing near the first end has a first cross-sectional area, a second external surface of the housing closer to the second end than the first external surface has a second cross-sectional area, and the first cross-sectional area is smaller than the second cross-section area.
US11/417,773 1996-12-16 2006-05-03 Positive flow valve Abandoned US20060200089A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/417,773 US20060200089A1 (en) 1996-12-16 2006-05-03 Positive flow valve

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US76758796A 1996-12-16 1996-12-16
US09/411,988 US6428520B1 (en) 1996-12-16 1999-10-04 Positive-flow valve
US10/163,719 US6932795B2 (en) 1996-12-16 2002-06-05 Positive flow valve
US11/085,808 US20050222541A1 (en) 1996-12-16 2005-03-21 Positive flow valve
US11/417,773 US20060200089A1 (en) 1996-12-16 2006-05-03 Positive flow valve

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/085,808 Continuation US20050222541A1 (en) 1996-12-16 2005-03-21 Positive flow valve

Publications (1)

Publication Number Publication Date
US20060200089A1 true US20060200089A1 (en) 2006-09-07

Family

ID=25079940

Family Applications (8)

Application Number Title Priority Date Filing Date
US09/411,988 Expired - Lifetime US6428520B1 (en) 1996-12-16 1999-10-04 Positive-flow valve
US10/163,719 Expired - Lifetime US6932795B2 (en) 1996-12-16 2002-06-05 Positive flow valve
US11/085,808 Abandoned US20050222541A1 (en) 1996-12-16 2005-03-21 Positive flow valve
US11/418,542 Abandoned US20060206061A1 (en) 1996-12-16 2006-05-03 Positive flow valve
US11/417,825 Abandoned US20060200090A1 (en) 1996-12-16 2006-05-03 Positive flow valve
US11/417,771 Abandoned US20060200088A1 (en) 1996-12-16 2006-05-03 Positive flow valve
US11/417,843 Abandoned US20060264849A1 (en) 1996-12-16 2006-05-03 Positive flow valve
US11/417,773 Abandoned US20060200089A1 (en) 1996-12-16 2006-05-03 Positive flow valve

Family Applications Before (7)

Application Number Title Priority Date Filing Date
US09/411,988 Expired - Lifetime US6428520B1 (en) 1996-12-16 1999-10-04 Positive-flow valve
US10/163,719 Expired - Lifetime US6932795B2 (en) 1996-12-16 2002-06-05 Positive flow valve
US11/085,808 Abandoned US20050222541A1 (en) 1996-12-16 2005-03-21 Positive flow valve
US11/418,542 Abandoned US20060206061A1 (en) 1996-12-16 2006-05-03 Positive flow valve
US11/417,825 Abandoned US20060200090A1 (en) 1996-12-16 2006-05-03 Positive flow valve
US11/417,771 Abandoned US20060200088A1 (en) 1996-12-16 2006-05-03 Positive flow valve
US11/417,843 Abandoned US20060264849A1 (en) 1996-12-16 2006-05-03 Positive flow valve

Country Status (13)

Country Link
US (8) US6428520B1 (en)
EP (1) EP0956088B1 (en)
JP (1) JP2001506156A (en)
CN (3) CN1915451A (en)
AT (1) ATE475451T1 (en)
AU (1) AU737266B2 (en)
CA (1) CA2275218C (en)
DE (1) DE69739948D1 (en)
HK (1) HK1026155A1 (en)
IL (1) IL130482A0 (en)
NO (1) NO992904L (en)
NZ (1) NZ336284A (en)
WO (1) WO1998026835A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070235676A1 (en) * 2006-04-11 2007-10-11 Vangsness Todd S Anti-Drawback medical valve and method
US7763199B2 (en) 2000-07-11 2010-07-27 Icu Medical, Inc. Method of making a seal having slit formed therein
US7824393B2 (en) 2004-11-05 2010-11-02 Icu Medical, Inc. Medical connector having high flow rate characteristics
US8105314B2 (en) 2006-10-25 2012-01-31 Icu Medical, Inc. Medical connector
US8177772B2 (en) 2005-09-26 2012-05-15 C. R. Bard, Inc. Catheter connection systems
US8337475B2 (en) 2004-10-12 2012-12-25 C. R. Bard, Inc. Corporeal drainage system
US8568371B2 (en) 2009-06-22 2013-10-29 Np Medical Inc. Medical valve with improved back-pressure sealing
US8636721B2 (en) 2003-11-20 2014-01-28 Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Portable hand pump for evacuation of fluids
US8758306B2 (en) 2010-05-17 2014-06-24 Icu Medical, Inc. Medical connectors and methods of use
WO2015006495A1 (en) * 2013-07-12 2015-01-15 Carefusion 303, Inc. Check valve system
US9138572B2 (en) 2010-06-24 2015-09-22 Np Medical Inc. Medical valve with fluid volume alteration
USD786427S1 (en) 2014-12-03 2017-05-09 Icu Medical, Inc. Fluid manifold
USD793551S1 (en) 2014-12-03 2017-08-01 Icu Medical, Inc. Fluid manifold
US10369349B2 (en) 2013-12-11 2019-08-06 Icu Medical, Inc. Medical fluid manifold
US11344318B2 (en) 2016-07-18 2022-05-31 Merit Medical Systems, Inc. Inflatable radial artery compression device

Families Citing this family (226)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ149294A3 (en) 1991-12-18 1994-11-16 Icu Medical Inc Medicinal valve
US5738663A (en) 1995-12-15 1998-04-14 Icu Medical, Inc. Medical valve with fluid escape space
US7789864B2 (en) 1996-11-18 2010-09-07 Nypro Inc. Luer-activated valve
US20020013556A1 (en) * 1996-11-18 2002-01-31 Cote Andrew L. Swabbable luer-activated valve
IL130482A0 (en) * 1996-12-16 2000-06-01 Icu Medical Inc Positive flow valve
US6245048B1 (en) * 1996-12-16 2001-06-12 Icu Medical, Inc. Medical valve with positive flow characteristics
US6029946A (en) * 1997-09-15 2000-02-29 Tiva Medical Inc. Needleless valve
AU2003220703B2 (en) * 1998-05-14 2006-11-23 Icu Medical, Inc. Medical valve with positive flow characteristics
US6228069B1 (en) * 1999-04-05 2001-05-08 Filtertek Inc. Needleless access device
US6706022B1 (en) 1999-07-27 2004-03-16 Alaris Medical Systems, Inc. Needleless medical connector with expandable valve mechanism
FR2802432B1 (en) * 1999-12-16 2002-03-08 Vygon AUTOMATIC SHUTTER CONNECTOR FOR CONNECTING A LIQUID INJECTION HEAD TO AN INJECTION OUTPUT
US6689109B2 (en) 2000-05-02 2004-02-10 Lawrence A. Lynn Positive flow generator for indwelling medical fluid systems
WO2002034326A2 (en) 2000-10-23 2002-05-02 Nypro, Inc. Anti-drawback medical valve
JP4086458B2 (en) * 2000-10-24 2008-05-14 テルモ株式会社 Disc
JP2005500142A (en) * 2001-08-22 2005-01-06 ナイプロ・インク Medical valve with expansion member
WO2003018105A1 (en) 2001-08-23 2003-03-06 Occupational & Medical Innovations Ltd A valve for use with a syringe and which prevents backflow
US6869426B2 (en) * 2001-11-13 2005-03-22 Nypro Inc. Anti-drawback medical valve
US7753892B2 (en) 2001-11-13 2010-07-13 Nypro Inc. Anti-drawback medical valve
US7837658B2 (en) 2001-11-13 2010-11-23 Nypro Inc. Anti-drawback medical valve
US6802490B2 (en) 2001-11-29 2004-10-12 Alaris Medical Systems, Inc. Needle free medical connector with expanded valve mechanism and method of fluid flow control
US6908459B2 (en) 2001-12-07 2005-06-21 Becton, Dickinson And Company Needleless luer access connector
ITMI20020819A1 (en) * 2002-04-18 2003-10-20 Gambro Lundia Ab CONNECTION ELEMENT AND CONNECTION DEVICE FOR MEDICAL USE PIPES
US7244249B2 (en) * 2002-05-08 2007-07-17 Cardinal Health 303, Inc. Needle-free medical connector with expandable valve mechanism and method of fluid flow control
US7160272B1 (en) * 2002-05-31 2007-01-09 Elcam Plastic Y-site medical valve
US7326188B1 (en) 2002-08-02 2008-02-05 Elcam Medical Anesthesia manifold and induction valve
JP4000125B2 (en) * 2002-08-06 2007-10-31 フカイ工業株式会社 Syringe connection port
WO2004012794A1 (en) * 2002-09-06 2004-02-12 Durect Corporation Implantable flow regulator with failsafe mode and reserve drug supply
IL152950A0 (en) * 2002-11-19 2003-06-24 Biometrix Ltd A fluid administrating manifold
JP2004195016A (en) * 2002-12-19 2004-07-15 Top:Kk Coupling device
US7125396B2 (en) 2002-12-30 2006-10-24 Cardinal Health 303, Inc. Safety catheter system and method
DE602004031818D1 (en) 2003-01-09 2011-04-28 Fukai Kogyo K K Hemispherical valve for a medical device
US6871838B2 (en) * 2003-04-03 2005-03-29 B. Braun Medical Inc. Injection port valve
EP1639286B1 (en) * 2003-06-17 2014-12-03 Filtertek Inc. Fluid handling device
US6855138B2 (en) * 2003-07-08 2005-02-15 Hsi-Chin Tsai Injection joint for an intravenous (IV) device tube
US7914502B2 (en) 2003-07-31 2011-03-29 Nypro Inc. Anti-drawback medical valve
US20080009822A1 (en) * 2003-12-18 2008-01-10 Halkey-Roberts Corporation Needleless access vial
HK1077154A2 (en) 2003-12-30 2006-02-03 Vasogen Ireland Ltd Valve assembly
JP4621029B2 (en) * 2004-02-19 2011-01-26 テルモ株式会社 connector
US7594911B2 (en) 2004-03-18 2009-09-29 C. R. Bard, Inc. Connector system for a proximally trimmable catheter
US8083728B2 (en) * 2004-03-18 2011-12-27 C. R. Bard, Inc. Multifunction adaptor for an open-ended catheter
US7854731B2 (en) * 2004-03-18 2010-12-21 C. R. Bard, Inc. Valved catheter
US7594910B2 (en) 2004-03-18 2009-09-29 C. R. Bard, Inc. Catheter connector
ES2323793T3 (en) 2004-03-26 2009-07-24 Unomedical A/S INFUSION SET
US7377915B2 (en) 2004-04-01 2008-05-27 C. R. Bard, Inc. Catheter connector system
US7615041B2 (en) * 2004-07-29 2009-11-10 Boston Scientific Scimed, Inc. Vial adaptor
US10478607B2 (en) 2004-08-09 2019-11-19 Carefusion 303, Inc. Connector for transferring fluid and method of use
US7600530B2 (en) 2004-08-09 2009-10-13 Medegen, Inc. Connector with check valve and method of use
US8062250B2 (en) 2004-08-10 2011-11-22 Unomedical A/S Cannula device
US7469458B1 (en) * 2004-08-11 2008-12-30 Proteckt Catheters, Llc Method of assembling a catheter with integrated pre-slit cannula diaphragm
US20060058734A1 (en) * 2004-09-15 2006-03-16 Phillips John C Self-sealing male Luer connector with molded elastomeric tip
US7921874B2 (en) * 2004-11-12 2011-04-12 Cook Medical Technologies Llc Flow variation valve assembly
US7887519B2 (en) 2005-01-14 2011-02-15 Nypro Inc. Valve with internal lifter
US7670322B2 (en) * 2005-02-01 2010-03-02 Icu Medical, Inc. Check valve for medical Y-site
US7510545B2 (en) * 2005-02-09 2009-03-31 B. Braun Medical Inc. Needleless access port valves
US7114701B2 (en) * 2005-03-02 2006-10-03 B. Braun Medical, Inc. Needleless access port valves
US20060200072A1 (en) * 2005-03-02 2006-09-07 Peppel Peter W Needleless access port valves
WO2006096960A1 (en) * 2005-03-15 2006-09-21 Vasogen Ireland Limited Controlled flow adapter for medical fluid containers
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
US7615035B2 (en) * 2005-03-24 2009-11-10 B. Braun Medical Inc. Needleless access port valves
US8100866B2 (en) * 2005-03-24 2012-01-24 B. Braun Medical Inc. Needleless access port valves
JP4708423B2 (en) * 2005-03-28 2011-06-22 株式会社トップ connector
US8444416B2 (en) * 2005-04-26 2013-05-21 Braun Gmbh Valves for personal care devices
WO2006124756A2 (en) * 2005-05-13 2006-11-23 Bob Rogers Medical substance transfer system
FR2886709B1 (en) * 2005-06-06 2008-12-05 Vygon Sa CONNECTOR FOR LIQUID TRANSFER, IN PARTICULAR IN THE MEDICAL FIELD
US7875019B2 (en) 2005-06-20 2011-01-25 C. R. Bard, Inc. Connection system for multi-lumen catheter
US20070088293A1 (en) * 2005-07-06 2007-04-19 Fangrow Thomas F Jr Medical connector with closeable male luer
US7998134B2 (en) 2007-05-16 2011-08-16 Icu Medical, Inc. Medical connector
US7503908B2 (en) * 2005-07-22 2009-03-17 B. Braun Medical Inc. Needleless access port valves
DK1762259T3 (en) 2005-09-12 2011-01-03 Unomedical As Infusion set insertion device with a first and a second spring assembly
US20070083162A1 (en) * 2005-10-11 2007-04-12 Span-America Medical Systems, Inc. Valve for intravenous catheter
US7302960B2 (en) * 2005-10-26 2007-12-04 Smiths Medical Asd, Inc. Momentary high pressure valve
CN103203054B (en) 2005-12-02 2016-08-03 C.R.巴德有限公司 Pressure-activated proximal valves
EP1962925B1 (en) 2005-12-23 2009-04-22 Unomedical A/S Device for administration
US7842026B2 (en) * 2005-12-29 2010-11-30 Nmt Medical, Inc. Syringe activated-valve for flushing a catheter and methods thereof
US9695953B2 (en) * 2006-02-14 2017-07-04 B. Braun Medical Inc. Needleless access port valves
KR20080104342A (en) 2006-02-28 2008-12-02 우노메디컬 에이/에스 Inserter for infusion part and infusion part provided with needle protector
JP4769103B2 (en) * 2006-03-17 2011-09-07 日本シャーウッド株式会社 connector
US20070225647A1 (en) 2006-03-23 2007-09-27 Luther Ronald B Flush entrance hemostasis valve with unobstructed passageway
US7867204B2 (en) * 2006-05-04 2011-01-11 B. Braun Medical Inc. Needleless access port valves
US20070270756A1 (en) * 2006-05-22 2007-11-22 Peter Peppel Needleless access port valves
US8439838B2 (en) 2006-06-07 2013-05-14 Unomedical A/S Inserter for transcutaneous sensor
BRPI0712361A2 (en) 2006-06-09 2012-06-19 Unomedical As mounting bracket
US7806890B2 (en) * 2006-07-28 2010-10-05 Mckinnon Austin Jason Vascular access device volume displacement
US20080027415A1 (en) * 2006-07-28 2008-01-31 Becton, Dickinson And Company Vascular access device volume displacement
CA2658577A1 (en) 2006-08-02 2008-02-07 Unomedical A/S Cannula and delivery device
WO2008022040A1 (en) 2006-08-11 2008-02-21 Nypro Inc. Medical valve with expandable member
WO2008066991A2 (en) * 2006-08-30 2008-06-05 Arthur Harris Continuous feed hypodermic syringe with self contained cartridge dispenser
JP5048776B2 (en) * 2006-09-29 2012-10-17 タイコ ヘルスケア グループ リミテッド パートナーシップ Surgical fluid transfer device
US7981090B2 (en) 2006-10-18 2011-07-19 Baxter International Inc. Luer activated device
US8221363B2 (en) 2006-10-18 2012-07-17 Baxter Healthcare S.A. Luer activated device with valve element under tension
US7753338B2 (en) 2006-10-23 2010-07-13 Baxter International Inc. Luer activated device with minimal fluid displacement
EP1917990A1 (en) 2006-10-31 2008-05-07 Unomedical A/S Infusion set
US8337483B2 (en) * 2006-11-02 2012-12-25 Becton, Dickinson And Company Vascular access device chamber replacement
US8540677B2 (en) * 2006-11-02 2013-09-24 Becton, Dickinson And Company Vascular access device chamber venting
FR2910817B1 (en) * 2007-01-03 2009-02-13 Vygon Sa CONNECTOR FOR ESTABLISHING A FLUID COMMUNICATION UNDER THE CONTROL OF A VALVE, IN PARTICULAR FOR USE IN THE MEDICAL FIELD
US8419713B1 (en) 2012-08-01 2013-04-16 The University Of Utah Research Foundation Carrier assembly with caps for medical connectors
US8523830B2 (en) * 2007-01-16 2013-09-03 Catheter Connections Disinfecting caps for medical female luer connectors
US8197749B2 (en) 2007-01-16 2012-06-12 The University Of Utah Research Foundation Methods for cleaning luer connectors
US8343112B2 (en) 2009-10-30 2013-01-01 Catheter Connections, Inc. Disinfecting caps having an extendable feature and related systems and methods
US8177761B2 (en) * 2007-01-16 2012-05-15 The University Of Utah Research Foundation Assembly for cleaning luer connectors
US8647326B2 (en) * 2007-01-16 2014-02-11 Catheter Connections, Inc. System for cleaning luer connectors
US8172825B2 (en) 2007-01-16 2012-05-08 The University Of Utah Research Foundation Methods for disinfecting medical connectors
JP2008200312A (en) * 2007-02-21 2008-09-04 Nippon Sherwood Medical Industries Ltd Utensil for mixed injection of liquid
JP2010530266A (en) 2007-06-20 2010-09-09 ウノメディカル アクティーゼルスカブ Catheter and catheter manufacturing method and apparatus
US7896863B2 (en) * 2007-06-27 2011-03-01 Tyco Healthcare Group Lp Positive displacement fluid lock port
JP2010531692A (en) 2007-07-03 2010-09-30 ウノメディカル アクティーゼルスカブ Inserter with bistable equilibrium
AU2008274311A1 (en) 2007-07-10 2009-01-15 Unomedical A/S Inserter having two springs
US7876121B2 (en) * 2007-09-14 2011-01-25 Mayo Foundation For Medical Education And Research Link analysis compliance and calibration verification for automated printed wiring board test systems
ITTO20070141U1 (en) * 2007-11-14 2009-05-15 Borla Ind SYRINGE
CA2646265A1 (en) * 2007-12-20 2009-06-20 Tyco Healthcare Group Lp Cap assembly for use with a prefilled lock solution syringe
US20090171279A1 (en) * 2007-12-26 2009-07-02 Cook Incorporated Balloon catheter assembly and controller therefor
US20090182309A1 (en) * 2008-01-11 2009-07-16 Dartmouth-Hitchcock Clinic Medical fluid coupling port with guide for reduction of contamination
US20090204080A1 (en) * 2008-02-12 2009-08-13 Baxter International Inc. Two-way valve connector
US10898643B2 (en) 2008-02-13 2021-01-26 Unomedical A/S Sealing between a cannula part and a fluid path
CA2715667A1 (en) 2008-02-20 2009-08-27 Unomedical A/S Insertion device with horizontally moving part
CA2715144A1 (en) * 2008-02-25 2009-09-03 Unomedical A/S Bubble shaped membrane and use of such membrane in a device
US8414554B2 (en) 2008-05-14 2013-04-09 J & J Solutions, Inc. Systems and methods for safe medicament transport
ITTO20080381A1 (en) * 2008-05-21 2009-11-22 Industrie Borla Spa VALVE VALVE FOR MEDICAL LINES
US9788773B2 (en) 2008-05-21 2017-10-17 Robert J. Perry Vein presentation enhancement device
US7905873B2 (en) * 2008-07-03 2011-03-15 Baxter International Inc. Port assembly for use with needleless connector
US8172823B2 (en) * 2008-07-03 2012-05-08 Baxter International Inc. Port assembly for use with needleless connector
WO2010017161A2 (en) * 2008-08-04 2010-02-11 Np Medical Inc. Medical valve with raised seal
US8062280B2 (en) * 2008-08-19 2011-11-22 Baxter Healthcare S.A. Port assembly for use with needleless connector
US8145652B2 (en) * 2008-10-09 2012-03-27 International Business Machines Corporation Automated propagation of non-conflicting queries in distributed databases
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
JP2010142363A (en) * 2008-12-17 2010-07-01 Nipro Corp Medical valve
US8679090B2 (en) 2008-12-19 2014-03-25 Icu Medical, Inc. Medical connector with closeable luer connector
US9168366B2 (en) 2008-12-19 2015-10-27 Icu Medical, Inc. Medical connector with closeable luer connector
AU2009331635A1 (en) 2008-12-22 2011-06-23 Unomedical A/S Medical device comprising adhesive pad
US8882714B1 (en) 2009-01-23 2014-11-11 Robert J. Perry Needle with gated stylet
EP2405968B1 (en) * 2009-03-06 2015-01-14 DEKA Products Limited Partnership Devices and methods for occluding a flexible tube
US9078697B2 (en) * 2009-03-18 2015-07-14 Covidien Lp Surgical portal apparatus including movable housing
CN104613232B (en) * 2009-03-22 2018-02-09 爱康医学农业合作协会有限公司 The public luer connector of closure
US8454579B2 (en) 2009-03-25 2013-06-04 Icu Medical, Inc. Medical connector with automatic valves and volume regulator
US20100268162A1 (en) * 2009-04-15 2010-10-21 Ethicon Endo-Surgery, Inc. Cannula with sealing elements
US8394080B2 (en) * 2009-05-14 2013-03-12 Baxter International Inc. Needleless connector with slider
WO2010141458A2 (en) 2009-06-03 2010-12-09 Biometrix Ltd Apparatus and method for bedside collection of body fluids and automatic volume level monitoring
US9357950B2 (en) 2009-06-03 2016-06-07 Biometrix Ltd. Apparatus and method of fluid aspiration
WO2010151825A1 (en) 2009-06-26 2010-12-29 C. R. Bard, Inc. Proximally trimmable catheter including pre-attached bifurcation and related methods
JP2013500099A (en) 2009-07-30 2013-01-07 ウノメディカル・アー/エス Insertion device with horizontally movable member
US9533092B2 (en) 2009-08-07 2017-01-03 Unomedical A/S Base part for a medication delivery device
US8231587B2 (en) 2009-10-30 2012-07-31 Catheter Connections Disinfecting caps for medical male luer connectors
WO2011066586A1 (en) * 2009-11-30 2011-06-03 Catheter Connections, Inc. Disinfecting caps having sealing features and related systems and methods
US8353874B2 (en) * 2010-02-18 2013-01-15 Covidien Lp Access apparatus including integral zero-closure valve and check valve
USD644731S1 (en) 2010-03-23 2011-09-06 Icu Medical, Inc. Medical connector
EP2552513B1 (en) 2010-03-30 2014-03-19 Unomedical A/S Medical device
US8671964B2 (en) 2010-04-05 2014-03-18 Daniel Py Aseptic connector with deflectable ring of concern and method
WO2011139995A2 (en) 2010-05-06 2011-11-10 Icu Medical, Inc. Medical connector with closeable luer connector
NZ603808A (en) 2010-05-27 2014-10-31 J & J Solutions Inc Closed fluid transfer system
US8522813B2 (en) * 2010-09-08 2013-09-03 Covidien Lp Needleless sampling port
EP2433663A1 (en) 2010-09-27 2012-03-28 Unomedical A/S Insertion system
EP2436412A1 (en) 2010-10-04 2012-04-04 Unomedical A/S A sprinkler cannula
US20120153201A1 (en) * 2010-12-21 2012-06-21 Amsino International, Inc. Luer access valve
CN102188761B (en) * 2011-03-14 2015-08-05 张亚根 A kind of positive-pressure pinch valve
US9440059B2 (en) 2011-03-18 2016-09-13 Cook Medical Technologies Llc Adjustable diameter hemostatic valve
CA2834769C (en) * 2011-05-01 2019-11-26 Halkey-Roberts Corporation Male reflux valve
US10016587B2 (en) 2011-05-20 2018-07-10 Excelsior Medical Corporation Caps for needleless connectors
CN103796704B (en) 2011-07-12 2016-12-07 博讯瓦勒公司 For the device that antimicrobial is delivered in percutaneous catheter
EP3760275A1 (en) 2011-09-09 2021-01-06 ICU Medical, Inc. Medical connectors with fluid-resistant mating interfaces
CN103957962B (en) 2011-10-05 2017-07-07 犹诺医药有限公司 Insert for inserting multiple percutaneous parts simultaneously
EP2583715A1 (en) 2011-10-19 2013-04-24 Unomedical A/S Infusion tube system and method for manufacture
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts
MX341975B (en) 2011-12-13 2016-09-07 Oridion Medical 1987 Ltd Luer connectors.
EP2799108B1 (en) * 2011-12-27 2019-05-15 Nipro Corporation Needleless connector
US8801678B2 (en) * 2012-01-20 2014-08-12 Carefusion 303, Inc. Piston for a needleless valve system
EP2826502A4 (en) * 2012-03-12 2015-10-28 Terumo Corp Blood-flow-path connecting device and blood-bag system
IN2014DN09043A (en) 2012-04-17 2015-05-22 Institute Llc Dr Py
US10351271B2 (en) 2012-05-01 2019-07-16 Dr. Py Institute Llc Device for connecting or filling and method
US9989177B2 (en) 2012-05-01 2018-06-05 Dr. Py Institute Llc Device for connecting or filling and method
EP2852430B1 (en) * 2012-05-21 2019-04-17 Carmel Pharma AB Arrangement in a medical connector device
US10213536B2 (en) 2012-10-01 2019-02-26 Circulite, Inc. Implantable connector assembly and method of communicating an element to an implantable device
US9919143B2 (en) * 2012-10-12 2018-03-20 Catheter IP Holding Company Ltd. Medical connection device with valve and method
US9549666B2 (en) 2012-11-10 2017-01-24 Curvo Medical, Inc. Coaxial micro-endoscope
US9320881B2 (en) * 2013-02-13 2016-04-26 Becton, Dickinson And Company Septum actuator with insertion depth limiter and compression compensator
US9308362B2 (en) * 2013-03-12 2016-04-12 Carefusion 303, Inc. Male luer with fluid path and vent path seals
US9370651B2 (en) * 2013-03-13 2016-06-21 Carefusion 303, Inc. Needleless connector with reduced trapped volume
US9144672B2 (en) 2013-03-13 2015-09-29 Carefusion 303, Inc. Needleless connector with compressible valve
US9089682B2 (en) 2013-03-14 2015-07-28 Carefusion 303, Inc. Needleless connector with support member
US9278205B2 (en) 2013-03-13 2016-03-08 Carefusion 303, Inc. Collapsible valve with internal dimples
US20140263322A1 (en) * 2013-03-14 2014-09-18 Salah Ghodbane Coring-free valve system
US9381320B2 (en) 2013-03-18 2016-07-05 Becton, Dickinson And Company Multiple-use intravenous catheter assembly septum and septum actuator
MX371346B (en) 2013-08-02 2020-01-27 J&J Solutions Inc D/B/A Corvida Medical Compounding systems and methods for safe medicament transport.
CN103599577A (en) * 2013-12-03 2014-02-26 上海康德莱企业发展集团医疗器械有限公司 Needleless medication addition infusion positive pressure connector
US9987477B2 (en) 2014-02-10 2018-06-05 Nexus Medical, Llc Split septum assembly for an intravenous injection site
EP3137122B1 (en) 2014-05-02 2019-09-04 Excelsior Medical Corporation Strip package for antiseptic cap
US11628288B1 (en) 2014-07-14 2023-04-18 Merit Medical Systems, Inc. Disinfecting cap for needleless injection sites
DE102014213947A1 (en) 2014-07-17 2016-01-21 B. Braun Melsungen Ag Closure device for a fluid system for medical purposes
WO2016044821A1 (en) 2014-09-19 2016-03-24 Children's Medical Center Corporation Apparatuses for cleaning catheter ports
CA2967015C (en) 2014-11-07 2023-02-28 C.R. Bard, Inc. Connection system for tunneled catheters
DK3223902T3 (en) 2014-11-24 2022-01-24 Merit Medical Systems Inc DISINFECTING CAP FOR MEDICAL CONNECTORS
CN104353148B (en) * 2014-11-25 2016-10-05 上海康德莱企业发展集团医疗器械有限公司 A kind of Needleless dosing transfusion positive-pressure joint
CN104758997A (en) * 2015-04-17 2015-07-08 南通恒泰医疗器材有限公司 Integrated micro-resistance needle-free anti-counterflow infusion positive pressure connector
JP6822978B2 (en) 2015-05-08 2021-01-27 アイシーユー・メディカル・インコーポレーテッド Medical connector configured to accept the emitter of a therapeutic agent
KR102593070B1 (en) 2015-05-22 2023-10-23 프레제니우스 카비 도이치란트 게엠베하 Connection assembly for conducting a medical liquid
US11883364B2 (en) 2015-05-22 2024-01-30 Fresenius Kabi Deutschland Gmbh Connection assembly for directing a medical liquid
US10780260B2 (en) 2015-06-23 2020-09-22 The Johns Hopkins University Sterile connection luer access device
US10888496B2 (en) 2015-09-17 2021-01-12 Corvida Medical, Inc. Medicament vial assembly
US10195415B2 (en) 2015-09-21 2019-02-05 Carefusion 303, Inc. Priming device
EP3359242B1 (en) * 2015-10-08 2023-12-06 Colder Products Company Reusable aseptic fluid couplings
AU2016339958B2 (en) 2015-10-13 2021-03-18 J&J SOLUTIONS, INC. d/b/a Corvida Medical Automated compounding equipment for closed fluid transfer system
EP3377420A4 (en) 2015-11-16 2019-07-10 Merit Medical Systems, Inc. Disinfecting cap for male luers
EP3405231A4 (en) 2016-01-19 2019-10-16 Daniel Py Single use connectors
WO2017124169A1 (en) 2016-01-21 2017-07-27 Kardium Inc. Medical device flushing systems and methods
DE102016203519B4 (en) 2016-03-03 2023-10-05 B. Braun Melsungen Aktiengesellschaft Valve body and connection device for a medical infusion system
EP3525865B1 (en) 2016-10-14 2022-10-12 ICU Medical, Inc. Sanitizing caps for medical connectors
US10603481B2 (en) 2017-01-27 2020-03-31 Merit Medical Systems, Inc. Disinfecting luer cap and method of use
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
CA3073550A1 (en) 2017-08-23 2019-02-28 C.R. Bard, Inc. Catheter assemblies and methods thereof
EP3691741A4 (en) 2017-10-04 2021-07-28 Merit Medical Systems, Inc. Disinfecting cap for valved connectors and method of use
EP3790617B1 (en) * 2018-05-10 2023-10-11 Kardium Inc. Catheter sheath devices
EP3569282A1 (en) * 2018-05-16 2019-11-20 Codan Holding GmbH Valve with prefabricated compressed dilatable opening
JP6779254B2 (en) * 2018-05-16 2020-11-04 カルメル ファルマ アクチボラゲット Placement in medical connector equipment
CN108837224B (en) * 2018-07-16 2021-02-02 青岛市精神卫生中心(青岛市第七人民医院、青岛市心理咨询中心) Liquid medicine delivery device capable of preventing backflow
US11602619B2 (en) 2018-10-05 2023-03-14 Biosense Webster (Israel) Ltd. Coupling assembly for variable diameter surgical instrument
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11433215B2 (en) 2018-11-21 2022-09-06 Icu Medical, Inc. Antimicrobial device comprising a cap with ring and insert
DE102019000248A1 (en) * 2019-01-15 2020-07-16 Sartorius Stedim Biotech Gmbh Connector and method for sterile connection
CN111255967B (en) * 2020-01-14 2022-03-29 华为技术有限公司 Liquid plug connector, liquid plug assembly and equipment interconnection system
US11872357B2 (en) 2020-11-09 2024-01-16 Agile Devices, Inc. Devices for steering catheters
WO2022102300A1 (en) * 2020-11-12 2022-05-19 テルモ株式会社 Medical connector
CN114177408A (en) * 2021-12-08 2022-03-15 江苏采纳医疗科技有限公司 Adjustable needleless infusion joint
WO2023132965A1 (en) * 2022-01-06 2023-07-13 Entegris, Inc. Aseptic coupling assembly and method of aseptic coupling

Citations (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756740A (en) * 1954-04-30 1956-07-31 William V Deane Drinking device for hospital patients
US2847995A (en) * 1954-08-23 1958-08-19 Becton Dickinson Co Transfusion needle sheath
US2999499A (en) * 1958-07-11 1961-09-12 Cutter Lab Flexible check valve
US3171412A (en) * 1956-06-15 1965-03-02 Brann Bernd Container for biological liquids
US3193154A (en) * 1961-05-17 1965-07-06 Frank T Johmann Closure means
US3385301A (en) * 1965-10-11 1968-05-28 American Hospital Supply Corp Balloon catheter having a deformable one-way inflation valve
US3570484A (en) * 1967-08-31 1971-03-16 Eschmann Bros & Walsh Ltd Intravenous valve assembly
US3726282A (en) * 1971-09-30 1973-04-10 Kendall & Co Inflation valve for catheter retention balloon
US3788519A (en) * 1971-03-01 1974-01-29 Eastman Kodak Co Apparatus for piercing a container
US3831629A (en) * 1972-01-24 1974-08-27 Halkey Roberts Corp Check valve
US3965910A (en) * 1975-04-28 1976-06-29 Walpak Company Urinary irrigation valve
US3986508A (en) * 1973-08-22 1976-10-19 Abcor, Inc. Sterilizable, medical connector for blood processing
US4243034A (en) * 1978-10-17 1981-01-06 Viggo Ab Cannula or catheter assembly
US4324239A (en) * 1980-06-20 1982-04-13 Whitman Medical Corp. Safety valve for preventing air embolism and hemorrhage
US4334551A (en) * 1979-04-30 1982-06-15 Becton Dickinson & Company Connector
US4512766A (en) * 1982-12-08 1985-04-23 Whitman Medical Corporation Catheter valve
US4610469A (en) * 1983-02-02 1986-09-09 Steritech B.V. Connector assembly for sterile connection or two internally sterile containers of tubings
US4666429A (en) * 1986-02-26 1987-05-19 Intelligent Medicine, Inc. Infusion device having improved valving apparatus
US4804015A (en) * 1985-12-20 1989-02-14 Steridose Systems Ab Connection device avoiding contamination
US4874377A (en) * 1988-05-26 1989-10-17 Davis Newgard Revocable Family Living Trust Self-occluding intravascular cannula assembly
US4915687A (en) * 1989-02-17 1990-04-10 Sivert George A Needleless injection port arrangement
US4917668A (en) * 1988-03-18 1990-04-17 B.. Braun Melsungen Ag Valve for permanent venous cannulae or for catheter insertion means
US5006114A (en) * 1990-04-20 1991-04-09 Rogers Bobby E Medical valve assembly
US5041067A (en) * 1988-07-20 1991-08-20 Agri-Fab, Inc. Differential gearing transmission
US5049128A (en) * 1990-02-06 1991-09-17 Duquette Irene A Valved infusion port
US5061253A (en) * 1988-11-14 1991-10-29 Nissho Corporation Fluid-communicating device with valve function
US5065783A (en) * 1990-09-20 1991-11-19 George Braddock Ogle, II Valve with self-sealing internal cannula
US5122123A (en) * 1991-01-30 1992-06-16 Vaillancourt Vincent L Closed system connector assembly
US5147333A (en) * 1991-05-13 1992-09-15 Burron Medical Inc. Needleless injection port with automatic backcheck valve
US5154703A (en) * 1990-10-30 1992-10-13 Care Medical Devices, Inc. Bloodless catheter
US5163922A (en) * 1991-04-29 1992-11-17 Charles E. McElveen, Jr. Dual-valved connector for intravenous systems
US5201717A (en) * 1990-12-05 1993-04-13 Philip Wyatt Safety enclosure
US5203775A (en) * 1990-09-18 1993-04-20 Medex, Inc. Needleless connector sample site
US5221271A (en) * 1991-08-15 1993-06-22 Medex, Inc. Sample site with flow directors
US5242432A (en) * 1991-09-26 1993-09-07 Ivac Needleless adapter
US5242393A (en) * 1992-06-18 1993-09-07 Becton, Dickinson And Company Valved blunt cannula injection site
US5253842A (en) * 1992-07-30 1993-10-19 Lab Products, Inc. Quick disconnect water valve assembly
US5255676A (en) * 1991-11-08 1993-10-26 Russo Ronald D Safety sealed tracheal suction system
US5280876A (en) * 1993-03-25 1994-01-25 Roger Atkins Limited restriction quick disconnect valve
US5293902A (en) * 1993-06-07 1994-03-15 Tif Instruments, Inc. Quick-disconnect fluid coupling
US5295657A (en) * 1992-06-04 1994-03-22 Vernay Laboratories, Inc. Medical coupling site valve body
US5306265A (en) * 1991-12-13 1994-04-26 Hospal, Ltd. Sampling and infusion connector for an extracorporeal blood circulation line
US5322518A (en) * 1991-04-27 1994-06-21 B. Braun Melsungen Ag Valve device for a catheter
US5342316A (en) * 1991-02-14 1994-08-30 Wallace Henry G Resealable sampling port
US5342326A (en) * 1993-09-22 1994-08-30 B. Braun Medical, Inc. Capless medical valve
US5348542A (en) * 1993-05-05 1994-09-20 Joseph P. Padula Holder for percutaneously introduced tubes
US5353837A (en) * 1986-03-04 1994-10-11 Deka Products Limited Partnership Quick-disconnect valve
US5360413A (en) * 1991-12-06 1994-11-01 Filtertek, Inc. Needleless access device
US5380306A (en) * 1991-11-25 1995-01-10 Vygon Unitary composite connector for a liquid circuit, in particular for medical applications
US5401245A (en) * 1993-11-26 1995-03-28 Haining; Michael L. Medical connector with valve
US5407437A (en) * 1991-07-23 1995-04-18 Bent Heimreid Closure of a medicament well
US5417673A (en) * 1993-01-13 1995-05-23 Medex, Inc. Whole blood sample needleless sample site
US5439451A (en) * 1994-03-22 1995-08-08 B. Braun Medical, Inc. Capless medical backcheck valve
US5470319A (en) * 1994-06-20 1995-11-28 Critical Device Corporation Needleless injection site
US5480393A (en) * 1993-07-02 1996-01-02 Bommarito; Alexander A. Needle free access adapter
US5501426A (en) * 1992-06-04 1996-03-26 Vernay Laboratories, Inc. Medical coupling site valve body
US5509433A (en) * 1993-10-13 1996-04-23 Paradis; Joseph R. Control of fluid flow
US5520665A (en) * 1992-09-07 1996-05-28 Bespak Plc Connecting apparatus for medical conduits
US5533708A (en) * 1992-06-04 1996-07-09 Vernay Laboratories, Inc. Medical coupling site valve body
US5533996A (en) * 1994-08-24 1996-07-09 Baxter International, Inc. Transfer set connector with permanent, integral cam opening closure and a method of using the same
US5535785A (en) * 1994-09-08 1996-07-16 Nypro, Inc. Luer-activated check valve
US5535771A (en) * 1994-08-10 1996-07-16 Becton, Dickinson And Company Valved PRN adapter for infusion devices
US5540661A (en) * 1994-05-03 1996-07-30 Medex, Inc. Needleless valve having a covalently bonded lubricious coating
US5549566A (en) * 1994-10-27 1996-08-27 Abbott Laboratories Valved intravenous fluid line infusion device
US5549651A (en) * 1994-05-25 1996-08-27 Lynn; Lawrence A. Luer-receiving medical valve and fluid transfer method
US5549577A (en) * 1993-12-29 1996-08-27 Ivac Corporation Needleless connector
US5555908A (en) * 1995-06-23 1996-09-17 Becton, Dickinson And Company Valved PRN adapter for medical access devices
US5569235A (en) * 1994-06-21 1996-10-29 Modern Medical Devices Valve and valved container for use with a syringe fitting
US5577706A (en) * 1995-10-25 1996-11-26 King; Robert J. Water faucet with automatic shut-off mechanism for water conservation
US5578059A (en) * 1993-11-30 1996-11-26 Medex, Inc. Anti-reflux valve with environmental barrier
US5603706A (en) * 1992-09-29 1997-02-18 Wyatt; Philip Infusion apparatus
US5620434A (en) * 1994-03-14 1997-04-15 Brony; Seth K. Medicine vial link for needleless syringes
US5676346A (en) * 1995-05-16 1997-10-14 Ivac Holdings, Inc. Needleless connector valve
US5730418A (en) * 1996-09-30 1998-03-24 The Kipp Group Minimum fluid displacement medical connector
US5749861A (en) * 1996-02-26 1998-05-12 Industrie Borla S.P.A. Connector with protection valve for medical infusion/transfusion lines and the like
US5806831A (en) * 1993-10-13 1998-09-15 Paradis; Joseph R. Control of fluid flow with internal cannula
US5820601A (en) * 1994-06-20 1998-10-13 Critical Device Corporation Needleless injection site
US5836923A (en) * 1994-06-20 1998-11-17 Critical Device Corp. Needleless injection site with fixed flow rate
US5839715A (en) * 1995-05-16 1998-11-24 Alaris Medical Systems, Inc. Medical adapter having needleless valve and sharpened cannula
US5882348A (en) * 1997-02-03 1999-03-16 Sorenson Critical Care, Inc. Valved manifold
US5967490A (en) * 1997-01-08 1999-10-19 Vadus, Inc. Catheter hubs having a valve
US6009902A (en) * 1997-11-12 2000-01-04 Westinghouse Air Brake Company Dual valve fitting for enabling quick measurement of pressure
US6029946A (en) * 1997-09-15 2000-02-29 Tiva Medical Inc. Needleless valve
US6036171A (en) * 1997-09-17 2000-03-14 Halkey-Roberts Corporation Swabbable valve assembly
US6050978A (en) * 1997-05-09 2000-04-18 Becton Dickinson And Company Needleless valve connector
US6063062A (en) * 1997-04-18 2000-05-16 Paradis; Joseph R. Universal luer activatable and swabbable antireflux valve
US6079432A (en) * 1996-07-02 2000-06-27 Paradis; Joseph R. Control of fluid flow by oval shaped valve member containing a cam interface
US6089541A (en) * 1998-09-10 2000-07-18 Halkey-Roberts Corporation Valve having a valve body and a deformable stem therein
US6113068A (en) * 1998-10-05 2000-09-05 Rymed Technologies Swabbable needleless injection port system having low reflux
US6117114A (en) * 1998-05-07 2000-09-12 Paradis; Joseph R. Swabbable needleless valve adaptations
US6170800B1 (en) * 1993-11-19 2001-01-09 Novoste Corporation Automatic fluid control valve
US6245048B1 (en) * 1996-12-16 2001-06-12 Icu Medical, Inc. Medical valve with positive flow characteristics
US6428520B1 (en) * 1996-12-16 2002-08-06 Icu Medical, Inc. Positive-flow valve
US20030050610A1 (en) * 2001-08-22 2003-03-13 Newton Brian L. Medical valve with expandable member
US6616130B2 (en) * 2000-09-08 2003-09-09 Tokai Rubber Industries, Ltd. Cylindrical vibration-isolating device
US7014169B2 (en) * 2000-10-23 2006-03-21 Nypro Inc. Anti-drawback medical valve
US7100890B2 (en) * 1996-11-18 2006-09-05 Nypro Inc. Swabbable luer-activated valve

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1578517A (en) * 1924-12-23 1926-03-30 George N Hein Valve piston and barrel construction for hypodermic syringes
US2746740A (en) * 1953-01-28 1956-05-22 Surface Combustion Corp Cycle annealing furnace
US3134380A (en) * 1962-02-08 1964-05-26 Thomas A Armao Shielded hypodermic needle
US3352531A (en) * 1964-04-02 1967-11-14 Scovill Manufacturing Co Check valve
US3502097A (en) * 1966-06-08 1970-03-24 Us Catheter & Instr Corp Catheter-infuser connector
US3648684A (en) * 1970-08-04 1972-03-14 Cleora W Barnwell Device for the direct transfer of blood from a human to culture bottles
US3659602A (en) * 1970-12-30 1972-05-02 Nosco Plastics Two component syringe
US3861388A (en) * 1973-07-30 1975-01-21 Robert Lee Vaughn Apparatus for administering supplemental medication with parenteral solutions
DE2340405C3 (en) * 1973-08-09 1978-05-03 Ekkehard 7050 Waiblingen Mohr Process for the treatment of flush and waste water from salt bath hardening shops
US4022205A (en) * 1973-11-05 1977-05-10 Tenczar Francis J Fluid connectors
CA1014278A (en) * 1975-01-24 1977-07-19 Ronald B. Hunter Seating cushion
US4005710A (en) * 1975-02-12 1977-02-01 Abbott Laboratories Parenteral apparatus with one-way valve
US4076285A (en) * 1975-08-01 1978-02-28 Erika, Inc. Laminar flow connector for conduits
US4019512A (en) * 1975-12-04 1977-04-26 Tenczar Francis J Adhesively activated sterile connector
LU77252A1 (en) * 1976-05-06 1977-08-22
US4079738A (en) * 1976-09-20 1978-03-21 Sorenson Research Co., Inc. Needle restraining apparatus
US4080965A (en) * 1976-09-30 1978-03-28 Baxter Travenol Laboratories, Inc. In-line cannula valve assembly
US4078285A (en) * 1976-10-28 1978-03-14 Xerox Corporation Hard alloy fuser members
US4143853A (en) * 1977-07-14 1979-03-13 Metatech Corporation Valve for use with a catheter or the like
US4191183A (en) * 1977-10-31 1980-03-04 Barry Mendelson Mixing chamber for use in plural medical liquid intravenous administration set
US4133441A (en) * 1978-03-23 1979-01-09 Baxter Travenol Laboratories, Inc. Injection site
US4187846A (en) * 1978-06-22 1980-02-12 Union Carbide Corporation Sterile connectors
US4508367A (en) * 1979-01-09 1985-04-02 Oreopoulos Dimitrios G Connector
US4306705A (en) 1979-01-22 1981-12-22 Svensson Jan A Slide valve and coupler assembly
US4257416A (en) * 1979-05-03 1981-03-24 David Prager Multi-channel venipuncture infusion set
US4328802A (en) * 1980-05-14 1982-05-11 Survival Technology, Inc. Wet dry syringe package
US4810241A (en) * 1980-06-09 1989-03-07 Rogers Phillip P Ambulatory dialysis system and connector
US4439188A (en) * 1980-09-15 1984-03-27 Baxter Travenol Laboratories, Inc. Tube connector
US4329987A (en) * 1980-11-21 1982-05-18 Thomas Derrill Rogers Subclavian intravenous clamp
US4439193A (en) * 1982-02-19 1984-03-27 Abbott Laboratories Apparatus for connecting medical liquid containers
US4432759A (en) * 1982-04-26 1984-02-21 Abbott Laboratories Connecting device for medical liquid containers
US4432765A (en) * 1982-07-14 1984-02-21 Oscarsson Rolf A Attachment device for medical fluids bag
US4511359A (en) * 1982-09-29 1985-04-16 Manresa, Inc. Sterile connection device
US4449693A (en) * 1982-09-30 1984-05-22 Gereg Gordon A Catheter check valve
US5199947A (en) * 1983-01-24 1993-04-06 Icu Medical, Inc. Method of locking an influent line to a piggyback connector
CA1215945A (en) * 1983-03-20 1986-12-30 Bengt Gustavsson Fluid transfer system
US4604015A (en) * 1984-03-08 1986-08-05 Mccord Heat Transfer Corporation Means for retaining a radiator rigid
US4645494A (en) * 1985-10-22 1987-02-24 Renal Systems, Inc. Peritoneal device system
DE3681158D1 (en) * 1986-04-11 1991-10-02 Braun Melsungen Ag INJECTION SHUT-OFF VALVE.
CH670955A5 (en) 1986-09-08 1989-07-31 Contempo Products Two=part coupling for medical liq. exchange - has sleeves with chambers, each contg. tube, and elastic component in second chamber
CH672363A5 (en) * 1986-09-29 1989-11-15 Contempo Products
US4725267A (en) * 1987-05-06 1988-02-16 Vaillancourt Vincent L Post-injection needle sheath
US4813938A (en) * 1987-09-17 1989-03-21 Raulerson J Daniel Catheter introduction syringe
EP0309426A3 (en) * 1987-09-25 1991-04-03 INDUSTRIE BORLA S.p.A. A gas-tight closure device for the connecting ends of tubes for biomedical fluid-transporting apparatus, particularly haemodialysis lines, which are sterilised by means of sterilising gas
US4882348A (en) * 1987-12-29 1989-11-21 Smithkline Beckman Corporation 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
US5100394A (en) * 1988-01-25 1992-03-31 Baxter International Inc. Pre-slit injection site
CA1335167C (en) * 1988-01-25 1995-04-11 Steven C. Jepson Pre-slit injection site and associated cannula
US4832214A (en) * 1988-03-18 1989-05-23 Schrader Jerome W Glowing baby bottle nipple collar
US5041087A (en) * 1988-08-11 1991-08-20 Loo George D H Needle-less parenteral fluid injector
JPH02131221A (en) * 1988-11-11 1990-05-21 Pioneer Electron Corp Photoconduction type liquid crystal light valve
IT1229245B (en) * 1989-05-09 1991-07-26 Mazzucchelli King Plasti ANTI-THEFT DEVICE FOR ITEMS EQUIPPED WITH AT LEAST ONE BAR ELEMENT, IN PARTICULAR GLASSES
US4998927A (en) * 1989-08-18 1991-03-12 Vaillancourt Vincent L Connector
US4998713A (en) * 1990-01-10 1991-03-12 Vaillancourt Vincent L Needle connector
US5049126A (en) * 1990-02-16 1991-09-17 Isg/Ag Breast pump with nipple stimulating insert
US5206861A (en) * 1990-08-28 1993-04-27 International Business Machines Corporation System timing analysis by self-timing logic and clock paths
CZ149294A3 (en) * 1991-12-18 1994-11-16 Icu Medical Inc Medicinal valve
US5284475A (en) * 1992-07-21 1994-02-08 Mackal Glenn H Luer valve adapter with expandable end
US5290254A (en) * 1992-11-16 1994-03-01 Vaillancourt Vincent L Shielded cannula assembly
US5269771A (en) 1993-02-24 1993-12-14 Thomas Medical Products, Inc. Needleless introducer with hemostatic valve
US5296657A (en) * 1993-04-16 1994-03-22 Usm Corporation Method of sound-deadening for vehicles
US5398530A (en) * 1993-07-15 1995-03-21 Derman; Jay S. Electrical cord locking device
US5699821A (en) 1993-10-13 1997-12-23 Paradis; Joseph R. Control of fluid flow
US5487731A (en) * 1994-02-22 1996-01-30 Wolfe Tory Medical, Inc. Esophageal intubation detector with indicator
US5609584A (en) * 1994-05-18 1997-03-11 Gettig Technologies, Inc. Adaptor system for use with a syringe
US5616130A (en) * 1994-06-20 1997-04-01 Nima Enterprises, Inc. Needleless injection site
US6183448B1 (en) * 1994-06-20 2001-02-06 Bruno Franz P. Mayer Needleless injection site
US5552118A (en) * 1994-07-22 1996-09-03 Critical Device Corporation Needleless vacuum container port system
US5620424A (en) * 1995-06-26 1997-04-15 Abramson; Daniel J. Device for preventing catheter related infection
US5662615A (en) * 1995-09-01 1997-09-02 Blake, Iii; Joseph W. Valve and valve cartridge for trocar
US5738663A (en) 1995-12-15 1998-04-14 Icu Medical, Inc. Medical valve with fluid escape space
US5700248A (en) 1995-12-15 1997-12-23 Icu Medical, Inc. Medical valve with tire seal
US5817069A (en) 1996-02-28 1998-10-06 Vadus, Inc. Valve assembly
US5678346A (en) * 1996-05-24 1997-10-21 Kellett; Keith Craige Multi-use decoy
AU732833B2 (en) * 1997-05-20 2001-05-03 Baxter International Inc. Needleless connector
US6159192A (en) * 1997-12-04 2000-12-12 Fowles; Thomas A. Sliding reconstitution device with seal
DE29807803U1 (en) 1998-04-30 1998-07-30 Wu Jean Ton Hose coupling
BR9910754A (en) * 1998-05-29 2001-07-03 Lawrence A Lynn Luer receiver and fluid transfer method
US6706022B1 (en) * 1999-07-27 2004-03-16 Alaris Medical Systems, Inc. Needleless medical connector with expandable valve mechanism
US6695817B1 (en) * 2000-07-11 2004-02-24 Icu Medical, Inc. Medical valve with positive flow characteristics
ES2569996T3 (en) * 2001-01-24 2016-05-13 Becton Dickinson And Company Elastomeric partition with polymeric coating
US6543745B1 (en) * 2001-10-09 2003-04-08 Halkey-Roberts Corporation Male luer valve
US6871838B2 (en) * 2003-04-03 2005-03-29 B. Braun Medical Inc. Injection port valve

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756740A (en) * 1954-04-30 1956-07-31 William V Deane Drinking device for hospital patients
US2847995A (en) * 1954-08-23 1958-08-19 Becton Dickinson Co Transfusion needle sheath
US3171412A (en) * 1956-06-15 1965-03-02 Brann Bernd Container for biological liquids
US2999499A (en) * 1958-07-11 1961-09-12 Cutter Lab Flexible check valve
US3193154A (en) * 1961-05-17 1965-07-06 Frank T Johmann Closure means
US3385301A (en) * 1965-10-11 1968-05-28 American Hospital Supply Corp Balloon catheter having a deformable one-way inflation valve
US3570484A (en) * 1967-08-31 1971-03-16 Eschmann Bros & Walsh Ltd Intravenous valve assembly
US3788519A (en) * 1971-03-01 1974-01-29 Eastman Kodak Co Apparatus for piercing a container
US3726282A (en) * 1971-09-30 1973-04-10 Kendall & Co Inflation valve for catheter retention balloon
US3831629A (en) * 1972-01-24 1974-08-27 Halkey Roberts Corp Check valve
US3986508A (en) * 1973-08-22 1976-10-19 Abcor, Inc. Sterilizable, medical connector for blood processing
US3965910A (en) * 1975-04-28 1976-06-29 Walpak Company Urinary irrigation valve
US4243034A (en) * 1978-10-17 1981-01-06 Viggo Ab Cannula or catheter assembly
US4334551A (en) * 1979-04-30 1982-06-15 Becton Dickinson & Company Connector
US4324239A (en) * 1980-06-20 1982-04-13 Whitman Medical Corp. Safety valve for preventing air embolism and hemorrhage
US4512766A (en) * 1982-12-08 1985-04-23 Whitman Medical Corporation Catheter valve
US4610469A (en) * 1983-02-02 1986-09-09 Steritech B.V. Connector assembly for sterile connection or two internally sterile containers of tubings
US4804015A (en) * 1985-12-20 1989-02-14 Steridose Systems Ab Connection device avoiding contamination
US4666429A (en) * 1986-02-26 1987-05-19 Intelligent Medicine, Inc. Infusion device having improved valving apparatus
US5353837A (en) * 1986-03-04 1994-10-11 Deka Products Limited Partnership Quick-disconnect valve
US4917668A (en) * 1988-03-18 1990-04-17 B.. Braun Melsungen Ag Valve for permanent venous cannulae or for catheter insertion means
US4874377A (en) * 1988-05-26 1989-10-17 Davis Newgard Revocable Family Living Trust Self-occluding intravascular cannula assembly
US5041067A (en) * 1988-07-20 1991-08-20 Agri-Fab, Inc. Differential gearing transmission
US5061253A (en) * 1988-11-14 1991-10-29 Nissho Corporation Fluid-communicating device with valve function
US4915687A (en) * 1989-02-17 1990-04-10 Sivert George A Needleless injection port arrangement
US5049128A (en) * 1990-02-06 1991-09-17 Duquette Irene A Valved infusion port
US5006114A (en) * 1990-04-20 1991-04-09 Rogers Bobby E Medical valve assembly
US5203775A (en) * 1990-09-18 1993-04-20 Medex, Inc. Needleless connector sample site
US5065783A (en) * 1990-09-20 1991-11-19 George Braddock Ogle, II Valve with self-sealing internal cannula
US5154703A (en) * 1990-10-30 1992-10-13 Care Medical Devices, Inc. Bloodless catheter
US5201717A (en) * 1990-12-05 1993-04-13 Philip Wyatt Safety enclosure
US5122123A (en) * 1991-01-30 1992-06-16 Vaillancourt Vincent L Closed system connector assembly
US5342316A (en) * 1991-02-14 1994-08-30 Wallace Henry G Resealable sampling port
US5322518A (en) * 1991-04-27 1994-06-21 B. Braun Melsungen Ag Valve device for a catheter
US5163922A (en) * 1991-04-29 1992-11-17 Charles E. McElveen, Jr. Dual-valved connector for intravenous systems
US5147333A (en) * 1991-05-13 1992-09-15 Burron Medical Inc. Needleless injection port with automatic backcheck valve
US5407437A (en) * 1991-07-23 1995-04-18 Bent Heimreid Closure of a medicament well
US5221271A (en) * 1991-08-15 1993-06-22 Medex, Inc. Sample site with flow directors
US5242432A (en) * 1991-09-26 1993-09-07 Ivac Needleless adapter
US5255676A (en) * 1991-11-08 1993-10-26 Russo Ronald D Safety sealed tracheal suction system
US5380306A (en) * 1991-11-25 1995-01-10 Vygon Unitary composite connector for a liquid circuit, in particular for medical applications
US5360413A (en) * 1991-12-06 1994-11-01 Filtertek, Inc. Needleless access device
US5306265A (en) * 1991-12-13 1994-04-26 Hospal, Ltd. Sampling and infusion connector for an extracorporeal blood circulation line
US5501426A (en) * 1992-06-04 1996-03-26 Vernay Laboratories, Inc. Medical coupling site valve body
US5295657A (en) * 1992-06-04 1994-03-22 Vernay Laboratories, Inc. Medical coupling site valve body
US5533708A (en) * 1992-06-04 1996-07-09 Vernay Laboratories, Inc. Medical coupling site valve body
US5242393A (en) * 1992-06-18 1993-09-07 Becton, Dickinson And Company Valved blunt cannula injection site
US5253842A (en) * 1992-07-30 1993-10-19 Lab Products, Inc. Quick disconnect water valve assembly
US5520665A (en) * 1992-09-07 1996-05-28 Bespak Plc Connecting apparatus for medical conduits
US5603706A (en) * 1992-09-29 1997-02-18 Wyatt; Philip Infusion apparatus
US5417673A (en) * 1993-01-13 1995-05-23 Medex, Inc. Whole blood sample needleless sample site
US5280876A (en) * 1993-03-25 1994-01-25 Roger Atkins Limited restriction quick disconnect valve
US5348542A (en) * 1993-05-05 1994-09-20 Joseph P. Padula Holder for percutaneously introduced tubes
US5293902A (en) * 1993-06-07 1994-03-15 Tif Instruments, Inc. Quick-disconnect fluid coupling
US5480393A (en) * 1993-07-02 1996-01-02 Bommarito; Alexander A. Needle free access adapter
US5342326A (en) * 1993-09-22 1994-08-30 B. Braun Medical, Inc. Capless medical valve
US5806831A (en) * 1993-10-13 1998-09-15 Paradis; Joseph R. Control of fluid flow with internal cannula
US5509433A (en) * 1993-10-13 1996-04-23 Paradis; Joseph R. Control of fluid flow
US6170800B1 (en) * 1993-11-19 2001-01-09 Novoste Corporation Automatic fluid control valve
US5401245A (en) * 1993-11-26 1995-03-28 Haining; Michael L. Medical connector with valve
US5578059A (en) * 1993-11-30 1996-11-26 Medex, Inc. Anti-reflux valve with environmental barrier
US5549577A (en) * 1993-12-29 1996-08-27 Ivac Corporation Needleless connector
US5620434A (en) * 1994-03-14 1997-04-15 Brony; Seth K. Medicine vial link for needleless syringes
US5439451A (en) * 1994-03-22 1995-08-08 B. Braun Medical, Inc. Capless medical backcheck valve
US5540661A (en) * 1994-05-03 1996-07-30 Medex, Inc. Needleless valve having a covalently bonded lubricious coating
US5549651A (en) * 1994-05-25 1996-08-27 Lynn; Lawrence A. Luer-receiving medical valve and fluid transfer method
US5616129A (en) * 1994-06-20 1997-04-01 Nima Enterprises, Inc. Needleless injection site
US5820601A (en) * 1994-06-20 1998-10-13 Critical Device Corporation Needleless injection site
US5470319A (en) * 1994-06-20 1995-11-28 Critical Device Corporation Needleless injection site
US5836923A (en) * 1994-06-20 1998-11-17 Critical Device Corp. Needleless injection site with fixed flow rate
US5569235A (en) * 1994-06-21 1996-10-29 Modern Medical Devices Valve and valved container for use with a syringe fitting
US5535771A (en) * 1994-08-10 1996-07-16 Becton, Dickinson And Company Valved PRN adapter for infusion devices
US5533996A (en) * 1994-08-24 1996-07-09 Baxter International, Inc. Transfer set connector with permanent, integral cam opening closure and a method of using the same
US5535785A (en) * 1994-09-08 1996-07-16 Nypro, Inc. Luer-activated check valve
US5549566A (en) * 1994-10-27 1996-08-27 Abbott Laboratories Valved intravenous fluid line infusion device
US5839715A (en) * 1995-05-16 1998-11-24 Alaris Medical Systems, Inc. Medical adapter having needleless valve and sharpened cannula
US5676346A (en) * 1995-05-16 1997-10-14 Ivac Holdings, Inc. Needleless connector valve
US5555908A (en) * 1995-06-23 1996-09-17 Becton, Dickinson And Company Valved PRN adapter for medical access devices
US5577706A (en) * 1995-10-25 1996-11-26 King; Robert J. Water faucet with automatic shut-off mechanism for water conservation
US5749861A (en) * 1996-02-26 1998-05-12 Industrie Borla S.P.A. Connector with protection valve for medical infusion/transfusion lines and the like
US6079432A (en) * 1996-07-02 2000-06-27 Paradis; Joseph R. Control of fluid flow by oval shaped valve member containing a cam interface
US5730418A (en) * 1996-09-30 1998-03-24 The Kipp Group Minimum fluid displacement medical connector
US7100890B2 (en) * 1996-11-18 2006-09-05 Nypro Inc. Swabbable luer-activated valve
US6932795B2 (en) * 1996-12-16 2005-08-23 Icu Medical, Inc. Positive flow valve
US6428520B1 (en) * 1996-12-16 2002-08-06 Icu Medical, Inc. Positive-flow valve
US6245048B1 (en) * 1996-12-16 2001-06-12 Icu Medical, Inc. Medical valve with positive flow characteristics
US5967490A (en) * 1997-01-08 1999-10-19 Vadus, Inc. Catheter hubs having a valve
US5882348A (en) * 1997-02-03 1999-03-16 Sorenson Critical Care, Inc. Valved manifold
US6063062A (en) * 1997-04-18 2000-05-16 Paradis; Joseph R. Universal luer activatable and swabbable antireflux valve
US6050978A (en) * 1997-05-09 2000-04-18 Becton Dickinson And Company Needleless valve connector
US6029946A (en) * 1997-09-15 2000-02-29 Tiva Medical Inc. Needleless valve
US6036171A (en) * 1997-09-17 2000-03-14 Halkey-Roberts Corporation Swabbable valve assembly
US6009902A (en) * 1997-11-12 2000-01-04 Westinghouse Air Brake Company Dual valve fitting for enabling quick measurement of pressure
US6117114A (en) * 1998-05-07 2000-09-12 Paradis; Joseph R. Swabbable needleless valve adaptations
US6089541A (en) * 1998-09-10 2000-07-18 Halkey-Roberts Corporation Valve having a valve body and a deformable stem therein
US6113068A (en) * 1998-10-05 2000-09-05 Rymed Technologies Swabbable needleless injection port system having low reflux
US6616130B2 (en) * 2000-09-08 2003-09-09 Tokai Rubber Industries, Ltd. Cylindrical vibration-isolating device
US7014169B2 (en) * 2000-10-23 2006-03-21 Nypro Inc. Anti-drawback medical valve
US20030050610A1 (en) * 2001-08-22 2003-03-13 Newton Brian L. Medical valve with expandable member

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8221391B2 (en) 2000-07-11 2012-07-17 Icu Medical, Inc. Needleless medical connector
US7763199B2 (en) 2000-07-11 2010-07-27 Icu Medical, Inc. Method of making a seal having slit formed therein
US9238129B2 (en) 2000-07-11 2016-01-19 Icu Medical, Inc. Medical connector
US8870850B2 (en) 2000-07-11 2014-10-28 Icu Medical, Inc. Medical connector
US8444628B2 (en) 2000-07-11 2013-05-21 Icu Medical, Inc. Needleless medical connector
US10213532B2 (en) 2003-11-20 2019-02-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Portable hand pump for evacuation of fluids
US9907887B2 (en) 2003-11-20 2018-03-06 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Portable hand pump for evacuation of fluids
US9393353B2 (en) 2003-11-20 2016-07-19 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Portable hand pump for evacuation of fluids
US8636721B2 (en) 2003-11-20 2014-01-28 Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Portable hand pump for evacuation of fluids
US9295764B2 (en) 2004-10-12 2016-03-29 C. R. Bard, Inc. Corporeal drainage system
US9913935B2 (en) 2004-10-12 2018-03-13 C. R. Bard, Inc. Corporeal drainage system
US10946123B2 (en) 2004-10-12 2021-03-16 Merit Medical Systems, Inc. Corporeal drainage system
US8337475B2 (en) 2004-10-12 2012-12-25 C. R. Bard, Inc. Corporeal drainage system
US7824393B2 (en) 2004-11-05 2010-11-02 Icu Medical, Inc. Medical connector having high flow rate characteristics
US9884176B2 (en) 2004-11-05 2018-02-06 Icu Medical, Inc. Medical connector
US11883623B2 (en) 2004-11-05 2024-01-30 Icu Medical, Inc. Medical connector
US10722698B2 (en) 2004-11-05 2020-07-28 Icu Medical, Inc. Medical connector
US9186494B2 (en) 2004-11-05 2015-11-17 Icu Medical, Inc. Medical connector
US8177772B2 (en) 2005-09-26 2012-05-15 C. R. Bard, Inc. Catheter connection systems
US8235971B2 (en) 2005-09-26 2012-08-07 C. R. Bard, Inc. Catheter connection systems
US20070255229A1 (en) * 2006-04-11 2007-11-01 Kane Jeffrey F Medical valve with resilient sealing member
US8002755B2 (en) 2006-04-11 2011-08-23 Nypro Inc. Anti-drawback medical valve and method
US7879012B2 (en) 2006-04-11 2011-02-01 Nypro Inc. Medical valve with resilient sealing member
US7815168B2 (en) 2006-04-11 2010-10-19 Nypro Inc. Medical valve with rotating member and method
US20070235676A1 (en) * 2006-04-11 2007-10-11 Vangsness Todd S Anti-Drawback medical valve and method
US7857284B2 (en) 2006-04-11 2010-12-28 Nypro Inc. Medical valve with movable member
US8105314B2 (en) 2006-10-25 2012-01-31 Icu Medical, Inc. Medical connector
US9533137B2 (en) 2006-10-25 2017-01-03 Icu Medical, Inc. Medical connector
US8398607B2 (en) 2006-10-25 2013-03-19 Icu Medical, Inc. Medical connector
US8628515B2 (en) 2006-10-25 2014-01-14 Icu Medical, Inc. Medical connector
US9259565B2 (en) 2009-06-22 2016-02-16 Np Medical Inc. Medical valve with improved back-pressure sealing
US9849274B2 (en) 2009-06-22 2017-12-26 Np Medical Inc. Medical valve with improved back-pressure sealing
US10744314B2 (en) 2009-06-22 2020-08-18 Np Medical Inc. Medical valve with improved back-pressure sealing
US8568371B2 (en) 2009-06-22 2013-10-29 Np Medical Inc. Medical valve with improved back-pressure sealing
US9205243B2 (en) 2010-05-17 2015-12-08 Icu Medical, Inc. Medical connectors and methods of use
US9750926B2 (en) 2010-05-17 2017-09-05 Icu Medical, Inc. Medical connectors and methods of use
US11071852B2 (en) 2010-05-17 2021-07-27 Icu Medical, Inc. Medical connectors and methods of use
US9192753B2 (en) 2010-05-17 2015-11-24 Icu Medical, Inc. Medical connectors and methods of use
US8758306B2 (en) 2010-05-17 2014-06-24 Icu Medical, Inc. Medical connectors and methods of use
US10195413B2 (en) 2010-05-17 2019-02-05 Icu Medical, Inc. Medical connectors and methods of use
US9138572B2 (en) 2010-06-24 2015-09-22 Np Medical Inc. Medical valve with fluid volume alteration
WO2015006495A1 (en) * 2013-07-12 2015-01-15 Carefusion 303, Inc. Check valve system
AU2014287212B2 (en) * 2013-07-12 2018-08-16 Carefusion 303, Inc. Check valve system
EP3019214A4 (en) * 2013-07-12 2017-03-22 CareFusion 303, Inc. Check valve system
US10369349B2 (en) 2013-12-11 2019-08-06 Icu Medical, Inc. Medical fluid manifold
US11364372B2 (en) 2013-12-11 2022-06-21 Icu Medical, Inc. Check valve
USD849939S1 (en) 2014-12-03 2019-05-28 Icu Medical, Inc. Fluid manifold
USD890335S1 (en) 2014-12-03 2020-07-14 Icu Medical, Inc. Fluid manifold
USD826400S1 (en) 2014-12-03 2018-08-21 Icu Medical, Inc. Fluid manifold
USD793551S1 (en) 2014-12-03 2017-08-01 Icu Medical, Inc. Fluid manifold
USD786427S1 (en) 2014-12-03 2017-05-09 Icu Medical, Inc. Fluid manifold
US11344318B2 (en) 2016-07-18 2022-05-31 Merit Medical Systems, Inc. Inflatable radial artery compression device

Also Published As

Publication number Publication date
CN1172727C (en) 2004-10-27
AU7736198A (en) 1998-07-15
WO1998026835A1 (en) 1998-06-25
CA2275218A1 (en) 1998-06-25
DE69739948D1 (en) 2010-09-09
US20020147431A1 (en) 2002-10-10
NO992904D0 (en) 1999-06-14
US6428520B1 (en) 2002-08-06
US6932795B2 (en) 2005-08-23
IL130482A0 (en) 2000-06-01
US20060200090A1 (en) 2006-09-07
HK1026155A1 (en) 2000-12-08
US20050222541A1 (en) 2005-10-06
US20060264849A1 (en) 2006-11-23
CN1915451A (en) 2007-02-21
JP2001506156A (en) 2001-05-15
NZ336284A (en) 2001-05-25
US20060206061A1 (en) 2006-09-14
CN1246073A (en) 2000-03-01
US20060200088A1 (en) 2006-09-07
CA2275218C (en) 2008-10-14
ATE475451T1 (en) 2010-08-15
AU737266B2 (en) 2001-08-16
NO992904L (en) 1999-08-11
EP0956088B1 (en) 2010-07-28
CN1768871A (en) 2006-05-10
EP0956088A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
US6932795B2 (en) Positive flow valve
EP2585162B1 (en) Medical valve with fluid volume alteration
US7717884B2 (en) Medical valve and method of use
US9468749B2 (en) Closed male luer device for minimizing leakage during connection and disconnection
US6325782B1 (en) Medical valve with fluid escape space
JP5086811B2 (en) Self-sealing male connector device with foldable body
US7938805B2 (en) Radially compressible blood control valve
JP2001516626A (en) Needleless valve
NZ543493A (en) Self-sealing male connector typically for medical intravenous application
AU2004216652B2 (en) Positive flow valve
AU774532B2 (en) Positive flow valve

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION